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CHAPTER I 
INTRODUCTION 
In 1979 a symposium was organized in Utrecht, called "New 
Criteria for Antimicrobial Chemotherapy : Maintenance of Digestive 
Tract Colonization Resistance" (1). In this symposium a strong plea 
was made to give preference to antimicrobial agents that do not 
disturb the anaerobic flora that provides colonization resistance (CR) 
against potentially pathogenic aerobic flora. In this way the risk of 
provoking superinfections by antimicrobial therapy would be 
eliminated. Moreover, administration of antimicrobial agents that 
attain high concentrations in the digestive tract while sparing the 
anaerobic flora that provides CR, would offer a method of long-
term antimicrobial prophylaxis in high risk patients. This method 
was called "selective decontamination". Successful application of 
selective decontamination in neutropenic patients had been reported 
since 1977 (2), but (surprisingly) the method was not applied in 
other groups of patients at high risk of infections. 
At that time we did already depend heavily on co-trimoxazole and 
doxycycline in our hospital, not because they would spare CR, but 
because they were cheap and rather effective. In case of serious 
infections with Gram-negative bacilli we used cefotaxime, but in the 
lowest dosage calculated to be effective (3). So, in general our 
antibiotic policy was in agreement with the recommendations given 
by van der Waaij (1). The major difference was that there was no 
active policy to restrict the use of penicillins and clindamycin. 
In 1983, at a symposium in Brussels, successful application of 
selective decontamination in mechanically ventilated patients was 
reported (4). At about that time dr. H. Clasener, who had worked 
with dr. R. van Saene in Groningen, started working in our hospital 
as a microbiologist and tried to convince everyone of the importance 
of the concept of CR as a guideline for antibiotic policy. We agreed 
that it would be justified to propose selective decontamination for 
neutropenic patients and for patients on mechanical ventilation in our 
hospital. However, because the Groningen-regimen was very 
expensive, we devised an alternative regimen, which was more than 
ten times cheaper (5). The favourable results we obtained with this 
alternative regimen in both kinds of patients (6, 7) strongly increased 
our conviction that the concept of CR was an important hypothesis 
for the selection of antimicrobial agents. 
In the mean time we had started extensive study and lengthy 
discussions of available literature concerning this topic, resulting in 
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three review articles (8, 9, 10). The last of these is chapter II of this 
thesis. It summarizes our points of view in about 1988. Although 
our opinions have changed considerably since then, this review has 
been included in the thesis because it describes the historical back-
ground of the concept of CR. 
Charmed by the concept of CR, we wanted to restrict as much as 
possible the use of antibiotics that disturb this mechanism of defense. 
However, the experiments on which the classification of antibiotics 
by van der Waaij depended, had been performed in mice only. The 
extrapolation of the doses used in mice to the comparable dosage in 
man seemed rather speculative. Especially the suggestion that some 
antibiotics would be "safe at any dosage" met our suspicion. 
Therefore, we decided to start this kind of investigations in man. In 
the first two studies (chapters III and IV) we used the conventional 
study design, which investigates the influence of antibiotics on the 
median concentration of aerobic flora in a group of individuals. We 
used volunteers in stead of patients, because CR may also be 
influenced by disease (chapter II). All volunteers were treated with 
one drug that was believed to impair CR (positive control), with one 
drug that was believed to spare CR (negative control), and with one 
or two drugs for which we (or the sponsoring company) wanted to 
establish the influence on CR. Although we presumed that microbial 
CR is provided exclusively by obligate anaerobic flora, we analysed 
aerobic flora only, because the composition of the anaerobic flora 
that provides CR is unknown and most anaerobic species cannot be 
cultured. Moreover, it cannot be excluded that CR can be impaired 
by a decrease of the production of inhibiting substances, despite 
unchanged concentration of the anaerobic flora that provides CR. 
Therefore, we decided to restrict ourselves to investigation of the 
impact of administration of antimicrobial agents on the concentration 
of aerobic flora of the digestive tract (which is the clinically 
important event anyhow). 
Originally, we investigated microbial concentrations both in saliva 
and in faeces. However, because we did not observe an increase in 
the concentration of Gram-negative bacilli or yeasts in saliva 
following antimicrobial agents that did increase the concentration of 
those micro-organisms in faeces, only faeces was analyzed in sub-
sequent investigations. Probably, demonstration of impairment of 
CR in volunteers is easier in faeces than in saliva, because in the 
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oropharynx other factors than anaerobic flora, for example the 
presence of fibronectin (see chapter II) or of alpha-haemolytic 
streptococci (11), are the dominant factors in CR against Gram-
negative bacilli and yeasts. 
The results of the first two studies were according to our 
expectations concerning the influence of the antimicrobial agents on 
the faecal concentration of Gram-negative bacilli and yeasts. 
Unexpectedly, low-level colonization by other Gram-negative bacilli 
than Escherichia coli (secondary colonization) appeared to be facili-
tated by agents like roxithromycin and doxycyclin, although the total 
faecal concentrations of Gram-negative bacilli, of enterococci and of 
yeasts did not demonstrate disturbance of CR following those agents. 
This posed the problem whether increase of secondary colonization 
is a more sensitive indicator of disturbance of the anaerobic flora 
that provides CR than the faecal concentration of aerobic flora, or 
that selective reduction of the concentration of E. coli enables low-
level colonization by other species of Gram-negative bacilli 
("substitution colonization"). 
After publication of those studies we realized ourselves new 
problems concerning the interpretation of the data. For example, 
following amoxycillin the concentration of Gram-negative bacilli and 
yeasts increased, but the concentration of enterococci decreased. The 
obvious explanation for this decrease, is that the volunteers did not 
harbour or acquire resistant enterococci. However, this implied that 
the decrease of Gram-negative bacilli observed following erythromy-
cin, roxithromycin, co-trimoxazole, doxycycline and cefaclor could 
also be explained by absence of sufficiently resistant Gram-negative 
bacilli. Therefore, the absence of a spontaneous increase of the con-
centration of Gram-negative bacilli following those agents did not 
prove that they spare the anaerobic flora that provides CR. We con-
cluded that the methodology should be improved by inclusion of a 
challenge with resistant micro-organisms. We hesitated to do so, 
however, because we heard that one of the volunteers of van Saene 
in Groningen had developed haemorrhagic colitis after ingestion of a 
Klebsiella oxytoca challenge strain during adminstration of 
amoxycillin. 
A possible alternative for the use of challenge strains, was the faecal 
concentration of bèta-aspartylglycine, which increases when CR is 
impaired. However, this is a rather insensitive indicator of impair-
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ment of CR, and we did not dispose of the required analytical equip-
ment. Therefore we became interested in work of Midvedt, who 
studied the influence of antimicrobial agents on the concentration of 
several substances in faeces of laboratory animals. It appeared that 
the faecal concentration of urobilinogen decreased strongly following 
agents that (in our opinion) disturbed CR, and not following agents 
that did not. Therefore the faecal concentration of urobilinogen 
might be useful as a substitute for challenge with resistant micro-
organisms in our investigations. 
In chapter V we describe our study of the influence of four 
antibiotics on the faecal concentration of urobilinogen. The data 
confirmed the idea that major impairment of CR (following clinda-
mycin or dicloxacillin), strongly decreases the faecal concentration 
of urobilinogen. However, though not statistically significant (P = 
0.08), the concentration of urobilinogen also decreased following 
norfloxacin, which was considered not to impair CR. This might 
indicate that the urobilinogen-method was not sensitive enough to 
achieve statistical significance for a possible minor disturbance of 
CR following norfloxacin. In our view, this could only be investi-
gated by returning to the original idea of using a resistant challenge 
strain. At that time we made regular surveillance cultures of faeces 
of an 85 year old diabetic patient in a nursing home, who was on 
continuous prophylaxis with norfloxacin 200 mg once daily for the 
prevention of urinary tract infections. Following 9 months of 
prophylaxis, this patient became colonized with a strain of Klebsiella 
pneumoniae, highly resistant to norfloxacin and amoxycillin, but 
very sensitive to co-trimoxazole and cefotaxime. Due to delays in 
communication, the patient was colonized for more than one month, 
in a concentration of about 10* cfu/gram faeces, before we started 
administration of Colistin in order to eliminate this strain. Because 
high level colonization of the bowel in this old, diabetic patient did 
not cause her any problems, we considered it unlikely that this strain 
would cause problems in healthy volunteers. So we started adminis-
tration of this strain to ourselves in increasing dosages, in order to 
study the rate of elimination from the bowel before and during 
administration of antibiotics. In this way we lost our fear for the use 
of a challenge with antibiotic-resistant micro-organisms. It can even 
be argued that adminstration of resistant challenge strains during 
treatment with antimicrobial agents is safer than eating food, 
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especially salads, because this contains Gram-negative bacilli with an 
unknown susceptibility profile. 
The challenge strain was used in a study in which we compared the 
influence on CR of amoxycillin and of oral and parenteral 
Pefloxacin. The results of these studies have been published in 
combination with new studies with amoxycillin (chapter VI), and 
Pefloxacin (chapter X). 
Another problem with the conventional methodology is that the data 
are analyzed for the whole group of volunteers. We realized that this 
is not logical, because the antibiotic susceptibility-profile of the 
anaerobic flora is not necessarily the same in all volunteers. 
Therefore, the influence of antimicrobial agents on CR may differ 
between volunteers. Actually, this might have been the explanation 
for our observation that some of the volunteers in the first 
amoxycillin-study did not show the expected increase in the faecal 
concentration of Gram-negative bacilli (chapter III). We concluded 
that we needed a method for statistical analysis of the data in each 
volunteer separately. This appeared to be a problem. The statis-
ticians we approached stated that statistical analysis of data in 
individuals is impossible. A few months later however, one of the 
pharmacists in our hospital told me that he had discussed this issue 
with a statistician he knew, who assured him that statistical analysis 
on data of individuals is possible indeed, though it is rarely practised 
in medical studies. In this way dr. H. Wynne (from the Centre for 
Biostatistics, State University of Utrecht) made an essential 
contribution to the development of our study design, by making it 
possible to analyze the data in individual volunteers in subsequent 
studies. 
The method of single person analysis enabled us to study the 
correlation between five different possible indicators of disturbance 
of CR in subsequent studies : The faecal concentration 1) of Gram-
negative bacilli, 2) of aerobic Gram-positive cocci, 3) of yeasts, 4) 
of spontaneously acquired secondary Gram-negative bacilli (spon-
taneous challenge) and 5) of the challenge strain administered 
intentionally. As a working hypothesis, we supposed that impair-
ment of the anaerobic flora that provides CR would cause an 
increase in indicators 1), 2) and 3), if resistant species are present 
or are acquired during the period of antibiotic-administration. 
Further, we expected that indicator 4) might be fai se-negative due to 
6 
the absence of resistant strains and false-positive due to "substitution 
colonization", and that indicator 5) would be the most reliable and 
most sensitive indicator of impairment of the anaerobic flora that 
provides CR. 
The results of a new study with amoxycillin (chapter VI), demon-
strated that the indicators 4) and 5) may also be false-negative due to 
competition between different species of Gram-negative bacilli. If 
for example amoxycillin disturbs CR in a volunteer, but his strain of 
E. coli is resistant to amoxycillin, this E. coli will grow out. If this 
occurs fast enough, E. coli may occupy all the increased "space" for 
Gram-negative bacilli that came available due to disturbance of CR, 
and may prevent secondary colonization by Gram-negative bacilli 
acquired spontaneously (indicator 4) or administered intentionally 
(indicator 5). The result of the challenge may also be negative 
because the challenge strain may loose the competition with 
secondary Gram-negative bacilli acquired before adminstration of the 
intentional challenge. Therefore, indicators 1) - 3) are more reliable 
indicators of the influence of an antimicrobial agent on CR than 
indicators 4) and 5), if Gram-negative bacilli resistant to that agent 
are prevalent. If such strains are rare however, as is the case with 
cefotaxime, facilitation of colonization by the challenge strain is a 
very reliable and possibly the most sensitive indicator of impairment 
of CR against bacteria (chapter VII). 
As discussed before, the results in chapters III and IV suggested that 
it might be possible that selective elimination of E. coli (that is 
without impairing anaerobic flora) might allow low-level 
colonization by secondary Gram-negative bacilli ("substitution 
colonization"). In order to investigate whether this is true, resistant 
challenge strains should be administered after selective elimination 
of E. coli. However, because the anaerobic flora that provides CR is 
unknown, absence of impairment of this flora can not be proven. 
So, the only way to study the consequences of "selective" 
elimination of indigenous Gram-negative bacilli (mostly E. coli) is 
the administration of the lowest effective dosage of an agent that has 
a large difference between minimal inhibitory concentration (MIC) 
against Gram-negative bacilli on one hand, and against the most 
susceptible (known) species of anaerobic bacteria on the other hand. 
For this, quinolones are prime candidates. In a pilot trial we had 
found indications that the diffusible faecal concentration of 
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Pefloxacin is about equal to the microbiologically active 
concentration in the bowel, and that a dosage of 800 mg daily results 
in an active faecal concentration of about 160 mg/gram (chapter XI). 
Therefore we decided to eliminate indigenous Gram-negative bacilli 
in our volunteers with a dosage of 20 mg Pefloxacin daily, in order 
to achieve a diffusible faecal concentration of 4 mg pefloxacin/g 
faeces (chapter IX). This study showed that spontaneous absence of 
indigenous Gram-negative bacilli (as occurred in one volunteer), or 
elimination of E. coli and other indigenous Gram-negative bacilli 
from faeces, did not facilitate colonization of the bowel by a resis­
tant challenge strain. Hence, if the phenomenon exists at all, sub­
stitution colonization does not occur easily. Therefore, it is our 
present view that increase of low-level secondary colonization is 
suggestive evidence for impairment of the anaerobic flora that 
provides CR. 
Our studies confirmed the idea that impairment of the anaerobic CR-
flora may cause a simultaneous increase in the faecal concentration 
of Gram-negative bacilli, aerobic Gram-positive cocci and yeasts (in­
dicators 1-3), if resistant species are present. However, contrary to 
our hypothesis, this appeared not to be invariably so. In four of five 
volunteers with significant disturbance of the CR against aerobic 
Gram-positive cocci and yeasts following cefotaxime, the faecal 
concentration of a highly resistant challenge strain did not exceed the 
pretreatment concentration of indigenous Gram-negative bacilli 
(chapter VII), and one volunteer with significant disturbance of CR 
against Gram-negative bacilli and aerobic Gram-positive cocci 
following clindamycin, did not experience any increase of the faecal 
concentration of yeasts (chapter IX). At present, the explanation for 
these observations is unknown. It might indicate that there is some 
selectivity of anaerobic species concerning their inhibiting action on 
groups of aerobic flora. It is also possible that other factors than 
microbial CR played a role, for example secretion of antibodies or 
lack of important nutrients for certain micro-organisms in the bowel 
of some volunteers. 
The study in chapter IX demonstrated that colonization of the bowel 
by E. coli от other Gram-negative bacilli, is not required for CR 
against yeasts or against streptococci and enterococci. So, "selective 
decolonization" of faeces from Gram-negative bacilli is possible. 
However, our original conviction that agents like cephradine, co-
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trimoxazole, doxycycline, cefotaxime and quinolones do not impair 
CR is not right. The fact that these agents cause less overgrowth by 
resistant Gram-negative bacilli than amoxycillin is due to their 
superior activity against Gram-negative bacilli, and not to absence of 
impairment of anaerobic flora. These agents are unmasked, if the 
faecal concentrations of enterococci, yeasts or resistant challenge 
strains are analyzed. 
Our studies indicate that most or all of the presently available anti­
microbial agents disturb microbial CR when administered in standard 
dosage. So, the original purpose of our studies, id est discovering 
antibiotics that do not disturb CR, has not been achieved. However, 
we improved the study design for investigation of the influence of 
antimicrobial agents on CR. With this study design we could demon­
strate that elimination of indigenous Gram-negative bacilli from 
faeces does not impair CR. Hence it is possible to use antimicrobial 
prophylaxis or therapy without increasing the risk of superinfections. 
Therefore the search for antimicrobial agents that do not impair CR 
should continue. 
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Abstract 
Infections in humans are most often caused by aerobic micro-organ-
isms colonizing the digestive tract. Aerobic micro-organisms are 
constantly entering the digestive tract with food, but colonization is 
resisted by autochthonous anaerobic flora (microbial colonization 
resistance) and by host-related factors (physiological colonization 
resistance). Antibiotics to which the autochthonous anaerobic flora is 
susceptible and that achieve sufficiently high concentrations at the 
sites of colonization will reduce colonization resistance (CR). 
Consequently, resistant aerobic flora of the digestive tract may reach 
high concentrations, increasing the risk of superinfection. Therefore, 
when choosing antimicrobial agents for therapy, the effect on CR 
should be taken into account. 
Immune-suppressed hosts and patients undergoing mechanical venti-
lation can be protected from serious infections by eliminating the 
most dangerous species of the aerobic indigenous flora, leaving CR 
intact. This is called selective decolonization. This article 
summarizes the effect of antimicrobial agents on CR 
Introduction 
Normal indigenous intestinal flora may be divided into 
autochthonous flora, consisting of anaerobes in high concentrations, 
and potentially pathogenic flora, consisting of aerobes in much lower 
concentrations. The concentration of potentially pathogenic aerobes 
is kept low by the anaerobic flora, annihilation of which may permit 
an enormous increase of potentially pathogenic micro-organisms in 
the intestine (1). The idea that the autochthonous anaerobic flora 
keeps the aerobic indigenous flora under control explains why anti-
biotics that disturb autochthonous anaerobic flora cause the 
occurrence of superinfections. This may also provide an explanation 
for the success of prophylaxis of endogenous infections in neutro-
penic patients by oral trimethoprim/sulfamethoxazole (not affecting 
anaerobes) although a combination of gentamicin and vancomycin 
(eliminating anaerobes) fails due to faecal overgrowth of resistant 
Gram-negative bacilli (1). 
Concomitant with the growing understanding of why some anti-
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biotics are not effective for long-term use, new antibiotics have been 
developed that do not lead to faecal overgrowth. The indication for 
long-term prophylaxis of endogenous infections might be extended 
from leukopenia to other populations (e.g., patients on mechanical 
ventilation), (2), and therefore it is useful to summarize available 
data. 
Colonization of the digestive tract and 
pathogenicity of the normal flora 
After birth, the skin and mucous membranes are colonized by large 
numbers of many different species of micro-organisms, which con-
stitute the normal human flora (3). The gastrointestinal tract is 
extensively populated by aerobic and anaerobic bacteria. The oro-
pharynx and the colon are colonized by the highest concentration of 
micro-organisms. Saliva contains about 10' anaerobic and 10* 
aerobic micro-organisms per millilitre. Faeces contain about 10" 
aerobic and 107 aerobic micro-organisms per gram. The following 
review of normal gastrointestinal flora is necessary to understand the 
concept of CR. 
anaerobes 
Anaerobes of the gastrointestinal tract rarely produce endogenous 
infections, even when resistance to infection is markedly reduced. 
However, infection may occur in the event of pulmonary aspiration 
or intestinal surgery. The most common anaerobic species colonizing 
the colon (Bacteroides spp., 10" organisms per gram of faeces) are 
also the most frequent causes of anaerobic infections following lower 
gastrointestinal surgery. 
The colon harbours more than 400 different anaerobic species (4). 
Most of these are present in much lower concentrations than 
Bacteroides. Therefore they cannot be isolated by terminal dilution 
and special selective media are required. Moreover, anaerobic 
culture does not exclude most aerobic species, like Escherichia coli 
and enterococci, because these are facultative anaerobes. Because of 
these technical problems, knowledge of the anaerobic flora of the 
digestive tract is incomplete 
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aerobes 
Streptococcus viridans is always present in the oropharynx (IO7 
organisms per millilitre of saliva), but rarely causes infections. Only 
in cases of underlying cardiac valvular disease or leukopenia is there 
a risk of endogenous infection. Haemophilus influenzae, Strepto­
coccus pneumoniae, and Branhamella catarrhalis may be frequently 
found in throat cultures (5). If resistance is normal they are not 
pathogenic, but colonization may lead to infection when resistance is 
impaired (6). Staphylococcus aureus colonizes the nasal vestibule in 
many health persons. The nose is the primary source of colonization 
of both skin and intestinal staphylococci (3). S. aureus may be 
involved in early respiratory tract infections in patients with 
nasotracheal intubation for artificial ventilation (7). 
E. coli (IO7 organisms per gram of faeces) is the predominant 
aerobic micro-organism of the lower gastrointestinal tract (8, 9) and 
the major pathogen of urinary tract infections (10). Normally E. coli 
is not found in the oropharynx (11). Other Enterobacteriaceae, such 
as Proteus, Klebsiella, Enterobacter, Citrobacter, and Serratia spp., 
as well as Pseudomonadaceae (e.g., P. aeruginosa) and Acineto-
bacter spp. (secondary aerobic flora) do not normally colonize the 
oropharynx (11) and colonize the intestine only to a small extent (8). 
These bacteria enter the gut in large numbers with food (12), but 
apparently do not displace E. coli as the predominant species in 
healthy subjects. With reduced resistance, colonization of the 
oropharynx (11), intestine (8) and vagina (13) occur, thereby 
increasing the risk of endogenous infections of the respiratory tract 
(14) and the urinary tract (13). Enterococcus colonizes the gut as 
frequently as E. coli but usually in lower concentrations. 
Enterococcus follows E. coli as the second most frequent cause of 
urinary tract infections in hospitalized patients (10). 
Candida albicans occurs in low numbers in many healthy subjects in 
the oropharynx, intestine, and vagina. Local infection, like oral 
thrush or vaginitis, only occurs in patients with reduced anti­
microbial defense. However, "persorption" (passage of viable micro­
organisms through intact gastrointestinal mucosa) has been described 
following ingestion of 10'2 colony-forming units (cfu) of С albicans 
in a healthy volunteer (16). 
Invasive fungal infections may occur in compromised hosts (e.g., 
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neutropenic or transplant patients) secondary to persorption of the 
gastrointestinal mucosa or other mechanisms of entry into the 
systemic circulation (17). 
Colonization Resistance 
Humans ingest millions of micro-organisms with food (12). Under 
normal circumstances these organisms do not persist in the digestive 
tract; however, when extremely large numbers of micro-organisms 
are ingested, they may be detected in the faeces for more than three 
days (1). 
The ability to prevent or limit colonization of the digestive tract by 
micro-organisms is called CR (1). This resistance is mediated by 
numerous anatomic and physiologic factors, including intact mucosa, 
swallowing, salivation, secretion of immunoglobulin A and gastric 
acid, desquamation of cells of the mucous membranes, and normal 
gastrointestinal motility (18). These factors prevent adhesion of 
micro-organisms to mucous membranes and promote rapid gastro-
intestinal transit. CR may be impaired by illness (19), old age (20), 
hospitalization (8), and stress of surgery (21). Patients with these 
impairments more frequently have secondary flora in the oropharynx 
and intestine than do healthy young people. 
The indigenous flora also plays an integral role in CR. In germfree 
mice and in mice that have been pre-treated with certain anti-
microbials (e.g., streptomycin), the oral dose of exogenous micro-
organisms that results in colonization is 1000- to 100,000 fold-less 
than that in untreated controls. Moreover, in mice that have been 
pre-treated with streptomycin and in germfree mice the concentration 
of aerobic Gram-negative challenge strains in faeces becomes 1000-
to 100,000-fold higher than the normal level of E. coli (IO5 organ-
isms per gram). This is followed by migration of viable E. coli from 
the gastrointestinal tract to mesenteric lymph nodes, the spleen, and 
other organs (1). Therefore, inhibition of autochthonous flora by 
antibiotics may decrease the dose of exogenous micro-organisms 
required to colonize the digestive tract and may increase the level of 
potentially pathogenic aerobic flora in the digestive tract. 
Microbial CR has been ascribed to anaerobic flora alone (1), and to 
both anaerobic and aerobic autochthonous flora (22). In germfree 
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mice, oral administration of Shigella flexneri resulted in faecal 
concentrations of 10' organisms per gram. In germfree mice that had 
first been colonized with a cultured mixture of anaerobic bacteria, 
colonization by 5. flexneri was limited to 105 organisms per gram of 
faeces. When E. coli was added to the cultured mixture of 
anaerobes, the faecal concentrations of S. flexneri was limited to 10' 
organisms per gram (24). 
Based upon these studies, which are possible only in germfree 
animals, it appears that the anaerobic flora is the most important part 
of the CR flora, although E. coli may act synergistically with 
anaerobic flora in preventing low-level secondary colonization of the 
bowel with Enterobacteriaceae. 
In order to impair CR, an antibiotic has to be not only effective 
against anaerobic bacteria but also present in sufficiently high 
concentrations in saliva, bile, intestinal mucus secretions, or faeces. 
This occurs when the antibiotic is incompletely absorbed or is 
sufficiently excreted in the digestive tract (25). 
If the anaerobic flora is resistant to the agent in use, the antibiotic 
will not impair CR (26, 27). This might explain the interindividual 
differences observed in the influence of antibiotics on CR. 
In humans also, the CR-flora appears to be mainly anaerobic, based 
on the following observations. Human anaerobic flora restores CR 
against P. aeruginosa in germfree mice (28). Cefoxitin increases the 
level of faecal Enterobacteriaceae, enterococci, and yeasts in human 
volunteers (29). The most plausible explanation for the increase of 
all three groups of aerobic micro-organisms following cefoxitin 
might be suppression of selected anaerobic flora. Quinolones, which 
have little impact on anaerobic flora, eliminate Enterobacteriaceae 
from the bowel and cause a small increase in the faecal concen-
tration of yeasts in some volunteers (30). On the contrary, cefo-
perazone inhibits both anaerobic and aerobic species, resulting in a 
million-fold increase in the concentration of yeasts in the lower 
gastrointestinal tract (29). Clindamycin is effective against 
anaerobes, reaches high faecal concentrations, and strongly impairs 
CR (31). 
Some antimicrobial agents that are effective against anaerobes (e.g. 
tinidazole and cephradine) do not reach the anaerobic flora of the gut 
in inhibitory concentration and therefore do not impair CR (1, 32). 
However, evidence that the CR-flora in humans is anaerobic will 
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remain circumstantial until the precise composition of this flora is 
known. 
Summarizing, we propose the following concept of CR of the lower 
gastrointestinal tract. Normal physiology of the gut limits 
colonization by many micro-organisms. This physiological resistance 
does not prevent colonization of the colon by a large number of 
anaerobic species. The autochthonous anaerobic flora limits 
colonization of the gut by potentially pathogenic micro-organisms 
through an undetermined mechanism. We propose to call this 
mechanism anaerobic microbial CR. The combination of physiologic 
CR and anaerobic microbial CR does not fully prevent colonization 
of the bowel by E. coli and enterococci, yet it limits the 
concentration of these micro-organisms to about 107 cfu per gram of 
faeces. The combination of physiologic CR, anaerobic microbial 
CR, and the presence of indigenous aerobic bacteria in normal 
concentration may limit colonization of the bowel by other aerobic 
micro-organisms (secondary colonization), (9). 
In the oropharynx also, the concentration of aerobic flora may be 
limited by anaerobic micro-organisms (33). 
Superinfections 
From the beginning of the antibiotic era, superinfections have 
represented a failure of treatment that initially seemed successful: 
adequate therapy may eliminate the infecting micro-organism, yet it 
is succeeded by a resistant micro-organism, usually of another 
species. In 1947 Weinstein proposed that superinfections following 
the use of antibiotics are caused by a disturbance of the 
autochthonous flora of the digestive tract (34). This insight did not 
have practical consequences until an animal model was developed by 
which the disturbance could be measured (1). Impairment of CR 
leads to "supercolonization" and subsequent superinfection: (1) New 
aerobic micro-organisms will now colonize the digestive tract, even 
when ingested in low numbers. (2) The aerobic flora (both primary 
and secondary) then reaches abnormally high concentrations. 
Therefore, superinfections will occur with considerable frequency 
after penicillin (especially at higher dosages), methicillin, 
tetracycline, chloramphenicol, and ampicillin. The species causing 
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these endogenous infections have frequently belonged to the 
Enterobacteriaceae, Pseudomonadaceae, or fungi (1). 
An instructive example of the occurrence of superinfections was 
given by Price and Sleigh, who reported an epidemic with ampi-
cillin-resislant Klebsiella aerogenes in a neurosurgical intensive care 
unit (ICU). Infections were noted 12 months after introduction of 
ampicillin and cloxacillin for prophylaxis and therapy. A marked 
increase in the number of patients with Klebsiella colonization was 
also observed. Modernization of the unit, sterilization of all 
equipment, and strict attention to nursing technique provided no 
improvement. After 11 patients had died of meningitis or pneumonia 
caused by this Klebsiella, it was decided to stop all antibiotics, both 
for therapeutic and for prophylactic indications. Soon after discon-
tinuation of antibiotics, the Klebsiella infections resolved and the 
total number of infections within the ICU dropped markedly. The 
frequency of respiratory infections decreased from 45 to 15 percent 
and that urinary tract infections from 21 to 8 percent, leading to a 
threefold decrease in the rate of infection (35). 
The occurrence of some epidemics with antibiotic-resistant strains in 
hospitals might be explained as follows. Widespread use of CR-im-
pairing antibiotics such as ampicillin reduces CR of many patients. 
When these patients are contaminated with antibiotic-resistant micro-
organisms, bacteria may multiply to large numbers, increasing the 
risk of cross-colonization of other patients. In the presence of 
reduced resistance infection may ensue (27). The usual attempts to 
prevent cross-colonization consist mainly of hygienic measures (e.g., 
handwashing, isolation of infected patients, and elimination of 
environmental sources) and are generally unsuccessful (35). Better 
results are obtained by using not only proper hygiene, but also by 
avoiding those antibiotics that impair CR and by selective 
decolonization of high-risk patients (7, 36). 
Occurrence of superinfection following antibiotic therapy is not 
confined to hospitalized patients. The use of oral amoxycillin and 
penicillin was regarded as the cause of an epidemic of resistant 
Salmonella newport infections. In this study, 12 of the 18 patients 
had taken amoxycillin or penicillin so shortly before the outbreak of 
salmonellosis that contamination of the antibiotics with Salmonella 
was initially suspected (37). It was subsequently thought, however, 
that the use of these antimicrobial agents greatly increased the 
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susceptibility to infection due to impairment of CR (38). 
In a prospective double-blind study in a general practice population 
with respiratory infections, the effects of amoxycillin and cefaclor 
on colonization and occurrence of superinfections were compared. In 
the amoxycillin group (72 patients) colonization of the pharynx with 
potentially pathogenic micro-organisms occurred in 30 patients (42 
percent). In the cefaclor group (67 patients) colonization occurred 
with potential pathogens in only 2 patients (3 percent). Super-
infection occurred within six weeks of therapy in five patients in the 
amoxycillin group; no superinfections were observed in the cefaclor 
group (39). Therefore, use of antibiotics that impair CR may result 
in superinfections in general practice. 
Classifying Micro-organisms According To 
Intrinsic Pathogenicity 
On the basis of the above, we may classify micro-organisms into 
three classes: pathogenic, potentially pathogenic, and low- or non-
pathogenic. 
Pathogenic micro-organisms overcome resistance to infection in 
healthy people and may cause epidemics among the normal 
population (diphtheria, pertussis, etc.) Prevention by means of 
vaccination may be indicated. 
Potentially pathogenic micro-organisms cause infections only when 
infection resistance is impaired. The chance of infection is increased 
if organisms are present in high concentrations due to impairment of 
CR. Urinary tract infections are usually caused by E. coli and 
enterococci (primary endogenous flora of the intestine), respiratory 
infection's by S. pneumoniae, H. influenzae, and B. catarrhalis 
(primary endogenous flora of the oropharynx), (40). When CR has 
been impaired, other potentially pathogenic micro-organisms, such 
as Proteus, Klebsiella, Enterobacter, and Pseudomonas spp. 
(secondary endogenous aerobic flora) may colonize the intestine and 
produce infection (secondary endogenous infection), (7,34). 
Low- or non-pathogenic micro-organisms rarely cause infections, 
even if present in relatively large numbers and when resistance to 
infection is impaired. A typical example is the anaerobic flora that is 
autochthonous to the intestinal tract. 
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Selective Decolonization 
Selective decolonization is the elimination of potentially pathogenic 
aerobic flora from the body without disturbing autochthonous 
anaerobic flora. Originally this was called "selective deconta-
mination". However, because "decontamination" suggests the 
elimination of micro-organisms from inanimate objects, we now 
prefer "decolonization" as the term for elimination of micro-
organisms from the body. 
Patients with cytostatic-induced leukopenia have such a serious 
reduction of resistance to infection that they may develop infections 
even in the presence of normal concentrations of primary aerobic 
flora. Initial attempts to protect these patients by suppressing both 
anaerobes and aerobes have failed due to superinfections with micro-
organisms resistant to the suppressive therapy. In view of ob-
servations that nearly all infections in such patients are caused by 
aerobic micro-organisms, and that CR is promoted by the presence 
of autochthonous anaerobic flora, it is logical to attempt selective 
decolonization with antibiotics that eliminate aerobic flora only (1). 
A great number of studies have been published on the effect of 
selective decolonization of the lower digestive tract in leukopenic 
patients. These have been summarized elsewhere, and in general a 
two- to threefold reduction in risk of bacterial infection was found 
(1). Further reduction in risk of infection may be obtained by 
broadening the spectrum of the antibiotic combination used (41). 
Additional improvement may be possible via decolonization of the 
oral cavity, which can be achieved by using sticky oral paste or 
lozenges containing antimicrobial agents (1). The optimal regimen in 
leukopenic patients also requires decolonization of warm meals in a 
magnetron (microwave) oven (1), and exclusion of raw vegetables 
(12). 
A novel application of selective decolonization is long-term 
prophylaxis of infection in patients on artificial ventilation. In these 
patients, the presence of a naso-tracheal cánula reduces resistance to 
colonization of the upper respiratory tract as well as the resistance to 
contamination of the lower respiratory tract. Respiratory infections 
are common in these patients and mortality is high (2). At the 
hospital of the University of Groningen in the Netherlands, selective 
decolonization was employed in these patients, using non-
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absorbable agents. The mouth was decolonized with an oral paste 
containing 2% concentrations of tobramycin, polymyxin B, and am­
photericin B. Gastric and intestinal decolonization were achieved by 
administering the same nonabsorbable antibiotics through a stomach 
tube. In case of infection, only antibiotics that were presumed not to 
impair CR were used. This resulted in a marked decrease in in­
fections due to Enterobacteriaceae. However, early respiratory in­
fections (through day 3) by primary aerobic oropharyngeal flora (S. 
pneumoniae and H. influenzae) and nasopharyngeal flora (5. aureus) 
did not decrease (7). Therefore, in the succeeding patients cefo­
taxime 1 g iv qid was added to the regimen, starting from the time 
of intubation until potentially pathogenic bacteria had been elimi­
nated from the oropharynx, usually within four days. The number of 
early infections was markedly reduced with this regimen. A decrease 
in incidence of infection from 81 to 16 percent among trauma 
patients requiring mechanical ventilation was observed in this study 
(42). 
At the Canisius-Wilhelmina hospital, all patients on artificial 
ventilation are selectively decolonized with a less expensive regimen 
consisting of a mouth paste containing 2% norfloxacin, Colistin and 
amphotericin B, and oral administration of norfloxacin 50 mg qid, 
amphotericin В 500 mg qid, and trimethoprim/sulfamethoxazole 
125/125 mg qid. In an analysis of ongoing surveillance data, it was 
shown that the incidence of infection in patients on artificial 
ventilation was reduced from 75 to 30 percent. The number of 
Gram-negative infections fell six-fold and the incidence of other 
infections did not increase. At both centres septicemia is rare since 
the introduction of selective decolonization (42, 43). 
We performed a prospective three-group randomized trial to assess 
the effect of selective decolonization and systemic antibiotic 
prophylaxis in patients on mechanical ventilation for at least five 
days. Preliminary results have been published. Patients in both 
control groups I (n = 18) and II (n=21) did not receive antibiotic 
prophylaxis, but differed in the antibiotic policy in case of infection. 
Group I received antibiotic therapy known to disturb CR and group 
II was treated with antimicrobials presumed not to disturb CR. 
Patients in group III (n = 17) received a prophylactic antimicrobial 
regimen designed to eliminate Gram-negative bacilli and yeasts from 
the digestive tract from the time of intubation until extubation. The 
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mouth was decolonized with an oral paste containing 2% tobra­
mycin, Colistin, and amphotericin B. One gram of this paste was 
applied to the oral mucosa four times daily. Gastric and intestinal 
decolonization were attempted by administration of Colistin 200 mg, 
norfloxacin 50 mg, and amphotericin В 500 mg qid via the gastric 
tube (gastric suction was discontinued for one hour after 
administration). Systemic antimicrobial prophylaxis in group III 
patients consisted of cefotaxime 500 mg iv tid for five days. 
Fourteen patients in group I (78 percent) and 13 patients in group II 
(62 percent) acquired at least one lower respiratory tract infection, 
with several acquiring more than one. A total of 25 infections were 
observed in the 14 patients in group I and 22 infections in the 13 
patients in group II. Of these 47 infections , 43 (91 percent) were 
preceded by colonization of either the oropharynx, the stomach, or 
both with the causative micro-organisms. In group III, only one 
patient (6 percent) acquired a respiratory tract infection (/>=0.0001). 
This infection (by Serratia marcescens) was not preceded by 
colonization of either the oropharynx or stomach. This study 
confirms the importance of gastrointestinal colonization in the 
etiology of respiratory infections, and the feasibility of preventing 
these infections by means of selective decolonization and short-term 
systemic prophylaxis. 
Classifying Antimicrobial Agents According to Influence on 
Colonization Resistance. 
Data citing the influence of antibiotics on CR are shown in the 
Table. Classification is based on data from healthy volunteers and 
from patients. 
Antibiotics are classified as disturbing CR if studies in volunteers or 
patients show overgrowth of Gram-negative bacilli, enterococci, or 
yeasts, or if superinfections due to these organisms are observed. 
Antibiotics classified as not disturbing CR do not increase the 
concentration of Gram-negative bacilli, enterococci, or yeasts. 
Cefoperazone, for example, eliminates both aerobic Gram-negative 
rods and aerobic Gram-positive cocci from the bowel, but the 
concentration of yeasts is greatly increased (29). This shows that 
cefoperazone decreases CR. Quinolones, on the other hand, 
22 
Table. Classification of antimicrobial agents according to their 
influence on colonization resistance. 
Antimicrobial 
agent (reference) 
Penicillins 
amoxycillin (9,39) 
ampicillin (35) 
benzylpenicillin 
(<3.106units/d, 44) 
(>3.106units/d, 44) 
oxacillin (45) 
pheneticillin (46) 
piperacillin (29) 
Cephalosporins 
cefaclor (5, 46) 
cefoperazone (29) 
cefotaxime 
cefoxitin (29) 
ceftazidime 
ceftriaxone (47) 
cefuroxime 
cephradine 1.5 g/d (1) 
cephradine 6 g/d (1) 
Other agents 
Chlortetracycline (1) 
clindamycin (31) 
Colistin (49) 
doxycycline (26, 46) 
erythromycin (46) 
quinolones (30) 
tetracycline (48) 
co-trimoxazole (1, 46) 
Yes 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
Disturbance of CR" : 
Unknown 
+ 
+ 
+ 
N o 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
colonization resistance 
23 
eliminate aerobic Gram-negative rods from the bowel and yield a 
temporary decrease in the concentration of enterococci. 
The concentration of yeasts is unchanged or only marginally in-
creased (30). Therefore, it is improbable that quinolones disturb 
anaerobic microbial CR. 
The absence of activity against anaerobes might explain the lack of 
effect on CR noted with the sulphonamides, polymyxins, quinolones, 
and trimethoprim. 
Similarly, the anti-anaerobic activity of beta-lactam antimicrobials 
might explain why penicillins and cephalosporins generally affect the 
CR, especially when given in high doses. Cephradine and cefaclor 
are exceptional, probably because they are well-absorbed and are 
eliminated or degraded so rapidly that they do not reach the CR-
flora in the colon and the oropharynx in sufficient concentration. 
However, dosage may be a limiting factor, as it has been shown that 
cephradine 6 g/d disturbs CR in at least 50 percent of patients (1). 
Tobramycin does not disturb CR when administered orally in doses 
of up 300 mg/d (50). Gastrointestinal excretion of tobramycin after 
parenteral administration is low and therefore tobramycin will 
probably not disturb CR when given in this way. Tetracyclines are 
apt to cause superinfections, possibly because of their activity on 
anaerobes together with incomplete absorption. However, a well-
absorbed tetracycline like doxycycline does not disturb CR (26, 46). 
Erythromycin has been used for selective decolonization of the 
intestinal tract and can be used safely for therapy, as can 
roxithromycin (9). 
Tinidazole yields very low concentrations in faeces and does not 
seem to disturb CR when used in low doses, in contrast to 
clindamycin (32). Metronidazole may be comparable with tinidazole 
with respect to its influence on CR. Therefore, nitro-imidazoles are 
the preferred agents for therapy of anaerobic infections. 
Implications for Antibiotic Policy 
Most infections of the respiratory tract are caused by micro-
organisms first colonizing the oropharynx (7, 14), whereas urinary 
tract infections are caused by micro-organisms first colonizing the 
intestinal tract (51) or vagina (13). The risk of infection may 
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increase with the concentration of colonizing micro-organisms. 
Therefore, administration of antibiotics that impair CR should be 
avoided because this may increase the number of superinfections. 
Effective treatment together with elimination of flora at the site of 
colonization will reduce the risk of re-infection (51). Even in the 
presence of normal concentrations of potentially pathogenic micro-
organisms, endogenous infections may occur when infection 
resistance is reduced by disease (e.g., leukopenia) or medical 
interventions (e.g., endotracheal intubation or transurethral 
catheterization). In these clinical settings, development of 
endogenous infections may be prevented by selective decolonization 
(7, 17, 52). For suppression of micro-organisms in the throat, an 
oral paste or lozenge should be used; suppression of gastrointestinal 
flora may be achieved by administering antibiotics by mouth or via 
gastric tube. 
In summary, we recommend the following policy : 
(1) If the effectiveness, toxicity, and price of antibiotics are 
equivalent, an agent that does not impair CR is preferred. 
(2) When possible, use an antibiotic that will both eradicate the 
infection and provide selective decolonization. 
(3) Selective decolonization of the oropharynx and gastrointestinal 
tract is indicated in all patients with markedly reduced resistance to 
infection. 
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Abstract 
We investigated the influence of oral administration of amoxycillin, 
erythromycin and roxithromycin on colonization resistance (CR) in 
healthy volunteers. Antibiotics were administered in a randomized 
cross-over design. 
No effect on the CR of the oropharynx could be demonstrated. 
Amoxycillin decreased the CR of the bowel against Gram-negative 
bacilli and yeasts, whose median concentration in faeces increased 
100-fold and 30-fold respectively. Roxithromycin and erythromycin 
decreased the concentration of Gram-negative bacilli in faeces. 
Secondary colonization with Gram-negative bacilli was detected as 
often following roxithromycin as following amoxycillin, but the 
level of colonization with these bacteria was much higher following 
amoxycillin. 
Following roxithromycin and erythromycin the level of secondary 
colonization did not exceed the original concentration of Gram-
negative bacilli, showing that these antibiotics did not decrease the 
CR against Gram-negative bacilli. 
The appearance of secondary colonization in faeces at levels equal to 
or lower than the concentration of Gram-negative bacilli before 
administration of antibiotics, should not be regarded as proof of 
disturbance of CR. 
Introduction 
As early as 1947, it was suggested that superinfections following the 
administration of streptomycin and penicillin are caused by their 
influence on the microbial flora of the digestive tract (1). It was 
later noted that some antibiotics caused tremendous overgrowth of 
minor microbial groups of the intestinal flora, increasing the total 
aerobic flora by 100-fold to 1000-fold (2). In mice, oral strepto-
mycin greatly increases susceptibility to intestinal colonization and 
subsequent infection by salmonellae (3, 4). 
From studies of the effect of oral penicillin, tetracycline and chlor-
amphenicol on the composition of the faecal flora of mice, and from 
morphological studies of the gut of germ-free mice, it was concluded 
that the normal intestinal flora is made up of two completely 
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different classes of micro-organisms : (1) autochthonous symbiotic 
flora consisting of anaerobic bacteria in high numbers, and (2) 
potentially pathogenic flora consisting of aerobic bacteria in much 
lower, variable numbers. The autochthonous flora is essential for 
normal development of the gut, and has a protective function by li-
miting the number of potentially pathogenic micro-organisms (5, 6). 
In 1971, the limiting action of autochthonous flora on the potentially 
pathogenic flora was rediscovered and named CR (7). Antimicrobial 
agents that decrease CR promote superinfections in two ways : (1) 
by lowering the dose of potentially pathogenic micro-organisms that 
is required for colonization of the intestinal tract, and (2) by 
allowing potentially pathogenic micro-organisms to attain high 
concentrations in the digestive tract. 
Antimicrobial agents that do not decrease CR have been used for a 
method of long-term prophylaxis of endogenous infections in leuko-
penia and in mechanical ventilation, called 'selective deconta-
mination' (8). This method consists of elimination of the digestive 
tract as a source of potentially pathogenic micro-organisms, while 
sparing the autochthonous flora. 
Although new antimicrobial agents appear abundantly, there is still a 
shortage of those that do not affect CR, not only for selective 
decontamination, but also for antimicrobial therapy that does not 
provoke superinfections. 
Therefore we took the opportunity to test the effect of roxithromycin 
on CR. Roxithromycin resembles erythromycin which has been 
claimed to be useful in selective decontamination (9). Apart from 
use in selective decontamination, roxithromycin might be useful for 
therapy of respiratory infections. In mice roxithromycin and ery-
thromycin do not affect CR (10). 
In our study roxithromycin is compared with erythromycin and with 
amoxycillin, which may decrease CR (11, 12). 
Influence of antimicrobial agents on CR can be studied best by 
measurement of their effects on the concentration of potentially 
pathogenic micro-organisms, because the anaerobic flora responsible 
for CR is still unknown. 
In this study, increase in the faecal concentration of Gram-negative 
bacilli will be considered as the most important indication of 
decrease of CR. Other parameters thought possibly useful are the 
appearance of Gram-negative bacilli in the oropharynx and the 
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appearance of new species of Gram-negative bacilli in faeces, 
referred to as secondary colonization. 
Studies in healthy volunteers are to be preferred, because CR may 
also be decreased by illness, (13, 14). A cross-over design was 
chosen to compensate for interindividual differences in CR. 
Methods 
Study design 
Healthy volunteers received one of the three study drugs, in a 
randomized cross-over study design, for seven days. This was 
followed by a 21-day wash-out period, after which the next 
treatment with another of the study drugs started. 
Oropharyngeal gargling samples (20 ml physiological saline) and 
faecal samples were taken on the morning of day 1 (before the first 
antibiotic dose), 4, 8, 15, 22 and 29. In the week before the start of 
the study two extra samples were taken, at days -7 and -4. 
Permission for this study was obtained from the ethics committee of 
the Canisius-Wilhelmina Hospital. 
Volunteers 
Twelve healthy normal volunteers (four female, eight male), aged 23 
to 49 (median 36) participated in the study. Written informed 
consent was obtained. The volunteers had not used antibiotics for at 
least one month before the start of the study. 
Drugs 
Amoxycillin (Clamoxyl, Beecham) 500 mg capsules were ad-
ministered three times daily. Erythromycin stéarate (Erythrocine, 
Abbott) 500 mg tablets were administered twice daily. 
Roxithromycin (Roussel) 150 mg tablets were administered twice 
daily. All drugs were given at the end of a meal. 
Bacteriology 
Serial 1/10 dilutions of faeces were made in Thioglycollate medium 
(BBL). One-microlitre volumes of each dilution were inoculated on 
to solid media, selective for, respectively, Gram-negative bacilli 
(Eosin-methylene-blue lactose sucrose agar, Merck) ; for enterococci 
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(5% sheep blood in blood agar base (Oxoid) with nalidixic acid 50 
mg/1) ; for Staphylococcus aureus (Mannitol salt agar (bio-
Merieux); and for yeasts (Sabouraud dextrose agar (Gibco) with 
chloramphenicol 125 mg/1. The solid selective media were also 
inoculated with 100-microlitre volumes of the first 1/10 dilution of 
faeces. Concentrations were expressed as the logarithms to the base 
of 10 of the counts per gram of faeces, rounded up or down to 
whole numbers. 
Gargling fluids were inoculated in volumes of 100 microliter on the 
selective media. 
Micro-organisms isolated were identified and antibiotic sensitivity 
profiles were determined by standard laboratory methods. 
Statistics 
Friedman's test was employed to evaluate the differences in concen-
tration of micro-organisms in faeces following administration of 
antibiotics 
Results 
Two volunteers missed one study period because of intercurrent 
illness. They were excluded from evaluation. 
Gargling fluid 
Yeasts were never detected in gargling fluid samples of four 
volunteers, and in 2, 2, 3, 5, 9, and 15 of 18 samples in the other 
volunteers. No relation with administration of antibiotics was 
detected, except in one volunteer, who had four positive cultures 
following amoxycillin and roxithromycin each, out of 9/18 positive 
cultures. 
S. aureus was never detected in gargling fluid samples of four 
volunteers and in 1, 4, 4, 7, 8 and 13 of 18 samples in the other 
volunteers. No relation with antibiotic administration was observed. 
Gram-negative bacilli were detected in gargling fluid samples of 
only two volunteers in 5 and 8/18 samples respectively. No relation 
with antibiotic administration was observed. 
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Faeces 
Yeasts 
The median count of yeasts was 102 cfu/g (range < 102 cfu/g - 105 
cfu/g). No differences were seen following adminstration of 
erythromycin (P = 0.57) and roxithromycin (P = 0.73), but 
following amoxycillin an increase to 1035 at day 8 (P < 0.001) was 
observed. 
S. aureus 
S. aureus was detected in 15/180 faecal samples. No relation with 
antibiotics could be found. 
Enterococci 
Enterococci were present in a median count of 105 cfu/g (range 102 
cfu/g - 10" cfu/g). They were suppressed to a level of 1033 cfu/g on 
day 8 by erythromycin (P = 0.02) and amoxycillin (P = 0.09), but 
not by roxithromycin (P = 0.98). 
Gram-negative bacilli 
1. Total level of colonization in faeces. 
During administration of amoxycillin the median concentration of 
Gram-negative bacilli increased from 10' cfu/g before administration 
to 10' cfu/g following one week of amoxycillin (P < 0.01, Figure 
1). The concentration of Gram-negative bacilli in faeces increased in 
eight volunteers and remained unchanged in two volunteers. 
Erythromycin and roxithromycin decreased the median concentration 
of Gram-negative bacilli from 107 cfu/g to 102 cfu/g and from 10* 
cfu/g to 103 cfu/g respectively (P < 0.001 in both cases), Figures 2 
and 3). Following both erythromycin and roxithromycin the 
concentration of Gram-negative bacilli decreased in nine volunteers 
and increased 1 log10 in one volunteer. 
One week after each drug normal concentrations of Gram-negative 
bacilli were found again. 
2. Secondary colonization with Gram-negative bacilli. 
Gram-negative bacilli other than Escherichia coli (secondary Gram-
negative bacilli) were not detected in any of the 20 pre-study 
samples and in only one of the 30 faecal samples taken at day 29 of 
the antibiotic periods. 
Antibiotic administration increased detection of secondary coloniza-
tion (Figure 4), which was caused most often by Klebsiella species 
(Table I). On day 8, secondary colonization was observed in 5/10 
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volunteers following amoxycillin and roxithromycin, and in 1/10 
volunteers following erythromycin. Following amoxycillin the 
counts were much higher (10* cfu/g - 1010 cfu/g) than following 
roxithromycin (103 cfu/g - 107 cfu/g, Figure 4). 
Following amoxycillin high counts of secondary Gram-negative 
bacilli were observed in the presence of high counts of E. coli. 
During administration of roxithromycin, secondary colonization 
occurred in 3/5 volunteers after disappearance of E. coli (day 4 or 
8), and ended when or shortly after E. coli had reached its original 
concentration (day 15 - 22, Table II). Following erythromycin few 
cases of secondary colonization were detected. All secondary 
colonizing Gram-negative bacilli were resistant to the antibiotic 
administered at the time of isolation. 
Disappearance of secondary colonization was much slower than 
normalization of the total level of colonization with Gram-negative 
bacilli (Figures 1 to 4). 
Discussion 
This study confirms the negative influence of amoxycilin on 
colonization resistance of the bowel (11, 12). In contrast to van 
Saene et al., (15), we found no disturbance of CR of the oropharynx 
by amoxycillin. Their study, however, was not done in volunteers 
but in patients. 
Erythromycin and roxithromycin decreased the level of Gram-
negative bacilli in faeces, but did not eliminate them. Thus in the 
prophylaxis of patients with very low infection resistance, such as 
those with leukopenia, they should be combined with a second 
decontaminating agent. 
Our results with erythromycin are in agreement with those of 
Andremont (9, 16) and Hartley (17). However, Heimdahl and Nord 
(18) claim major disturbance of the aerobic faecal flora in volunteers 
following erythromycin stéarate 500 mg twice daily for seven days. 
They found secondary colonization of the bowel with Gram-negative 
bacilli in 6/10 volunteers, but not exceeding 105 cfu/g of faeces. So 
in our view CR of the bowel was not disturbed. In contrast to our 
findings, they also found colonization of the oropharynx with Gram-
negative bacilli in 7/10 volunteers, in a concentration of 103 to 108 
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cfu/ml, showing disturbance of the CR of the oropharynx. This 
difference with our results is hard to explain. It should be noted, 
however, that our study followed a cross-over design. 
Secondary colonization with Gram-negative bacilli was observed as 
often following amoxycillin as following roxithromycin. In contrast 
to amoxycillin, roxithromycin did not cause secondary colonization 
in concentrations exceeding the normal concentration of Gram-
negative bacilli in the volunteers concerned. We therefore conclude 
that roxithromycin did not disturb the CR against Gram-negative 
bacilli. 
Acknowledgements 
Mrs A. Remie-Wijlhuizen, Mrs M.P.W.P. van Gemert-Toonen and 
Mr C.A. van Veen provided technical assistance, Mrs L. Janssen-
Lamers typed the manuscript and Roussel Laboratoria BV, the 
Netherlands, provided financial support. 
References 
1. Weinstein, L. (1947). The spontaneous occurrence of new bacterial infections 
during the course of treatment with streptomycin and penicillin. American Journal 
of Medical Sciences 214 , 56-63. 
2. McCoy, E. (1954). Changes in the host flora induced by chemotherapeutic 
agents. Annual Review of Microbiology 8 , 257-72. 
3. Bohnhoff, M., Drake, B.L. & Miller, C.P. (1954). Effect of streptomycin on 
susceptibility of the intestinal tract to experimental salmonella infection. 
Proceedings of the Society of Experimental Biology and Medicine 86 , 132-7. 
4. Meynell, G.C. (1954). Some factors affecting the resistance of mice to oral 
infection by Salmonella typhimurium. Proceedings of the Royal Society of 
Medicine 48 , 916-8. 
5. Dubos, R., Schaedler, R.W. & Stephens, M. (1963). The effect of antibacterial 
drugs on the faecal flora of mice. Journal of Experimental Medicine 117 , 231-
43. 
6. Dubos, R. (1966). The microbiota of the gastrointestinal tract. Gastro-
enterology 51 , 868-74. 
38 
7. van der Waaij, D., Berghuis-de Vries, J.M. & Lekkerkerk van der Wees, 
J.E.C. (1971). Colonization resistance of the digestive tract in conventional and 
antibiotic-treated mice. Journal of Hygiene 69 , 405-11. 
8. Clasener, H.A.L., Vollaard, E.J. & van Saene, H.K.F. (1987). Long-term 
prophylaxis of infection by selective decontamination in leukopenia and in 
mechanical ventilation. Reviews of Infectious Diseases 9 , 295-328. 
9. Andremont, Α., Tancrede, C , Andre, P. & Raibaud, P. (1983). Selective 
decontamination of the GI tract and resistance to colonization of the remaining 
flora: an experimental animal model and clinical applications. In : 13th 
International Cancer Congress, Part C, Biology of Cancer (2), (Mirand, E.A., 
Hutchinson, W.B. & Mihich, E., Eds), p. 453. Alan R. Liss, New York. 
10. Koopman, J.P., van den Brink, M.E., Scholten, P.M. & Hectors, M.P.C. 
(1987). Influence of roxithromycin and erythromycin on the gastro-intestinal 
ecology of mice. British Journal of Clinical Practice 42 , Suppl. 55, 43-6. 
11. Mittermayer, H.W. (1983). The effect of amoxicillin and of amoxicillin plus 
clavulanic acid on human bowel flora. In Augmentin (Croydon, E.A.P. & Michel, 
M.F., Eds), pp. 122-25. Excerpta Medica, Amsterdam. 
12. Levy, S.B. (1984). Playing antibiotic pool : time to tally the score. New 
England Journal of Medicine 311 , 663-5. 
13. Rose, H.D. & Schreier, J. (1968). The effect of hospitalization and antibiotic 
therapy on the gram negative flora. American Journal of Medical Sciences 255 , 
228-36. 
14. Le Frock, J.L., Ellis, CA. & Weinstein, L. (1979). The relation between 
aerobic faecal flora and oropharyngeal microflora in hospitalized patients. 
American Journal of Medical Science 277 , 275-80. 
15. van Saene, H.K.F., Willems, F.T.C., & Zweens, J. (1983). Influence of 
amoxycillin and cefaclor ол the colonization resistance of the oropharynx. 
Scandinavian Journal of Infectious Diseases , Suppl. 39, 97-9. 
16. Andremont, Α., Sancho-Gamier, H. & Tancrede, C. (1986). Epidemiology of 
intestinal colonization by members of the family Enterobacteriaceae highly 
resistant to erythromycin in a hematology unit. Antimicrobial Agents and 
Chemotherapy 29 , 1104-7. 
17. Hartley, C.L., Clements, H.M. & Linton, K.B. (1978). Effects of cephalexin, 
erythromycin and clindamycin on the aerobic Gram-negative faecal flora in man. 
Journal of Medical Microbiology 11 , 125-35. 
39 
18. Heimdahl, Α. & Nord, C E . (1982). Effect of erythromycin and 
roxithromycin on the mdigenous human anaerobic flora and on new colonization 
of the gastrointestinal tract. European Journal of Clinical Microbiology 1 , 38-
48. 
40 
Table I. Secondary colonization of faeces with Gram-negative 
bacilli following antibiotics 
Micro- Number of samples positive* during : 
organism amoxycillin erythromycin roxithromycin 
period(60)b period(60)b period(60)b total 
K. 
K. 
K. 
E. 
E. 
H. 
c. 
s. 
pneumoniae 
oxytoca 
group 47 
cloacae 
agglomerane 
alvei 
freundii 
liquefaciens 
10 
2 
1 
1 
1 
1 
-
-
UGNBC 
17 
11 
1 
3 
2 
3 
1 
1 
1 
(42.5%) 
(27.5%) 
( 2.5%) 
( 7.5%) 
( 5.0%) 
( 7.5%) 
( 2.5%) 
( 2.5%) 
( 2.5%) 
Some samples contained more than one species. 
Number of samples examined. 
Unidentified Gram-negative bacilli. 
Table II. Concentration of E. coli and other Gram-negative 
bacilli in five volunteers following administration of 
roxithromycin 
Volunteer Micro-organism 1 
Log10 concentration on day 
4 8 15 22 29 
a 
b 
с 
d 
e 
E. coli 
К. pneumoniae 
E. coli 
E. agglomerans 
E. coli 
K. oxytoca 
E. coli 
3 species 
E. coli 
2 species 
6 
-
7 
-
8 
-
7 
-
6 
-
4 
-
3 
-
-
6 
3 
-
7 
7 
4 
4 
-
3 
-
5 
-
3 
7 
7 
7 
3 
5 
-
6 
6 
7 
7 
8 
7 
7 
-
6 
-
6 
5 
7 
-
7 
6 
6 
-
7 
-
6 
-
8 
-
7 
-
Below detection limit (10 cfu/g). 
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Abstract 
The influence of oral administration of cefaclor, phenethicillin, co-
trimoxazole and doxycycline on colonization resistance (CR) of the 
oropharynx and of the colon was studied in healthy volunteers. 
Antimicrobial agents were administered in a randomized cross-over 
design. No effect on CR of the oropharynx could be demonstrated. 
Phenethicillin decreased CR of the colon against Gram-negative 
bacilli (P = 0.001). Co-trimoxazole significantly decreased the 
concentration of Gram-negative bacilli in faeces (P = 0.03), but the 
decrease caused by cefaclor and doxycycline did not reach statistical 
significance. Administration of antimicrobial agents increased the 
appearance of secondary colonization by Gram-negative bacilli in 
faeces, especially when Escherichia coli was eliminated. During 
administration of phenethicillin, secondary colonization occurred at a 
concentration exceeding 107/g in some volunteers. Following 
administration of cefaclor, co-trimoxazole and doxycycline, 
elimination of E. coli may result in the substitution by resistant 
Gram-negative bacilli in low concentration. 
Introduction 
An important problem following the use of antimicrobial agents is 
the appearance of resistant species and the occurrence of super-
infections. One solution to this problem is by advocating the 
restriction of antibiotic usage, and stressing the importance of 
hygienic measures. The prevention of resistant micro-organisms 
appearing at all would seem to be a more promising approach. 
According to the theory of colonization resistance (CR), suppress-
ion of a certain (anaerobic) part of the indigenous flora will promote 
colonization of the digestive tract by resistant micro-organisms at 
high concentrations, thereby increasing the source and thus the risk 
of cross-contamination and of superinfections. On the other hand, 
antimicrobial agents that do not disturb anaerobic indigenous flora 
and reach sufficiently high concentrations in the digestive tract, will 
achieve 'selective decontamination' of potentially pathogenic aerobic 
flora. Such agents have been used successfully for the prevention of 
infection in neutropenic patients and in those on mechanical 
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ventilation (1). Therefore, antimicrobial agents to be used for 
therapy or prophylaxis need to be investigated for their effects on 
the indigenous flora. 
Antimicrobial agents may influence the microbial flora of the 
digestive tract when incompletely absorbed following oral adminis­
tration, or when excreted in saliva, bile or mucus (2). 
In the intestine antibiotics are inactivated to a variable extent by 
decomposition (3, 4), or by binding (5, 6, 7). The remaining active 
antimicrobial agent may eliminate the susceptible part of the 
indigenous flora. In mice which have been pre-treated with strepto­
mycin (8, 9) or streptomycin and neomycin (10) the infective dose 
of exogenous micro-organisms is between 1000-fold and 100,000-
fold lower than in untreated controls. In mice which have been 
treated with streptomycin (9), penicillin (11) or ampicillin (12), or 
streptomycin and neomycin (13), and in germfree mice (14, 15), the 
concentration of aerobic Gram-negative challenge strains in faeces 
becomes between 1000-fold and 100,000-fold higher than the normal 
level of E. coli (с. 105/g) found in faeces. 
In man also, the administration of antimicrobial agents may result in 
overgrowth by resistant, potentially pathogenic aerobic flora and in 
decrease of the infective dose of enteric pathogens (16, 17, 18, 19). 
Conversely, in germfree mice (14) and in antibioticalîy 
decontaminated mice (13), the abnormally high susceptibility to 
colonization by aerobic micro-organisms may be strongly reduced by 
administration of murine or even human anaerobic flora (15). In 
man, a dramatic cure was reported in patients suffering from 
pseudomembranous colitis when fresh faecal suspensions were 
administered by an intrajejunal tube or by enemas (20, 21). 
The protective effect of indigenous flora against new colonization by 
exogenous micro-organisms has originally been called colonization 
resistance (CR) (10). The term CR has also been used to indicate the 
limiting action of indigenous flora on the concentration of potentially 
pathogenic aerobic flora in the intestine (22). The CR flora is 
probably mainly anaerobic, but the exact composition remains 
unknown (1). Consequently it is impossible to predict the influence 
of antimicrobial agents on CR by in-vitro determinations of the 
susceptibility of known anaerobic species. Therefore, the influence 
of antimicrobial agents on CR should be investigated by their 
administration to animals or humans, and measuring their influence 
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on the concentration of aerobic micro-organisms in faeces and on the 
appearance of Gram-negative bacilli and yeasts in the oropharynx. 
Preferably, these investigations should be performed in humans, 
because dose-response effects of antimicrobial agents on CR in 
animals are difficult to extrapolate to man. In patients, factors other 
than the microbial CR, such as salivation, swallowing, and 
peristalsis, may be disturbed. Consequently healthy volunteers are 
more suitable. 
In comparing the influence of different antibiotics on CR, a cross-
over study design is preferable, to compensate for inter-individual 
differences in normal CR. In this study, we investigated the 
influence of cefaclor, phenethicillin, co-trimoxazole and doxycy-
cline in human volunteers. Cefaclor, 250 mg three times daily, does 
not disturb CR in human volunteers (23). In patients with upper 
airway infections, cefaclor 250 mg three times daily did not provoke 
superinfections, in contrast to amoxycillin 375 mg three times daily 
(24). In our study a higher dosage of cefaclor was investigated. 
Phenethicillin is suspected of disturbing CR, because penicillin at 
high dosage is known to cause superinfections (25). Doxycycline is 
supposed to have little influence on CR (26), whilst co-trimoxazole 
is used in the selective decontamination of neutropenic patients (1). 
Increase in faecal aerobic flora was considered as the most important 
indication of a decrease in CR of the bowel. Detection of Gram-
negative bacilli in gargling fluid was considered as an indication of 
decrease in CR of the oropharynx. Another parameter thought 
possibly useful was the appearance of new species of Gram-negative 
bacilli in faeces, referred to as secondary colonization. 
Methods 
Study design 
Healthy volunteers received one of the four drugs in a randomized 
cross-over study for seven days, followed by a 14-day wash-out 
period, after which the next treatment with another of the study 
drugs started. Oropharyngeal gargling samples (20 ml of 
physiological saline) and faecal samples were taken on the morning 
of days 1 (before the first antibiotic dose), 4, 8, 11, 15 and 22. 
Permission for the study was obtained from the ethics committee of 
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the Canisius-Wilhelmina Hospital. 
Volunteers 
Twelve healthy normal volunteers (4 female, 8 male), age 22 to 52 
(median age 31), participated in the study. Written informed consent 
was obtained. The volunteers had not used antibiotics for at least one 
month prior to the start of the study. 
Drugs 
Cefaclor 500 mg capsules and phenethicillin 500 mg capsules were 
used three times daily. Co-trimoxazole 960 mg capsules were 
administered two times daily and doxycycline 100 mg capsules were 
administered once daily. 
The study was conducted in a double blind design, with identically 
looking capsules containing study drugs and placebos. The 
volunteers received separate bottles for the morning, noon and 
afternoon doses. Placebos were used for the noon dose of co-
trimoxazole and for the noon and afternoon dose of doxycycline. All 
drugs were taken at the end of a meal. 
Bacteriology 
Serial 1/10 dilutions of faeces were made in Thiogycollate medium 
(BBL). One-microlitre volumes of each dilution were inoculated on 
to solid media to isolate Gram-negative bacilli (Eosin methylene-
blue lactose sucrose agar, Merck), enterococci and viridans 
streptococci (5% sheep blood in agar base, Oxoid, with nalidixic 
acid 50 mg/1), Staphylococcus aureus (Mannitol salt agar, 
bioMérieux), and yeasts (Sabouraud dextrose agar, Gibco, with 
chloramphenicol 125 mg/1). The solid media were also inoculated 
with 100-microlitre volumes of the first 1/10 dilution of faeces, 
lowering the limit of detection to 100 micro-organisms per gram of 
faeces. Concentrations were expressed as the logarithms to the base 
10 of the counts per g of faeces, rounded up or down to whole 
numbers. Gargling fluids were inoculated in volumes of 100-
microlitre on to the solid media. Micro-organisms isolated were 
identified by standard laboratory methods. 
Statistics 
Friedmans's test was employed to evaluate the differences in counts 
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of micro-organisms in faeces following administration of antibiotics. 
The counts in samples on the first day of the study were used as a 
baseline. 
Results 
Two male volunteers missed one study period because of inter-
current illness. They were excluded from analysis. Results in the 
remaining ten volunteers are presented. 
Gargling fluid 
Yeasts were not detected in any sample from five volunteers and in 
2, 2,2, 11, and 12 samples out of 21 samples in the others. Counts 
did not exceed lOVml of gargling fluid. No obvious relation with 
administration of antibiotic was seen. S. aureus was not detected in 
nine volunteers. In the tenth, one sample was positive (102/ml). 
Strains of Gram-negative bacilli were detected in 1, 1, and 3 
samples from three volunteers respectively. The counts were 102/ml 
in all cases. The three positive samples from one volunteer occurred 
on days 11, 15 and 22 of the doxycycline period. 
Counts of viridans streptococci were 105 - lOVml in all 21 samples 
from four of the volunteers. In the others few samples showed 
counts outside this range. 
Faeces 
Yeasts 
At the start of the study, culture for yeasts was negative in 6/10 
volunteers. Two volunteers carried 102 yeasts per g faeces, one 10', 
and one 105. No significant differences were observed at the end of 
each study period. 
S. aureus 
S. aureus was not detected in nine volunteers. The tenth showed two 
positive samples (both 103/g) on day 11 when receiving cefaclor and 
phenethicillin. 
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Enterococci 
Before the start of antibiotics the median counts of enterococci were 
lOVg (range 104/g - 106/g). No significant differences were seen at 
the end of each study period. 
Administration of cefaclor and doxycyclin had no significant effect, 
but co-trimoxazole and phenethicillin decreased counts to a median 
of 107g (range < 107g - 107g, Ρ = 0.05) and 107g (range < 
107g - 107g, Ρ = 0.03) respectively. 
Gram-negative bacilli 
1. Total level of colonization in faeces. 
The median level at day 1 of the study was 107g (range lOVg -
107g). At the end of the study periods (day 22) the count was 
slightly lower, especially after co-trimoxazole (lOVg, Ρ > 0.05, 
Figure 3). During administration of phenethicillin an increase to a 
median count of lOVg (P = 0.001) was observed. Administration of 
cefaclor and doxycycline led to a slight decrease to lOVg and lOVg 
respectively, but only with co-trimoxazole was the decrease (to 
107g) significant (P = 0.03) (Figures 1-4). 
2. Secondary colonization with Gram-negative bacilli. 
Gram-negative bacilli other than E. coli (secondary Gram-negative 
bacilli) were detected in two of 40 faecal samples taken on day 1 of 
the study periods. Antibiotic administration increased the detection 
of secondary colonization, which was most often caused by 
Klebsiella species (Table I). Following phenethicillin, secondary 
colonization appeared sooner after the start end disappeared sooner 
after the end of administration than was the case following 
doxycycline or co-trimoxazole. Following cefaclor, few cases of 
secondary colonization were noted. Following phenethicillin, the 
counts of secondary colonizing Gram-negative bacilli were much 
higher (lOVg - 10l7g) than those following the other antibiotics 
(lOVg - 107g) (Figure 5 and Table II). 
Discussion 
The principal indication of disturbance of CR is an increase in the 
concentration of aerobic flora in the digestive tract. According to 
this criterion, our study shows disturbance of CR of the lower parts 
of the intestinal tract by phenethicillin, but not by cefaclor, co-
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trimoxazole or doxycycline. 
This is in accordance with earlier investigations in both patients and 
human volunteers with cefaclor (23, 24), co-trimoxazole (27, 28) 
and doxycycline (26, 29). The influence of phenethicillin on CR in 
the human bowel confirms the findings in mice (30). Another 
indication of impairment of CR is that colonization of the digestive 
tract will take place following challenge with lower numbers of 
Gram-negative bacilli than are needed in the presence of normal CR. 
Therefore the occurrence of secondary colonization with Gram-
negative bacilli has been considered an indication of a decrease in 
CR. However, increase in detection of secondary colonization using 
standard laboratory methods is not necessarily the same as an actual 
increase in the occurrence of secondary colonization. In this study 
16/26 cases of secondary colonization were found in samples in 
which E. coli was undetectable (Table II). In the other positive 
samples the concentration of E. coli was equal to or only slightly 
different from the concentration of the secondary Gram-negative 
bacilli. Appearance of secondary colonization when E. coli 
concentration falls, can be explained by the fact that strains present 
in a concentration of more than 100 times less than that of the 
dominant E. coli strain, will seldom be detected unless selective 
media are used. Faecal colonization by K. pneumoniae at a level of 
IO" cfu/g will seldom be noticed in the presence of 107 cfu of E. coli 
per g in faeces. However, the presence of K. pneumoniae at this 
level will be detected following elimination of E. coli by a suitable 
antimicrobial agent. Thus, increased detection of secondary 
colonization following elimination of E. coli does not prove 
increased occurrence. The data in Table II suggest however that the 
decrease or elimination of E. coli might improve the detection of 
secondary colonization, as well as increase the occurrence of 
secondary colonization following administration of cefaclor, co-
trimoxazole or doxycycline. 
In animal experiments it has been shown that E. coli may play a role 
in the prevention or suppression of secondary colonization (31, 32). 
As long as the anaerobic flora is not impaired however, absence of 
E. coli did not result in secondary colonization in a concentration 
exceeding the normal level of E. coli in faeces (14). The same kind 
of bacterial interference probably exists in the human intestine, 
because in this and in a previous study (33) secondary colonization 
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at a level of 10e cfu/g or higher only occurred following amoxycillin 
and phenethicillin, suggesting disturbance of anaerobic flora. 
Following roxithromycin, erythromycin, cefaclor, co-trimoxazole 
and doxycycline however, secondary colonization did appear, but 
always at a level equal to or lower than the normal concentration of 
E. coli in the volunteers concerned, suggesting no disturbance of 
anaerobic flora. 
Incomplete suppression of E. coli or increased occurrence of low 
concentrations of secondary Gram-negative bacilli, following 
elimination of E. coli, is probably not a dangerous consequence of 
an antibiotic in patients with normal infection resistance. In patients 
with very low infection resistance however, such as neutropenic 
patients, even the presence of low concentrations of potentially 
pathogenic micro-organisms in the digestive tract may result in 
infection. Therefore, in these patients the spectrum of the regimen 
should also cover secondary colonization. This may explain why the 
addition of Colistin improves the results obtained by selective 
decontamination with co-trimoxazole alone (34), and why 
ciprofloxacin is superior to the combination of co-trimoxazole and 
Colistin (35). 
The four antibiotics tested had no effect on oropharyngeal flora as 
detected in gargling fluid. Concentrations of viridans streptococci 
did not change, and no increase in secondary colonization occurred. 
This study did not demonstrate that any of these antibiotics 
predispose to superinfections of the upper airways. It is possible 
though that volunteers are less susceptible than patients to the 
facilitation of secondary colonization of the oropharynx by 
antibiotics. In another study (33) we did not observe an increase in 
secondary colonization of the oropharynx following amoxycillin in 
volunteers. Both Lacey (36) and van Saene (24) however, showed an 
increase in secondary colonization of the oropharynx following 
amoxycillin in patients. These authors did not use gargling samples, 
as we did, but pharyngeal swabs. As it has been shown that the 
gargling method is more sensitive (37), this fact alone cannot explain 
the discrepancy between the results. 
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Table I. Secondary colonization of faeces with Gram-negative 
bacilli day 4-22 
Micro-organism 
Number of samples positive* following: 
CFC 
(50)ь 
PTC 
(50)b 
CTX 
(50)b 
DXC 
(50)b Total 
K. 
K. 
P. 
P. 
с 
E. 
Α. 
Η. 
P. 
S. 
s. 
pneumoniae 
oxytoca 
aeruginosa 
putida 
freundii 
agglomerans 
Iwoffii 
alvei 
mirabilis 
liquefaciens 
marcescens 
1 
1 
1 
Total 11 28 
a
 : Some samples contained more than one species. 
CFC : cefotaxime ; PTC : phenethicillin ; CTX : co-trimoxazole, 
DXC : doxycycline. 
ь
 : Number of samples examined. 
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Table II. Concentrations of E. coli and other Gram-negative 
bacilli in faeces in which secondary colonization appeared 
Period and 
volunteer Micro-organism 1 
Log1Q concentration on day : 
4 8 11 15 22 
Cefacl 
В 
H 
or 
E. 
К. 
E. 
P. 
К. 
coli 
oxytoca 
coli 
aeruginosa 
pneumoniae 
Co-trimoxazole 
С 
H 
J 
К 
E. 
К. 
E. 
P. 
E. 
Α. 
Η. 
E. 
P. 
E. 
coli 
oxytoca 
coli 
aeruginosa 
coli 
Iwoffii 
alvei 
coli 
putida 
agglomerans 
: Below detection limit (10 cfu/g) 
(continued on next page) 
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Table II. Concentration of E. coli and other Gram-negative 
bacilli in faeces in which secondary colonization appeared 
(continued from preceding page). 
Period and 
Volunteer Micro-organism 1 
Log10 concentration on day 
4 8 11 15 22 
Doxycycline 
В E. coli 
С. freundii 
E. coli 
К. pneumoniae 
С. freundii 
E. coli 
К. pneumoniae 
E. coli 
P. mirabilis 
Phenethicillin 
С E. coli 
К. pneumoniae 
S. liquefaciens 
К. oxytoca 
E. coli 
К. oxytoca 
E. coli 
К. oxytoca 
К. pneumoniae 
E. coli 
S. marcescens 
К. pneumoniae 
E. coli 
К. pneumoniae 
6 
6 
8 
8 
8 
8 
10 
10 
Below detection limit (102 cfu/g) 
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following cefaclor. 
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Abstract 
The influence of clindamycin, dicloxacillin, minocycline and nor-
floxacin on the faecal concentration of urobilinogen was investi-
gated. The drugs were administered orally in standard dosage for 
six days to groups of six volunteers. A decrease in faecal 
concentration of urobilinogen following administration of 
clindamycin (P < 0.01) and dicloxacillin (P < 0.05) was found. 
The possible predictive value of a decrease of the faecal level of 
urobilinogen as an indicator for impairment of microbial coloniza-
tion resistance (CR) and for the risk of failure of oral 
anticonceptive treatment is discussed. It is suggested that 
clindamycin and dicloxacillin should not be combined with oral 
anticonceptive treatment unless more specific investigations have 
excluded interaction of these drugs with oestrogen metabolism in 
the bowel. 
Introduction 
Disturbance of the microbial ecology of the gut is an important 
side effect of some antimicrobial agents. These antimicrobial 
agents eliminate a certain part of the anaerobic gut flora, which 
results in overgrowth of aerobic flora, thereby increasing the 
source and thus the risk of endogenous infections (1). As the part 
of the anaerobic flora that provides this so called colonization 
resistance (CR) against aerobic flora has not yet been identified, its 
presence has to be deduced from the limitation it causes of the 
concentration of the aerobic faecal flora. Elimination of the 
anaerobic CR flora by agents like amoxycillin, readily results in 
overgrowth by aerobic Gram-negative bacilli because resistant 
bacteria like Klebsiella are generally available (2). Elimination of 
the anaerobic CR flora may go unnoticed, however, as long as the 
patient harbours nor encounters micro-organisms resistant to the 
antimicrobial agent used. In experimental studies in animals or in 
human volunteers, aerobic bacteria resistant to the antimicrobial 
agent investigated may even have to be administered when no 
resistant aerobic flora is naturally present (challenge). 
In studies in patients, another method is needed to assess the 
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presence of the CR flora. The faecal concentration of bèta-aspar-
tylglycine has been used as a metabolic indicator for disturbance of 
CR. However, the bèta-aspartylglycine test is too insensitive (1). 
The report that some antimicrobial agents which are known to 
affect the CR flora, decreased the faecal concentration of 
urobilinogen, a product of bacterial metabolism (3), suggested the 
possibility of another method. 
The concentration of urobilinogen in faeces might also be used as 
an indicator of the influence of antimicrobial agents on the 
capacity of the bowel flora to deconjugate glucuronides. 
Conjugated bilirubin is excreted by an active transport process 
from hepatic cells into the bile, mainly as glucuronides. In the 
large bowel it is deconjugated and converted to urobilinogen by 
intestinal micro-organisms. Suppression of the deconjugating 
bacterial flora will decrease the production and thus the level of 
urobilinogen in faeces. In germfree animals, for example, no 
urobilinogen is present in faeces (4). 
Suppression of deconjugating bacterial flora in the bowel decreases 
enterohepatic cycling of ©estrogens and therefore decreases the 
blood level of oestrogens. This might cause failure of oral 
anticonception (5). Therefore, the faecal level of urobilinogen 
might predict which antibiotics cause a risk for females on oral 
anticonceptive agents. 
Investigators of the Karolinska Institute at Stockholm, Sweden, 
have described the influence of several antimicrobial agents on the 
faecal level of urobilinogen (3, 6). However they only gave data 
on the level of urobilinogen before treatment and on day six of 
treatment. In this pilot study the time course of the influence of 
clindamycin, dicloxacillin, minocycline and norfloxacin on 
urobilinogen production was investigated. The urobilinogen level 
was determined by a semi-quantitative solid-phase chemical 
method using Urobilistix (R) test strips. 
Methods 
Subjects 
Twelve healthy adults (7 male and 5 female) aged between 22 and 
35 years (median age 28) volunteered for this study. They had no 
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significant medical history, in particular no renal or liver disease, 
and no hypersensitivity to the studied drugs. Routine screening 
tests, performed before and after the study, consisted of a full 
blood count, urine analysis and liver function tests. The volunteers 
did not use any drug within 2 months before and during the 
investigation. Female volunteers were warned that use of 
antibiotics might result in failure of oral anticonception. Written 
informed consent was given prior to the start of the study, which 
was performed in accordance with the revised Declaration of 
Helsinki. 
Volunteers were questioned about side effects after each study. 
Study design 
The volunteers were randomly divided into two groups. Group I (5 
males and 1 female) received norfloxacin (Noroxin (R), Merck 
Sharp & Dohme, Haarlem, the Netherlands) tablets 400 mg twice 
daily for six days, and after a wash-out period of six weeks, 
minocycline (Minocin (R), Lederle Nederland BV, Etten-Leur, the 
Netherlands) capsules 100 mg twice daily for six days. Group II (2 
males and 4 females) received dicloxacillin (Diclocil (R), Bristol-
Meyers, Weesp, the Netherlands) capsules 500 mg four times a 
day for six days, and after a wash-out period of six weeks, two 
clindamycin (Dalacin С (R), Upjohn, Ede, the Netherlands) 
capsules 150 mg twice daily for six days. 
Administration of the drugs started at day 0. The faecal sample 24 
hours after the first antibiotic administration was indicated as the 
first treatment sample (day 1). The faecal sample of the first day 
after the termination of antibiotic treatment was considered as the 
last treatment sample. The sample of day 0 was not included in 
analysis. 
From each volunteer daily pre-treatment samples were 
investigated, taken on five successive days before each of the two 
antibiotic periods. 
Faecal samples were analyzed daily during the drug period and on 
days 1-5, 10 and 14 of the post treatment period. 
Urobilinogen assay 
The faecal level of urobilinogen was determined by a semi­
quantitative solid-phase chemical method, using Urobilistix R 
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(Ames, Division Miles, (France) test strips. These test-strips 
employ the Ehrlich-reaction, which has been used before for 
determination of faecal urobilinogen by the Karolinska-group (4). 
The reaction is disturbed by the presence of nitrite. Nitrite-tests 
were negative however in 50 faecal samples in a pilot-study. 
Therefore, in the final study we omitted the nitrite-reaction. 
Because of the decomposition of urobilinogen in time, all samples 
were analyzed immediately, or they were stored in a refrigerator 
and analyzed within 2 hours after delivery into sample containers. 
Of the faeces 0,3 - 0,7 g were mixed with 5 ml of 0,9% NaCl 
solution. The samples were vigorously shaken by Vortex, until 
homogeneous suspensions were obtained. After centrifugation at 
1,000 g for 3 minutes, a test-strip was dipped in supernatant. 
The faecal concentration of urobilinogen was calculated according 
to the formula: 
Cim = Rx {(5.0 + WF)/WF} χ IO3 mmol/1 
where C^ is the faecal concentration of urobilinogen, R is the 
result of test strip-reading (micromol/1), WF is the weight of the 
faecal sample and 5.0 is the weight of 5 ml 0,9% NaCl solution. 
The result is found in mmol/1 faeces. As the specific gravity of 
faeces is about 1.0 final results will be expressed in mmol/kg 
faeces. All determinations were done in triplicate. 
Statistical analysis: 
Friedman two-way analysis by ranks was used to test the changes 
of urobilinogen level during the pre-treatment and the treatment 
period. Significance was assigned to a two tailed Ρ value of less 
than 0.05. 
Results 
Faecal level of urobilinogen 
Because of technical problems no determinations were made on 
day 10 after the administration of clindamycin. 
The mean faecal urobilinogen concentrations in the pre-treatment 
period and following the administration of antibiotics are shown in 
the Figure. The mean levels and ranges of urobilinogen before, 
during and after administration of antibiotics are shown in the 
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Table. 
The level of urobilinogen decreased in all volunteers, following 
administration of each drug. The decrease was significant 
following clindamycin (P < 0.01) and dicloxacillin (P < 0.05), 
but not following norfloxacin and minocycline administration. 
Tolerance 
No abnormal values were found for the routine screening tests per-
formed before and after drug treatment. However in group II, two 
in four female volunteers acquired symptomatic Candida vaginitis 
when clindamycin was administered and one volunteer when 
dicloxacillin was administered. The diagnosis was confirmed by 
culture. The symptoms disappeared within 3 days following 
application of a miconazole vaginal ovula 1,200 mg. Some gastro-
intestinal discomfort occurred in 3 volunteers during the 
clindamycin period. 
Discussion 
During clindamycin, the level of urobilinogen dropped to a median 
value of 0.3 mmol/kg (Table). It has been shown that clindamycin 
disturbs the microbial CR against aerobic flora, causing at least a 
100-fold increase in indigenous aerobic flora (7). So, even if we 
assume that conversion of bilirubin glucuronides in our volunteers 
was caused exclusively by the indigenous aerobic flora, this could 
only produce about 0.003 mmol urobilinogen/kg faeces in normal 
concentration. As the normal level of urobilinogen is about 1.0 
mmol/kg (Table), the influence of aerobic flora on the level of 
urobilinogen can be neglected. Therefore, decrease of the faecal 
level of urobilinogen indicates suppression of anaerobic flora. 
Anaerobic flora is the major determinant of microbial CR against 
potentially pathogenic aerobic flora (1). Therefore, reduction of 
the faecal concentration of urobilinogen might predict disturbance 
of microbial CR. In the study of the Karolinska team (3, 6), all 
drugs which are considered to impair CR (1) significantly 
decreased the concentration of urobilinogen. In the present study a 
significant decrease of urobilinogen was found for clindamycin (P 
< 0.01), which disturbs CR (7) and for dicloxacillin (P < 0.05), 
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which is suspected of disturbing CR (1). No significant influence 
was found for norfloxacin and minocycline. Quinolones are 
presumed not to impair CR. For minocycline no data about 
influence on CR are available, but it is probably comparable to 
doxycycline, which does not disturb CR (8, 9). 
So, the data of this pilot study is compatible with the hypothesis 
that the influence of antibiotics on the faecal level of urobilinogen 
is an indicator of their influence on microbial CR. Further study's 
are required which investigate this hypothesis directly. 
The decrease of the faecal level of urobilinogen following certain 
antibiotics also predicts disturbance of intra-intestinal 
deconjugation of other substances than bilirubinglucuronides. This 
may have consequences for enterohepatic cycling and therefore for 
the blood levels of some drugs. Adlercreutz found a thirty-fold 
increase in the faecal concentration of conjugated ©estrogens and a 
decrease of 30% in the concentration of free oestrogens in 24-
hour urine in pregnant females who used ampicillin (10). In this 
way, antibiotics which inhibit intestinal glucuronidase activity, like 
ampicillin and tetracycline, might cause failure of oral 
anticonception with oestrogens (5). 
In the Netherlands, a warning against possible induction of failure 
of oral anticonceptive drugs is not included in the package insert 
of clindamycin and dicloxacillin. However, until proof of the 
contrary is provided, clindamycin and dicloxacillin should be 
considered dangerous for users of oral anticonceptive agents. 
In female patients on oral anticonceptive agents who need anti-
microbial treatment, antimicrobial agents which do not decrease 
the faecal concentration of urobilinogen are to preferred, as long 
as the influence of individual antimicrobial agents on the blood 
level of oestrogens is unknown. 
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Table. Median value and range of faecal urobilinogen (mmol/kg) 
in six volunteers 
Sample* 
Tpt(5) 
1 
2 
3 
4 
5 
6 
+ 1 
+2 
+ 3 
+4 
+ 5 
+ 10 
+ 14 
Volunteers 1-6 
norfloxacin minocycline 
1.0(0.7-1.4) 
0.9(0.3-2.4) 
0.7(0.3-1.6) 
0.6(0.3-1.4) 
0.6(0.4-0.7) 
0.7(0.4-1.0) 
0.9(0.5-1.6) 
0.8(0.5-1.6) 
0.7(0.4-1,2) 
0.8(0.4-1.2) 
0.8(0.5-1.4) 
1.1(0.6-1.9) 
1.0(0.6-1.3) 
1.0(0.7-1.5) 
1.0(0.7-1.4) 
1.0(0.2-1.6) 
0.8(0.3-1.3) 
0.9(0.5-1.5) 
0.8(0.5-1.1) 
0.8(0.5-1.4) 
0.7(0.4-0.9) 
0.8(0.4-1.0) 
0,8(0.3-1.3) 
0.9(0.3-1.3) 
0.8(0.4-1.2) 
0.8(0.4-1.2) 
0.9(0.5-1.1) 
0.8(0.5-1.1) 
Volunteers 7-12 
dicloxacillin clindamycin 
1.1(0.9-1.4) 
0.6(0.3-0.9) 
0.4(0.2-0.7) 
0.5(0.2-0.7) 
0.5(0.2-0.8) 
0.4(0.2-0.7) 
0.5(0.2-0.7) 
0.5(0.3-0.8) 
0.5(0.3-0.8) 
0.5(0.3-0.8) 
0.6(0.3-1.3) 
0.6(0.3-1.5) 
0.7(0.5-1.1) 
0.8(0.6-1.0) 
1.0(0.5-1.1) 
0.4(0.2-0.9) 
0.5(0.2-0.9) 
0.4(0.2-0.8) 
0.3(0.0-0.4) 
0.3(0.0-0.4) 
0.3(0.1-0.4) 
0.3(0.2-0.5) 
0.3(0.2-0.4) 
0.4(0.2-0.6) 
0.5(0.3-1.0) 
0.5(0.3-0.6) 
ND 
0.9(0.4-1.3) 
Tpt(5) : Median value of six volunteers of five pre-treatment 
days. 
Samples 1 to +1 : Treatment samples (first sample after treat-
ment is counted as last treatment sample). 
Samples +2 to +14 : Post-treatment samples. 
ND : not determined. 
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Figure. The influence of four antimicrobial agents on the faecal 
level of urobilinogen. 
Samples Tpt(5) : Median value of six volunteers of five pre-
treatment days. 
Samples 1 - +1 : Treatment samples (first sample after treatment 
is counted as last treatment sample). 
Samples +2 - +14 : Post-treatment samples. 
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Abstract 
The influence of amoxycillin 500 mg tid on microbial colonization 
resistance (CR) was investigated in 11 healthy volunteers. Analysis 
was performed in each volunteer individually. In the first five 
volunteers we investigated the influence of amoxycillin on the faecal 
concentration of Gram-negative bacilli, enterococci and yeasts and 
on spontaneously occurring secondary colonization. In the next six 
volunteers we also investigated the influence of amoxycillin on CR 
against amoxycillin-resistant challenge strains, in order to be in-
dependent of the accidental presence of resistant Gram-negative 
bacilli. 
In three volunteers all indicators employed did not show disturbance 
of the anaerobic flora that provides CR. 
In five volunteers impairment of this flora was indicated both by 
increase of the faecal concentration of aerobic flora and by increase 
of spontaneously occurring secondary colonization or facilitation of 
colonization by the challenge strains. However, in the other three 
volunteers there was no concordance between the investigated indica-
tors of the influence of amoxycillin on CR. Possible explanations are 
discussed. It is concluded that increase of the faecal concentration of 
aerobic flora is a more reliable indicator of impairment of the 
anaerobic flora that provides CR than increase of secondary 
colonization by strains acquired spontaneously or by challenge 
strains administered deliberately. 
In one volunteer, who was excluded from the trial, high-level faecal 
colonization occurred after challenge with Enterobacter cloacae in 
the pre-treatment period. 
Introduction 
The autochthonous anaerobic flora limits the concentration of 
aerobic micro-organisms in the bowel ; this is known as microbial 
colonization resistance (1). The term colonization resistance was 
introduced by van der Waaij, to indicate the ability to withstand 
colonization of the bowel by aerobic challenge organisms (2). 
Subsequently the term colonization resistance has also been used to 
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indicate the limiting action of autochthonous anaerobic flora on the 
concentration of indigenous aerobic flora of the bowel (3). 
The influence of antimicrobial agents on the anaerobic flora that 
provides CR cannot be investigated directly, because the composition 
of this flora is unknown (1). However, disturbance of this flora 
might be deduced from (a) increase of the concentration of aerobic 
flora, (b) increase of the concentration of secondary Gram-negative 
bacilli (Gram-negative bacilli other than Escherichia coli) (4), or (c) 
facilitation of colonization of the bowel by resistant challenge strains 
administered deliberately. 
Until now, the correlation of these indicators of disturbance of the 
flora that provides CR has not been studied. Moreover, the influence 
of antimicrobial agents on CR in man has been investigated mostly 
by analyzing their influence on the median faecal concentration of 
aerobic flora in a group of volunteers. However, the concentration 
of antimicrobial agents in the bowel and the susceptibility to anti-
biotics of the anaerobic flora that provides CR may differ among 
volunteers. Therefore, this study was designed to investigate the 
influence of amoxycillin on CR in volunteers individually. Special 
attention has been given to the correlation of investigated indicators 
of impairment of CR in each volunteer. 
Methods 
Study design 
In five volunteers (1-5) daily faecal samples were analyzed for their 
concentration of Gram-negative bacilli, enterococci and yeasts 
during a pre-treatment period of 20 days, a treatment period of 10 
days and a post-treatment period of 10 days. 
From the data derived from these volunteers it was calculated that a 
pre-treatment period and a treatment period of 10 days each would 
be sufficient to find a significant difference if the antimicrobial agent 
was able to cause a change in the concentration of aerobic flora of 
ten-fold or more. Therefore, in the next six volunteers the pre-
treatment period was shortened to ten days (Volunteers 6-11). In 
these six volunteers we investigated the influence of amoxycillin on 
the faecal concentration of the aerobic flora as before. Moreover, to 
be independent of the accidental presence of resistant Gram-negative 
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bacilli, we also administered 10' cfu of amoxycillin-resistant 
challenge strains on the fifth day of the pre-treatment period and of 
the treatment period. 
Daily faecal production was a selection criterion for the volunteers 
for tíiis study. If more than one motion was passed, a sample of the 
morning portion was used for analysis. The data from the first day 
of antibiotic administration were not used for analysis. These 
samples cannot be used as pre-treatment samples as they may be 
influenced by drug treatment if they are produced after the first 
dosage of amoxycillin. On the other hand, the morning-samples of 
the first day of treatment will barely be influenced by the antibiotic. 
Therefore the faecal samples of the second day of treatment were 
counted as the first treatment samples and the morning-samples after 
the last day of amoxycillin-administration were counted as the last 
treatment samples. 
Volunteers 
Five healthy volunteers (two female, three male), age 27, 41, 42, 44 
and 53, participated in the first part of the study. Six other healthy 
volunteers (three female, three male), age 23, 25, 32, 40, 48 and 51 
participated in the second part of the study. The volunteers had not 
used antibiotics for at least one month before the start of the study. 
Written informed consent was obtained. Permission for this study 
was obtained from the ethics committee of the Canisius-Wilhelmina 
Hospital. 
Drugs 
Amoxycillin (Clamoxyl (R), Beecham) 500 mg capsules were 
administered three times daily after meals. 
Challenge 
As challenge strains we used a strain of Klebsiella pneumoniae and a 
strain of Enterobacter cloacae. Each strain was used in three volun-
teers of the second set (6-11). Both strains were highly resistant to 
amoxycillin (MICs 128 mg/1 and 256 mg/1, respectively). The K. 
pneumoniae strain was highly resistant to pefloxacin (MIC = 56 
mg/1) but susceptible to co-trimoxazole and cefotaxime. The E. 
cloacae strain was highly resistant to cefotaxime (MIC = 256 mg/1) 
but sensitive to quinolones. In this way, the challenge strains could 
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easily be isolated from faeces with selective culture media. At the 
same time, effective antibiotics would be available in case of 
infection by the challenge strains. The challenge strains were 
administered on the fifth day of the pre-treatment and of the 
treatment period in a dosage of 10" cfu. For administration, colonies 
of the challenge strain, grown overnight on solid media, were 
suspended in a glass of water, and drunk after a warm meal. In this 
situation, the bacterial suspension was expected to bypass the acidic 
environment of the stomach. 
Bacteriology 
Serial 1/10 dilutions of faeces were made in Thioglycollate medium 
(BBL). One-microlitre volumes of each dilution were inoculated on 
to solid media to isolate Gram-negative bacilli (Eosin methylene-
blue lactose sucrose agar, Merck), amoxycillin-resistant Gram-
negative bacilli (5% sheep blood in blood agar base, Oxoid, with 
amoxycillin 10 mg/1), cefotaxime-resistant Gram-negative bacilli 
(5% sheep blood in blood agar base, Oxoid, with cefotaxime 32 
mg/1), pefloxacin-resistant Gram-negative bacilli (Eosin methylene-
blue lactose sucrose agar, Merck, with Pefloxacin 5 mg/1), entero-
cocci (5% sheep blood in blood agar base, Oxoid, with nalidixic 
acid 50 mg/1), and yeasts (Sabouraud dextrose agar, Gibco, with 
chloramphenicol 125 mg/1). The solid media were also inoculated 
with 100-microlitre volumes of the first 1/10 dilutions of faeces, 
lowering the detection limit to 100 micro-organisms per gram of 
faeces. Concentrations were expressed as the logarithms to the base 
of 10 of the counts per gram of faeces, rounded up or down to 
whole numbers. 
Micro-organisms isolated were identified by standard laboratory 
methods. 
Statistics 
The influence of amoxycillin on the faecal concentration of aerobic 
flora was evaluated for each volunteer individually, using single-
case statistical techniques (5, 6). The absence of serial dependency 
of the data within each volunteer was verified by computing auto-
correlations for time lags of one to four days for each series of data. 
For time lags of two to four days the correlation coefficients 
scattered around zero value, as expected under the null-hypothesis of 
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zero correlation. For a time lag of one day a slight auto-correlation 
(r = 0.14) did not disprove sufficiently the prerequisite indepen-
dence of observations. Thus the Mann-Whitney-Wilcoxon test could 
be employed to evaluate the influence of amoxycillin on the concen-
tration of Gram-negative bacilli, enterococci and yeasts in faeces. 
The counts in the pre-treatment samples were used as a baseline. 
Results 
Volunteers 
Volunteer 8 acquired symptomatic Candida-vaginitis on day 7 of the 
amoxycillin-period, confirmed by culture. Complaints disappeared 
within 2 days following local application of a miconazole vaginal 
ovula (Daktarin R) 1200 mg. Amoxycillin-treatment was not 
discontinued. The other volunteers did not experience major 
complaints, although most of them reported some increase in 
defecation frequency. 
One volunteer showed an unexpected response to the E. cloacae 
challenge strain. In this volunteer (male, 36 years old) the faecal 
concentration of E. chacea was 10'° cfu/g on the second day after 
the challenge dose. Before the challenge dose the aerobic faecal flora 
was quite normal: Gram-negative bacilli 10*-108 cfu/g, enterococci 
lOMO5 cfu/g and yeast 103 cfu/g. He had not used antibiotics or any 
other drugs for several years and didn't have any health problem. 
Although this volunteer remained completely symptom-free, it was 
decided to take him out of the trial and to start decontamination with 
norfloxacin 400 mg twice daily. The challenge strain was below 
detection limit in faeces (102 cfu/g) following 4 days of treatment 
with norfloxacin. The faecal concentration of E. cloacae had been 
lOMO10 cfu/g (median 10' cfu/g) for seven days. This volunteer was 
replaced by another one in this trial. 
Faecal concentration of aerobic flora 
The median level and range of the faecal concentration of Gram-
negative bacilli, enterococci and yeasts in volunteers 1-5 are shown 
in Table I. 
From the fluctuation of the faecal concentration of aerobic flora in 
the 20-day pretreatment period, it was estimated that a 10-day 
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pretreatment period would have been sufficient in these volunteers to 
demonstrate a ten-fold increase or decrease of faecal concentration 
with statistical significance (P < 0.05). Therefore it was decided to 
shorten the pre-treatment period to ten days in the next six volun-
teers. For comparison with the data of volunteers 6-11, the data of 
volunteers 1-5 were recalculated, using the data of the last ten days 
of the 20-day pretreatment period as a baseline for the amoxycillin-
period. These data and the data of volunteers 6-11 are shown in 
Table II. In eight of 11 volunteers a significant increase in the faecal 
concentration of Gram-negative bacilli and/or yeasts was observed. 
Challenge strain 
In four of six volunteers amoxycillin did not facilitate colonization 
of the bowel by the challenge strain (Table III). 
In volunteer 7 the challenge strain re-appeared in faeces on day 2 of 
the amoxycillin-period, following four days with negative faecal 
samples. The faecal samples remained positive as long as amoxy-
cillin was administered, but they were negative again after day 1 of 
the post-treatment period. 
In volunteer 11 the first sample positive for the challenge strain in 
the amoxycillin-period occurred on the day after the challenge. In 
this volunteer the faecal samples of the post-treatment period 
remained positive during the amoxycillin-period and during the 10 
post-treatment days. 
Spontaneous secondary colonization with Gram-negative bacilli 
Table IV shows the influence of amoxycillin on the faecal concen-
trations of Gram-negative bacilli other than E. coli (secondary 
colonization), excluding the challenge strain. 
Following amoxycillin significant increase of spontaneous secondary 
colonization was found in seven of eight volunteers in whom dis-
turbance of the anaerobic flora that provides CR was also indicated 
by increase of the faecal concentration of aerobic flora (Table V). 
No increase in secondary colonization was found in the three 
remaining volunteers, in whom the faecal concentration of Gram-
negative bacilli and yeasts did not increase. In all volunteers E. coli 
was the dominant species of Gram-negative bacilli in all pre-
treatment samples. Apart from the challenge strains, no pefloxacin-
resistant or cefotaxime-resistant Gram-negative bacilli were detected. 
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During the amoxycillin-period the concentration of secondary Gram-
negative bacilli exceeded the concentration of E. coli in faecal 
samples of some volunteers, as in our previous study with 
amoxycillin (4). 
Discussion 
Analysis of data in volunteers separately 
This study confirms the impairment of CR against Gram-negative 
bacilli and yeasts by amoxycillin that we found in a previous study 
(4). In that study however, we applied conventional group analysis. 
We now think it is preferable to analyze the data in volunteers 
individually, because important data are lost when group-analysis is 
applied in biomedical studies if the study-subjects do not behave 
homogeneously (5, 6, 7). For example, amoxycillin or ceftriaxone 
do not always impair CR, probably because some people harbour 
bèta-lactamase-producing anaerobic flora. (8, 9). If the anaerobic 
flora that provides CR is not susceptible and E. coli is susceptible to 
amoxycillin, the faecal concentration of Gram-negative bacilli may 
even decrease, as happened in volunteer 4. If this occurs in a 
substantial part of the volunteers the median faecal concentration of 
Gram-negative bacilli of the group of volunteers may remain 
unchanged, even if CR is impaired in several volunteers. 
Faecal concentration of aerobic flora 
In our view, the total concentrations of Gram-negative bacilli, 
enterococci and yeasts in the digestive tract are limited by 
autochthonous obligate anaerobic flora (1). If the anaerobic flora that 
provides CR is disturbed by an antimicrobial agent, an increase is to 
be expected in the faecal concentration of Gram-negative bacilli, 
enterococci and yeasts, unless resistant species are not available. 
Most enterococci are sensitive to amoxycillin. In this study, all 
volunteers had at least one negative faecal sample for enterococci in 
the amoxycillin-period (Table II) and the median faecal concen-
tration of enterococci decreased at least ten-fold in eight of 11 
volunteers. In volunteer 10 a decrease was not possible because only 
two pretreatment samples were positive for enterococci. However, 
administration of amoxycillin may cause selection of resistant 
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enterococci in the bowel. In volunteer 8 amoxycillin eliminated 
enterococci from the first four faecal samples, but the following 
samples were positive and the faecal concentration of enterococci 
increased to 10' cfu/g in the last treatment sample. In this volunteer, 
the faecal concentration of enterococci in the last six samples of the 
amoxycillin-period was significantly higher than in the pre-treatment 
period (P = 0.02), indicating impairment of CR against enterococci. 
We conclude that in general the faecal concentration of enterococci 
is not suitable as an indicator for impairment of CR by amoxycillin, 
because most available enterococci are too sensitive. In this regard, 
volunteer 8 was exceptional. 
Good correlation was found between the influence of amoxycillin on 
the faecal concentrations of Gram-negative bacilli and of yeasts 
(Table V). In seven volunteers (1, 2, 3, 5, 6, 7 and 8) both were 
increased and in three volunteers (4, 9 and 10) both were not 
increased. Only in volunteer 11 the significant increase in the faecal 
concentration of yeasts was not accompanied by a significant in-
crease in the concentration of Gram-negative bacilli. In this volun-
teer however, increase of the faecal concentration of Gram-negative 
bacilli and yeasts was very small, indicating minor impairment of 
anaerobic flora (Table II). Moreover, the fluctuation of the faecal 
concentration of Gram-negative bacilli in faeces of this volunteer 
was exceptionally high. Therefore in this volunteer the number of 
samples was too small to expect statistically significant results for a 
tenfold increase of the faecal concentration of Gram-negative bacilli. 
The data in volunteer 8 support the hypothesis that disturbance of 
the flora that provides CR causes an increase in the faecal concen-
tration of Gram-negative bacilli as well as of enterococci and of 
yeasts. The simultaneous increase of the concentration of all three 
groups of aerobic flora in volunteer 8 indicates that none of them 
limits the concentration of the other ones. This supports the hypo-
thesis that the limiting action on the concentration of aerobic flora is 
provided by anaerobic flora. 
Secondary colonization 
Apart from an increase in the faecal concentration of resistant in-
digenous aerobic flora, impairment of anaerobic flora that provides 
CR may also increase secondary colonization by strains acquired 
spontaneously or by challenge strains administered on purpose. 
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In three volunteers (4, 9 and 10) amoxycillin did not cause an 
increase in the faecal concentration of Gram-negative bacilli or 
yeasts, indicating no disturbance of the anaerobic flora that provides 
CR. In these volunteers increase of secondary colonization by the 
challenge strains (volunteers 9 and 10) or by spontaneously occur-
ring Gram-negative bacilli (volunteers 4, 9 and 10) did also not 
occur (Tables III, IV, V). So, in these three volunteers all indicators 
for impairment of CR we investigated were negative (Table V). In 
five volunteers (1, 2, 3, 7 and 11) increase in their faecal concen-
trations of Gram-negative bacilli and/or yeasts indicated disturbance 
of the anaerobic flora that provides CR (Table II). In volunteers 1, 
2, and 3 this was associated with an increase in secondary 
colonization by spontaneously occurring Gram-negative bacilli 
(Table V). (In these volunteers challenge strains were not 
administered). In volunteers 7 and 11 increase in the concentration 
of aerobic flora was associated with an increase of secondary 
colonization by both spontaneously occurring and intentionally 
administered Gram-negative bacilli (Tables III, IV, V). So, in these 
five volunteers both the data for secondary colonization and the data 
for the faecal concentration of aerobic flora indicated disturbance of 
the anaerobic flora that provides CR (Table V). However, in the 
remaining three volunteers (5, 6, 8), increase in the faecal 
concentration of aerobic flora was not associated with an increase of 
spontaneously occurring secondary colonization (volunteer 5) or 
facilitation of colonization by the challenge strain (volunteers 6 and 
8). In volunteer 5, we found no statistically significant increase of 
the concentration of spontaneously occurring Gram-negative bacilli 
(Table IV). However, the first three treatment samples in this 
volunteer contained much higher concentrations of secondary Gram-
negative bacilli (106-10* cfu/g) than all pretreatment samples (Table 
IV). In the succeeding faecal samples the concentration of E. coli 
increased to high levels and secondary colonization could no longer 
be detected. However, this does not prove absence of secondary 
colonization, because it cannot be excluded that secondary 
colonization persisted in a concentration lower than the faecal 
concentration of E. coli. This points to a technical problem in 
studying spontaneously occurring secondary colonization. To exclude 
low level secondary colonization in volunteer 5 an appropriate 
selective medium should have been chosen after determination of the 
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antibiotic sensitivities of the strain of E. coli and the secondary 
strain that colonized this volunteer in the first few days of the 
amoxycillin-period, but this was not foreseen in the study design. Of 
course it is still possible that in volunteer 5 secondary colonization 
really disappeared, for example by competition with the increasing 
number of organisms of indigenous E.coli. 
In volunteers 6 and 8, not a single sample was positive for the 
K. pneumoniae challenge strain during the amoxycillin-period (Table 
III), although in both volunteers amoxycillin caused colonization by 
high concentrations of spontaneously acquired secondary Gram-
negative bacilli. The sensitivity profile of the challenge strain and 
the use of selective medium would have made the challenge strain 
detectable, even if outnumbered by other Gram-negative bacilli. We 
suggest that the challenge strain could not demonstrate impairment 
of CR in volunteers 6 and 8 because it lost the competition with 
other secondary Enterobacteriaceae or E. coli (Table V). 
Competition between Gram-negative bacilli has been demonstrated 
before. In streptomycin- pretreated mice and guinea pigs E. coli 
accelerated elimination of Shigella flexneri from faeces (10). 
Moreover, it has been shown in an in vitro model that from two 
microbial species that compete for the same ecological niche 
(mucosal receptors or food substrate) a competitive advantage exists 
for the first arriving species (11). So the success of a challenge 
strain, even in subjects with impaired CR, will depend on the time 
of administration, on the characteristics of the challenge strain and 
on the susceptibility of indigenous aerobic species and of species in 
food to the antimicrobial agent under investigation. Therefore, 
challenge strains are not always the most sensitive indicators for 
impairment of CR. 
We conclude that disturbance of the anaerobic flora that provides 
CR, frequently causes an increase in colonization of the bowel by 
secondary Gram-negative bacilli, but not necessarily so (false 
negative results). Conversely, on present evidence, it cannot be 
excluded that indigenous Gram-negative bacilli are also involved in 
the prevention of low-level secondary colonization of the bowel by 
exogenous Gram-negative bacilli (4, 12), making it uncertain 
whether increase of secondary colonization really proves disturbance 
of the anaerobic flora that provides CR (false positive results). So, 
because secondary colonization might be a false negative indicator as 
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well as a false positive indicator of disturbance of the anaerobic flora 
that provides CR, increase in the faecal concentration of aerobic 
flora is a more reliable indicator of impairment of this flora than 
increase of secondary colonization. Van Saene et al. concluded from 
their study with amoxycillin that secondary colonization by resistant 
challenge strains is the most sensitive indicator of impairment of CR 
(13). However, they used only three faecal samples from the amoxy-
cillin period. Such a study design allows detection of facilitation of 
secondary colonization, but is not suitable to detect a small increase 
in the total faecal concentration of groups of aerobic flora. So, part 
of the difference between their conclusion and ours may be ex-
plained by difference in study design. 
The high-level faecal colonization with E. cloacae in volunteer 12 
after challenge in the pretreatment period was totally unexpected. To 
our knowledge, successful high-level colonization of the bowel in 
healthy volunteers, following challenge with a low dosage of 
secondary Gram-negative bacilli, has never been described. This 
volunteer had been healthy all his life. His faecal flora before the 
challenge was quite normal. If this volunteer was so susceptible to 
secondary colonization, it is difficult to understand why this did not 
happen before with strains ingested with food. Exceptional 
colonizing properties of the challenge strain were not found in the 
three other volunteers who ingested this strain, even although one of 
those (volunteer 7) was very susceptible to secondary colonization 
following administration of amoxycillin (Table IV). 
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Table I. Influence of amoxycillin on aerobic faecal flora*, in 
the first part of the study 
Volun- Gram-negative 
teer bacilli 
number A В 
1 6( 6-8) 7(6-9)* 
2 6( 2-7) 7(4-8)** 
3 6( 4-7) 8(6-9)** 
4 6( 4-7) 4(3-5)"' 
5 2(<2-4) 8(5-9)** 
Enterococci 
A 
5(3-6) 
5(3-8) 
7(6-9) 
5(4-6) 
7(6-8) 
В 
2(<2-5)--
3(<2-5)·· 
5(<2-8) 
<2(<2-5)" 
3(<2-7)" 
Yeasts 
A 
<2(<2-2) 
<2(<2-2) 
<2(<2-2) 
<2(<2-<2) 
2(<2-3) 
В 
2(<2-4)** 
3(<2-4);* 
4( 3-6)** 
<2(<2-2) n s 
4( 3-4)** 
: Log10 median faecal concentration (cfu/g) and range. 
A : Pre-treatment period (n=20) ; В : Treatment period (n=10). 
** or " : Ρ < 0.01 ; * or ' : Ρ < 0.05 ; "* : Ρ > 0.05, two sided 
significance of a difference in concentration between periods 
A and В 
Table II. Influence of amoxycillin on aerobic faecal flora* in 
11 volunteers 
Volun- Gram-i negative 
teer bacilli 
number A 
1 6( 6-8) 
2 4( 2-7) 
3 6( 4-7) 
4 6( 4-7) 
5 3(<2-4) 
6 5( 3-6) 
7 6( 4-7) 
8 3(<2-4) 
9 7( 4-8) 
10 5(<2-7) 
11 6( 3-8) 
В 
7(6-9)** 
7(4-8); 
8(6-9)** 
4 ( з - 5 ) ; ; 
8 ( 5 - 9 ) ; ; 
8 ( 6 - 9 ) ; ; 
8(6-8)** 
8(3-9)** 
7(5-9)™ 
6(2-9) г а 
7(3-8) n s 
5( 
5( 
7( 
5( 
6( 
4( 
6( 
4( 
Enterococci 
A 
3-6) 
3-8) 
6-9) 
4-6) 
6-8) 
3-5) 
3-8) 
2-5) 
4(<2-5) 
<2(<2-3) 
5( 4-6) 
В 
2(<2-5)" 
3(<2-5) · 
5(<2-8)-
<2(<2-5)"" 
3(<2-7)'-
2(<2-3)-
5(<2-6) n s 
6(<2-9) n e 
4(<2-6) n s 
<2(<2-3) т е 
3(<2-4) г е 
A 
<2(<2-
2(<2-
2(<2-
<2(<2-
2(<2-
2(<2-
4( 3-
3(<2-
<2(<2-
3(<2-
3( 2-
Yeasts 
2) 
2) 
2) 
<2) 
3) 
4) 
5) 
4) 
2) 
4) 
3) 
В 
2(<2-
3(<2-
4( 3-
<2(<2-
4( 3-
3( 3-
5( 4-
5( 3-
<2(<2-
3(<2-
3( 3-
4) . 
4) 
6 ) " 
2 ) l l b 
AK' 4)* 
5C 7)** 
сг)'"· 
s)'"· 
4)* 
: Log10 median faecal concentration (cfu/g) and range. 
A : Pre-treatment period (n=10) ; В : Treatment period (n=10). 
** or : Ρ < 0.01 ; * or : Ρ < 0.05 ; ns : Ρ > 0.05 , two 
sided significance of a difference between periods A and B. 
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Table III. Influence of amoxycillin on colonization by challenge 
strains 
Volun­
teer 
number 
6 
7 
8 
9 
10 
11 
K. 
E. 
K. 
E. 
K. 
E. 
Challenge 
strain' 
pneumoniae 
cloacae 
pneumoniae 
cloacae 
pneumoniae 
cloacae 
Pre-
-treatment 
period 
c«," 
103 
105 
102 
<102 
<10г 
<102 
duration' 
2 
2 
1 
0 
0 
0 
Treatment 
period 
С
 D 
max 
<102 
10* 
<10г 
<102 
<10г 
10* 
duration' 
0 
9d 
0 
0 
0 
>15e 
Oral administration of 10 cfu on fifth day of pre-treatment 
and treatment period. Maximal faecal concentration (cfu/g) 
Number of days with positive faecal samples. Challenge 
strain re-appeared spontaneously on day 2 of amoxycillin period. 
e
 : Challenge strain had not disappeared at day 10 of the post-
treatment period. 
Table IV. Influence of amoxycillin on faecal concentration8 of 
Enterobacteriaceae other than E. coli (secondary colonization)15 
Volunteer 
number 
Pre-treatment period 
(n=10) 
Treatment period 
(n=10) 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
<2 
<2 
3 
<2 
2 
<2 
2 
<2 
<2 
3 
<2 
(<2- 4) 
(<2- 6) 
(<2- 6) 
(<2-<2) 
(<2- 3) 
(<2-<2) 
(<2- 4) 
(<2- 3) 
(<2-<2) 
(<2- 5) 
(<2-<2) 
3 
5 
7 
<2 
<2 
8 
7 
8 
<2 
2 
3 
ь . 
<2- 6)* 
4- 7 ) -
3- 8) 
<2-<2)ns 
<2- 8) n s 
<2- 9 ) ^ 
<2- 8) 
2- 9 ) " 
<2-<2)ns 
<2- 8) n s 
<2- 5)** 
Challenge a : Log10 median concentration (cfu/g) and range. 
strains are not taken into account. 
** or " : Ρ < 0.01 ; * or : Ρ < 0.05 ; "* : Ρ > 0.05, two sided 
significance of a difference in concentration between periods A 
and B. 
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Table У. Influence of amoxycillin on indicators of impairment of 
colonization resistance of the bowel 
Faecal concentration of: 
Volunteer Gram negative Yeasts Secondary Challenge 
number bacilli GNB" Strain 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
1 1 
+ 
+ 
+ 
-
+ 
+ 
+ 
+ 
_ 
-
+ 
+ 
+ 
-
+ 
+ 
+ 
+ 
_ 
+ 
+ 
+ 
+ 
-
-
+ 
+ 
+ 
_ 
+ 
# 
# 
# 
# 
# 
-
+ 
-
_ 
+ 
• : Gram-negative bacilli. 
# : Not done. 
+ : Increase. 
- : No increase. 
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Abstract 
The influence of cefotaxime 1000 mg given intravenously bid on 
colonization resistance (CR) was investigated in six healthy volun-
teers. Administration of cefotaxime allowed colonization of the 
bowel by a resistant challenge strain of Enterobacter cloacae in all 
volunteers. The faecal concentration of aerobic flora increased 
significantly in five of six volunteers. In one the faecal concentration 
of Gram-negative bacilli, enterococci and yeasts increased. In the 
other four the faecal concentration of enterococci and yeasts in-
creased, but Gram-negative bacilli did not rise above pretreatment 
level. It is concluded that cefotaxime impairs CR, although to a 
variable degree. Therefore the term "selective decontamination" is 
not fully justified for prophylactic regimens that include cefotaxime. 
Introduction 
Microbial CR limits the concentration of indigenous aerobic flora of 
the digestive tract and its colonization by potentially pathogenic 
aerobic micro-organisms ingested with food. Microbial CR is prob-
ably provided by autochthonous anaerobic flora (1,2). Therefore it 
should be possible to eliminate aerobic flora from the bowel without 
impairing CR. This is called selective decontamination. Prophylactic 
regimens designed to provide selective decontamination have been 
used successfully in neutropenic patients (1), in patients on mechan-
ical ventilation (3), and in patients with transurethral catheters (4). 
However, selectivity to aerobic flora has not been proved for any of 
these regimens by challenge with resistant micro-organisms. There-
fore, it is possible that the success of these regimens is caused by 
their broad spectrum of activity against aerobic flora and high 
concentration in the digestive tract, despite some disturbance of the 
anaerobic flora that provides CR. 
Parenteral administration of cefotaxime is included in most regimens 
for selective decontamination in intensive care patients, to prevent 
early infection with indigenous flora (5). Cefotaxime was chosen as 
part of the original Groningen-regimen, because of its useful spec-
trum against pulmonary pathogens and the absence of influence on 
microbial CR in an unpublished mouse-study (3). However, in a 
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recent study it was found that cefotaxime impaired CR against 
enterococci in mice treated according to the Groningen-regimen (6). 
Moreover, the influence of cefotaxime on microbial CR has never 
been investigated in man. We therefore decided to investigate the 
influence of cefotaxime on microbial CR in human volunteers. 
Because we expected a low prevalence of cefotaxime-resistant 
Gram-negative bacilli in the bowel of our volunteers and in food, we 
administered challenge doses of a highly resistant strain of 
Enterobacter cloacae. 
Methods 
Study design 
Daily faecal samples from volunteers were analyzed for the con-
centration of Gram-negative bacilli, enterococci and yeasts during a 
pre-treatment period, a cefotaxime-period and a post-treatment 
period of ten days each. If more than one motion was passed, a 
sample of the first motion of that day was used for analysis. The 
faecal samples of the first day of the cefotaxime-period were not 
used for analysis and the sample of the first day after the 
cefotaxime-period was counted as the last treatment sample, as 
described before (7). On the third day of the pretreatment period , 
the normal CR of the volunteers was challenged by oral 
administration of a cefotaxime-resistant strain. The challenge was 
repeated on the third day of the cefotaxime period. 
Volunteers 
Six male healthy volunteers, aged 19-44 years, participated in the 
study. The volunteers had not used antibiotics for at least one month 
prior to the start of the study. 
Written informed consent was obtained and permission for this study 
was obtained from the ethics committee of the Canisius-Wilhelmina 
hospital. 
Drugs 
Cefotaxime 1000 mg was administered intravenously twice daily at 
9.00 and at 17.00 hours. The antibiotic was dissolved in 4 ml 
water for injection and slowly injected. 
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Challenge 
As a challenge strain we administered 10e cfu of a strain of Entero-
bacter cloacae , highly resistant to cefotaxime (MIC = 256 mg/1), 
but sensitive to quinolones. In this way, the challenge strain could 
easily be isolated with selective culture medium. At the same time, 
effective treatment would be available in case of infection with the 
challenge strain. The same strain has been used in a previous study 
with amoxycillin (7). 
Bacteriology 
Serial 1/10 dilutions of faeces were made in Thioglycollate medium 
(BBL). One-microlitre volumes of each dilution were inoculated on 
to solid media to isolate Gram-negative bacilli (Eosin methylene-blue 
lactose sucrose agar, Merck), the challenge strain (Mc Conkey agar 
with cefotaxime 32 mg/1), amoxycillin-resistant Gram-negative 
bacilli (5% sheep blood in blood agar base, Oxoid, with amoxycillin 
10 mg/1), enterococci (5% sheep blood in blood agar base, Oxoid, 
with nalidixic acid 50 mg/1), and yeasts (Sabouraud dextrose agar, 
Gibco, with chloramphenicol 125 mg/1). The solid media were also 
inoculated with 100-microlitre volumes of the first 1/10 dilutions of 
faeces, lowering the detection limit to 100 micro-organisms per 
gram of faeces. Concentrations were expressed as the logarithms to 
the base of 10 of the counts per gram of faeces, rounded up or down 
to whole numbers. 
Micro-organisms isolated were identified by standard laboratory 
methods. 
Statistics. 
Because the faecal concentration of antibiotics and the antibiotic-
sensitivity of the anaerobic flora that provides CR may differ be-
tween volunteers, the data were analyzed for each volunteer indi-
vidually, using single-case statistical techniques (7). The absence of 
serial dependency of the data was verified by computing auto-correl-
ations for time lags of one to four days for each series of data. For 
time lags of two to four days the correlation coefficients scattered 
around zero value, as expected under the null-hypothesis of zero 
correlation. For a time lag of one day a slight autocorrelation (r = 
0.15) did not disprove sufficiently the prerequisite independence of 
observations. Thus the Mann-Whitney-Wilcoxon test could be 
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employed to evaluate the influence of cefotaxime on the faecal 
concentrations of Gram-negative bacilli, enterococci and yeasts. The 
counts in the pretreatment samples were used as a baseline. 
Results 
Volunteers 
Volunteer 1 got bowel cramps on the sixth day and bloody diarrhoea 
on the seventh day of cefotaxime-administration. The faecal concen-
tration of E. cloacae in the sample of the first day after the chal-
lenge was 1010 cfu/g. Therefore oral administration of norfloxacin 
400 mg bid was started and administration of cefotaxime was stopp-
ed. Because Clostridium difficile toxin was also found the volunteer 
was treated with oral metronidazole 500 mg tid at the same time. 
Three days later E. cloacae and C. difficile toxin were absent. Com-
plaints gradually subsided and disappeared in about five days. No 
problems occurred in the other volunteers. 
Faecal concentration of aerobic flora (Table I). 
The faecal concentration of Escherichia coli declined in all volun-
teers following administration of cefotaxime. After the challenge, 
the concentration of E. coli could not be determined in four of six 
volunteers, because it was lower than the concentration of the 
challenge strain and because a selective medium was not available 
for isolation of E. coli when outnumbered by the challenge strain. 
In volunteer 1 the faecal concentration of E. cloacae in the four 
samples between challenge and start of norfloxacin-therapy was 
significantly above the faecal concentration of Gram-negative bacilli 
in the pre-treatment period (P < 0.01). In the other five volunteers 
cefotaxime did not cause an increase in the faecal concentration of 
Gram-negative bacilli, because the concentration of E. cloacae did 
not increase above the original concentration of E. coli. 
The median faecal concentration of enterococci increased 100- to 
10,000-fold in five of six volunteers. The median faecal concen-
tration of yeasts increased ten-fold in the same volunteers. 
97 
Challenge strain (Table II). 
In the pre-treatment period, the faecal concentration of the challenge 
strain remained below detection limit (102 cfu/g) in three of six 
volunteers. In the other volunteers the challenge strain could be de-
tected for one, three and four days respectively. 
Cefotaxime markedly impaired resistance against colonization by the 
challenge strain. Volunteer 1 had one morning-sample with 1010 
cfu/gram and three morning-samples with 108 cfu/g of E. cloacae, 
before he was taken out of the trial because of side effects, as 
previously described. In the other volunteers the bowel remained 
colonized with E. cloacae as long as cefotaxime was administered. 
In volunteers 4 and 5, post-treatment samples remained positive for 
three and five days respectively. In volunteers 2, 3 and 6 all ten 
post-treatment samples remained positive. 
Spontaneous secondary colonization with Gram-negative bacilli. 
In the pre-treatment period, faecal colonization with Gram-negative 
bacilli other than E. coli (secondary colonization with Gram-negative 
bacilli) was not detected in volunteers 2, 3 and 4. In volunteers 1 
and 5 only one sample was positive. In volunteer 6, six of ten 
samples contained Acinetobacter anitratus. In the cefotaxime-period 
only E. coli and the challenge strain were observed in volunteers 1, 
2, 3, 4 and 5. In volunteer 6 the A. anitratus persisted up to the 
challenge with E. cloacae. E. cloacae was the dominant species of 
Gram-negative bacilli in the succeeding samples. 
Discussion 
It is assumed that the concentration of aerobic flora in the digestive 
tract is limited by autochthonous obligate anaerobic flora, and that 
disturbance of this flora by administration of an antimicrobial agent 
will cause an increase of aerobic flora if resistant species are present 
(1, 2). Since the anaerobic flora that provides this CR is unknown, 
disturbance of this flora can only be measured indirectly (7). 
The aerobic faecal flora might be divided into three groups : Gram-
negative bacilli. Gram-positive cocci and yeasts. To our knowledge 
it has never been shown that one of these groups limits the faecal 
concentration of one of the other two. 
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If there is one anaerobic flora that provides CR, disturbance of this 
flora will cause a simultaneous increase of the faecal concentration 
of all three groups of aerobic flora. In a previous study with amoxy-
cillin we found no impairment of CR in three of 11 volunteers. In 
seven of eight of the other volunteers the faecal concentrations of 
both Gram-negative bacilli and yeasts were significantly increased. 
In these volunteers the faecal concentration of enterococci was not 
increased, but this could be explained by a low prevalence of 
amoxycillin-resistant enterococci (7). 
The influence of cefotaxime on indicators of disturbance of the CR 
flora is less clear-cut (Table III). In volunteer 6 the faecal concentra-
tions of Gram-negative bacilli, enterococci and yeasts were not in-
creased, indicating no disturbance of the flora that provides CR. In 
volunteer 1 the faecal concentrations of all three groups of aerobic 
flora were increased, indicating disturbance of the flora that provides 
CR. In volunteers 2, 3, 4 and 5 however, the faecal concentrations 
of enterococci and yeasts were increased, but the concentration of 
Gram-negative bacilli did not increase above pre-treatment level, 
although these volunteers were colonized with the resistant challenge 
strain. An explanation might be that the concentration of Gram-nega-
tive bacilli in the bowel is limited by other anaerobic species than 
the concentration of yeasts and of aerobic Gram-positive cocci. 
Further research is required to test this theory. 
Cefotaxime caused colonization by the challenge strain in all six 
volunteers. However, in volunteer 6 the faecal concentration of 
Gram-negative bacilli, enterococci and yeasts did not increase above 
pretreatment level. So, in this volunteer, facilitation of secondary 
colonization with the resistant challenge strain appeared to be the 
most sensitive indicator of impairment of the flora that provides CR 
against Gram-negative bacilli. Conversely, increase of the faecal 
concentration of Gram-negative bacilli was the most sensitive indi-
cator of disturbance of CR-flora in a previous study with amoxycil-
lin (7). In that study, however, the challenge strain had to compete 
with increased concentrations of resistant Gram-negative bacilli 
present before the challenge, while in this study with cefotaxime the 
concentration of indigenous Gram-negative bacilli was decreased. 
Cefotaxime did not increase secondary colonization by spontaneous-
ly occurring Gram-negative bacilli, confirming a low prevalence of 
cefotaxime-resi slant strains in the bowel of volunteers and in food. 
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The incidence of superinfections following cefotaxime has been 
reported to be remarkably low (8). Nevertheless, our study shows 
that cefotaxime 1000 mg intravenously bid impairs microbial CR in 
human volunteers. Therefore, the same can be expected in patients. 
The increase of the faecal concentration of enterococci following 
administration of third generation cephalosporins might be one 
explanation of the recent observation of a striking increase of the 
relative percentage of enterococcal infections in hospitals in the last 
decade {although the absolute percentage of these infections remains 
low ;(9)}. Increase of the faecal concentration of yeasts and entero-
cocci in volunteers 1 - 5 , and of E. doaceae in volunteers 1-6 
suggest that cefotaxime may increase the risk of infection by yeasts, 
by enterococci and by resistant Gram-negative bacilli. This is in 
agreement with the report that the 1.1% superinfections in 2,187 
patients following cefotaxime were caused by Pseudomonas spp. (11 
isolates), Enterobacter spp. (five isolates), Candida spp. (three iso-
lates) and enterococci (two isolates), (10). In our study, sponta-
neous secondary colonization by Gram-negative bacilli other than the 
resistant challenge strain was not found in any volunteer during the 
cefotaxime-period. This confirms that the prevalence of cefotaxime-
resistant Gram-negative bacilli is low. Moreover, the faecal concen-
tration of the challenge strain remained low in five of six volunteers. 
On the contrary, following amoxycillin many volunteers are colon-
ized by spontaneously occurring secondary Gram-negative bacilli in 
concentrations exceeding the original concentration of E. coli (7, 
11). We therefore consider cefotaxime a safer drug than amoxycil-
lin, concerning the risk of superinfections with Gram-negative 
bacilli; at least in a dosage of 2 gram daily and in case of normal 
kidney and liver function. The success of cefotaxime-containing 
prophylactic regimens (5) is achieved, however, despite some 
impairment of CR. Apparently, the antimicrobial spectrum of activi-
ty of these regimens is broad enough to prevent an increase in 
potentially pathogenic flora in the digestive tract. 
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Table I.Influence of cefotaxime on faecal concentration of 
aerobic flora* 
Volun- Gram-negative Enterococci Yeasts 
teer bacilli 
number A B A B A B 
1 7 (5-8) (a) ** 5 (4-7) β (5-8)~ 2 (2-3) 3 (3-4)* 
2 7 (5-8) б (4-7)"" 4(<2-7) 6 (4-6)~ 2(<2-3) 3(<2-4)* 
3 7 (4-7) 6 (4-6)ns 4 (3-7) 8 (5-8)++ 2(<2-3) 3(<2-6)** 
4 4(<2-6) 4(<2-5)ns 3(<2-4) 6 (3-7)** 2(<2-3) 3 (2-3)** 
5 6 (5-8) 5 (3-6)ns 3(<2-6) 7(<2-7)** 2(<2-2) 3 (2-4)** 
6 6(<2-6) 5(<2-6)ns 4(<2-5) 4(<2-6)ns 3(<2-4) 3(<2-4)ns 
: Logla median faecal concentration (cfu/g) and range. 
A : Pre-treatment period (n=10); В : Treatment period (n=10, 
except for volunteer 1; n=6) . 
(a) : Significant increase (P < 0.01) for four samples between 
challenge and termination of treatment because of side effects. 
** or "" : Ρ < 0.01; * or : Ρ < 0.05 ; ns : Ρ > 0.05, two 
sided significance of a difference in concentration between 
periods A and B. 
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Table II. Influence of cefotaxime on colonization of the bowel 
by the challenge strain' 
Volun- Pretreatment Treatment Post-treatment 
teer Period Period Period 
number Cinaxb duration0 Ста χ duration duration 
1 
2 
3 
4 
5 
6 
< 1 0 2 
1 0 2 
< 1 0 2 
< 1 0 2 
1 0 3 
1 0 5 
0 
3 
0 
0 
1 
4 
1 0 1 0 
1 0 4 
1 0 6 
1 0 5 
10 
1 0 6 
6 d 
8 
8 
8 
8 
8 
# 
10 
10 
3 
5 
10 
" : 106 cfu Enterobacter cloacae (MIC
cefotaxim, = 256 mg/1) on the 
third day of pre-treatment and treatment period. 
ь
 : Maximal faecal concentration (cfu/g). 
c
 : Number of days with positive faecal samples. 
d
 : Cefotaxime administration terminated on this day because of 
side effects. 
# : Administration of cefotaxime stopped in treatment period. 
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Table H Z . Influence of cefotaxime on indicators of impairment 
of colonization resistance of the bowel. 
Volunteer Faecal concentration of: 
number Gram-negative Enterococci Yeasts Challenge 
bacilli strain 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ : Increase. 
- : No increase. 
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CHAPTER Vili 
INFLUENCE OF CEPHRADINE ON MICROBIAL 
COLONIZATION RESISTANCE IN HEALTHY 
VOLUNTEERS 
E.J. Vollaard', H.A.L. Clasener" and A.J.H.M. Janssen'. 
Departments of "Pharmacy and "Microbiology, Canisius-Wilhelmina 
Hospital, St. Annastraat 289, 6525 GT Nijmegen, The Netherlands 
Abstract 
The influence of cephradine, 500 mg twice daily, on microbial 
colonization resistance (CR) was investigated in six healthy 
volunteers. Increase in the faecal concentration of Gram-negative 
bacilli, aerobic Gram-positive cocci or yeasts and increase in 
secondary colonization by strains acquired spontaneously or 
administered deliberately (challenge), were used as indicators for 
disturbance of the flora that provides CR. In two of six volunteers 
none of these indicators were found to be positive. In the other four 
volunteers minor impairment of CR was found. It is concluded that 
the flora that provides CR is not spared completely in all persons 
following cephradine 1 gram daily. However, the degree of 
impairment is much less than following amoxycillin. Therefore, the 
risk of superinfections is probably lower following cephradine. 
Introduction 
Antimicrobial agents may cause superinfections by disturbing the 
autochthonous anaerobic flora that provides CR (1). Therefore, it is 
preferable to select antibiotics for prophylaxis and for therapy that 
do not impair CR (2). Impairment of CR may go unnoticed if the 
prevalence of Gram-negative bacilli resistant to the intestinal 
concentration of the antibiotic is low, and if the number of samples 
in the study is too low to detect a small increase in the faecal 
concentration of indigenous aerobic flora (3). Therefore, up to now 
not a single antibiotic has been reliably classified as not sparing the 
microbial CR. 
At the first international congress on CR, it has been suggested that 
cephradine does not impair CR up to a dosage of 9 gram daily (4). 
Afterwards however, it has been found that cephradine strongly 
impairs CR in almost half of the patients in a dosage of 6 g daily 
(1). At a dosage of 1.5 g daily, cephradine selected much less 
resistant Gram-negative bacilli in faeces than amoxycillin 1.5 g daily 
(5). This suggests that cephradine at this dosage has less influence 
on CR than amoxycillin, but the difference could also be caused by 
a lower prevalence of cephradine-resistant strains than of 
amoxycillin-resistant strains. 
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Therefore we decided to start a new study for investigation of the 
influence of cephradine on the microbial CR, using a sufficiently 
high number of samples to detect a small increase in the faecal 
concentration of yeasts (3), and including challenge with a 
cephradine-resistant challenge strain. 
We used a dosage of 500 mg twice daily because we consider this 
dosage sufficiently high for treatment of urinary tract infections. 
Methods 
Study design 
Daily faecal samples were analyzed for their concentrations of 
Gram-negative bacilli, aerobic Gram-positive cocci and yeasts during 
a pre-treatment period, a treatment period and a post-treatment 
period of ten days each. 10' cfu of a cephradine-resistant challenge 
strain was administered at day 2 of the pre-treatment period and at 
day 5 of the treatment period. 
Volunteers 
Six healthy volunteers, one female (age 52 years) and five male (age 
20 - 49 years ; median age 41 years) participated in the study. The 
volunteers had not used antibiotics for at least one month before the 
start of the study. Written informed consent was obtained from the 
volunteers and permission for the study was granted by the ethics 
committee of the Canisius-Wilhelmina Hospital. 
Drug 
Cephradine 500 mg capsules were administered twice daily after 
meals. 
Challenge 
As a challenge, we used a strain of Klebsiella pneumoniae, that has 
been described before (3). The MIC for cephradine is 32 mg/1 and 
the MIC for Pefloxacin is 56 mg/1. Therefore, this strain can easily 
be isolated from faeces with selective culture medium. Because this 
strain is highly sensitive to cefotaxime and to co-trimoxazole, 
effective antibiotics are available in case of infection with the 
challenge strain. 
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An oral dose of 10' cfu of the challenge strain was administered on 
the second day of the pretreatment period and on the fifth day of the 
treatment period. Colonies of the challenge strain grown overnight 
on solid medium were suspended in saline. This suspension was 
poured in a glass of water, and drunk after a warm meal, 
immediately followed by another glass of water. In this way, the 
bacterial suspension was expected to bypass the acidic environment 
of the stomach. 
Bacteriology 
Serial 1/10 dilutions of faeces were made in Thioglycollate medium 
(BBL). One microliter-volumes of each dilution were inoculated on 
to solid media to isolate Gram-negative bacilli (eosin-methylene-
blue lactose sucrose agar, Merck), amoxycillin-resistant Gram-
negative bacilli (5% sheep-blood in blood agar base, Oxoid, with 
amoxycillin 10 mg/1), pefloxacin-resistant Gram-negative bacilli 
(McConkey agar, Oxoid, with norfloxacin 8 mg/1), enterococci and 
streptococci (5% sheep blood in blood agar base, Oxoid, with 
nalidixic acid 50 mg/1), staphylococci (mannitol salt agar, bió 
Merieux), and yeasts (Sabouraud dextrose agar, Gibco, with 
chloramphenicol 125 mg/1). The solid media were also inoculated 
with 100-microlitre volumes of the first 1/10 dilutions of faeces, 
lowering the detection limit to 100 micro-organisms per gram of 
faeces. The detection limit of the challenge strain was lowered to 10 
micro-organisms per gram of faeces by inoculating 1 ml-volumes of 
the first 1/10 dilution of faeces on to extra-large Petri-dishes 
(diameter 14 cm) containing the specific medium. Concentrations of 
micro-organisms were expressed as the logarithms to the base of 10 
of the counts per gram of faeces, rounded up or down to whole 
numbers. Micro-organisms isolated were identified by standard 
laboratory methods. 
Faecal concentration ofcephradine 
Faecal concentration of cephradine was determined by an agar-
diffusion method. Faeces was put in a well in a solid medium 
(isosensitest-agar, Oxoid), seeded with Staphylococcus aureus 
(ATCC 29213). The MIC of this strain for cephradine is 1 mg/1. 
The diameter of the inhibition zone was compared to the diameters 
of the inhibition zones around standard solutions of cephradine in 
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normal saline. The concentration found in this way will be called the 
diffusible faecal concentration of cephradine 
Statistics 
The influence of cephradine on the faecal concentrations of aerobic 
micro-organisms in faeces was evaluated for each volunteer 
individually, using single case statistics as described before (3). The 
absence of serial dependency of the data within volunteers was 
verified by computing auto-correlations for time lags of one to four 
days for each series of data. The correlation coefficients scattered 
around zero value, as expected under the null-hypothesis of zero 
correlation. Thus the Mann-Whitney-Wilcoxon test could be 
employed to evaluate the influence of cephradine on the 
concentrations of aerobic flora in faeces. The counts in the pre-
treatment samples were used as a baseline. 
Results 
The diffusible faecal concentration of cephradine was below 
detection limit ( 8 mg/1) in all samples. 
The influence of cephradine on the faecal concentration of aerobic 
flora was small (Tables I-IV). The total faecal concentration of 
Gram-negative bacilli increased significantly in volunteer 5 only, but 
the actual increase was very low. 
In the pre-treatment period, E. coli was the dominant species of 
Gram-negative bacilli in all samples in all volunteers. Cephradine 
caused a strong increase in spontaneously occurring secondary 
colonization with Gram-negative bacilli in volunteers 3 and 5 (Table 
II). In both of these patients nine of ten treatment samples contained 
Citrobacter freutuiii (MIC for cephradine > 512 mg/1 in both 
cases). Citrobacter remained detectable in the first eight samples of 
the post-treatment period in volunteer 3 and in all ten samples in 
volunteer 5. Colonization with the challenge strain was facilitated 
only in volunteer 6 (Table III). 
Enterococci were the dominant species of aerobic Gram-positive 
cocci in almost all samples. Non-haemolytic staphylococci were 
dominant in three out of 30 samples in volunteer 3 and in one 
sample in volunteer 4. Streptococci were detected in all pre-
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treatment samples in volunteer 3 (haemolytic streptococci group G), 
and in volunteer 5 (haemolytic streptococci group C) in a 
concentration about equal to the enterococci in both volunteers. 
Cephradine immediately eliminated the streptococci from faeces in 
both volunteers, and streptococci did not re-appear during the post-
treatment period. The decrease in the faecal concentration of Gram-
positive cocci in volunteer 5 was due to elimination of streptococci, 
the concentration of enterococci remained unchanged. 
Cephradine caused a small, but significant increase in the faecal 
concentration of yeasts in three out of six volunteers (Table I). 
Discussion 
The autochthonous anaerobic flora that provides CR can not be 
measured directly. However, disturbance of this flora is indicated by 
an increase in the intestinal concentration of 1) Gram-negative 
bacilli, 2) aerobic Gram-positive cocci or 3) yeasts, or by an 
increase in the secondary colonization by strains 4) ingested with 
food or 5) administered deliberately (3). In volunteers 1 and 4 none 
of these five indicators of impairment of CR were found to be 
positive (Table IV). In the other four volunteers one or more 
indicators demonstrated disturbance of the anaerobic flora that 
provides CR. The concentration of yeasts was slightly but 
significantly increased in volunteers 2, 5 and 6, and the same 
applied to the concentration of Gram-negative bacilli in volunteer 5. 
In volunteers 3 and 5 a marked increase in secondary colonization 
was observed. So, although cephradine causes selection of Gram-
negative bacilli less frequently than amoxycillin (5), cephradine is 
not devoid of the risk of this unfavourable effect. 
Facilitation of colonization by the challenge strain administered 
deliberately was observed only in volunteer 6, but even in this 
volunteer the concentration of the challenge-strain declined during 
cephradine treatment and the strain was no more detected during the 
post-treatment period. The lack of facilitation of colonization by the 
challenge strain in volunteers 3 and 5, in whom susceptibility to 
secondary colonization appeared to be strongly increased, 
demonstrates again that the behaviour of a resistant challenge strain 
is not the most reliable indicator of the influence of antibiotics on 
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the flora that provide CR. It appears that the challenge strain may 
loose the competition with indigenous Gram-negative bacilli or 
Gram-negative bacilli ingested with food (3). 
This study shows a small impairment of microbial CR in four out of 
six volunteers who used cephradine 1 g daily. So, even at this low 
dosage cephradine is not completely safe. It should be noted 
however, that absence of influence on CR has not yet been proven 
for any antibiotic administered in therapeutic dosage. The increase in 
the faecal concentration of resistant aerobic flora following 
cephradine certainly is much less than following amoxycillin (3). 
Therefore, cephradine is preferable to amoxycillin for the treatment 
of urinary tract infections caused by Gram-negative bacilli. 
However, we consider this low dosage not suitable for treatment of 
other than urinary tract infections. 
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Table I. Influence of cephradine on aerobic faecal flora, 
expressed as log10 median faecal concentration (cfu/g) and range 
Volun­
teer 
number 
1 
2 
3 
4 
5 
6 
Gram-negative 
bacilli 
A В 
6 (4-7) 
3(<2-5) 
7 (4-8) 
6 (5-7) 
6 (5-6) 
5 (3-6) 
4(4-7)"* 
4(2-5)"* 
8(6-9)"* 
6(4-7)"* 
6(6-7)** 
6(5-7)"* 
Gram-positive 
cocci 
A В 
4(<2-5) 
4 (3-5) 
3 (3-5) 
3(<2-5) 
4 (3-5) 
5 (3-6) 
4(2-5)"* 
3(<2-4)-· 
4(3-6)"* 
3(2-6)™ 
3(<2-3)" 
5(<2-7)n* 
Yeasts 
A В 
3(2-4) 3 (3-4)"* 
<2(<2-3) 3(<2-3)* 
<2(<2-4) <2(<2-4)"* 
<2(<2-2) <2(<2-3)"s 
3(2-3) 3 (3-4)* 
2(<2-4) 3 (3-4)* 
A : Pretreatment period (n=10). В : Treatment period (n=10). 
** or : Ρ < 0.01 ; * or " : Ρ < 0.05 ; "* : Ρ > 0.05, two sided 
significance of a difference in concentration between periods A 
and B. 
Table II. Influence of cephradine on faecal concentration* of 
Gram-negative bacilli other than Escherichia coli (secondary 
colonization)ь 
Volunteer 
number 
Pre-treatment Period Treatment Period 
4 (<2-5) 
<2 (<2-2) 
<2 (<2-3) 
<2 (<2-3) 
<2 (<2-4) 
<2 (<2-4) 
3 ( ^ ^ ) ' 
^ ( ^ - ^ ) ' 
7 ( 4-9f 
<2 (<2-4)r 
5 (<2-7)< 
<2 (<2-4)r 
8
 : Log,,, median faecal concentration (cfu/g) and range. 
ь
 : Challenge strain not taken into account. 
: Ρ < 0.01 ; "* : Ρ > 0.05, two sided significance of a 
difference in concentration between pre-treatment period and 
treatment period. 
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Table III. Influence of cephradine on colonization of the bowel 
by the challenge strain* 
Volunteer 
number 
Pre-treatment Period 
С .
ь
 duration0 
Treatment Period 
C„.b duration0 
1 ο­
ίο
3 
<101 
10* 
103 
101 
10* 
<101 
<101 
IO1 
103 
106 
Oral administration of 10 cfu of Klebsiella pneumoniae, 
.(MIC = 32 mg/1) 
•~~cephr0dine ""^' ~ ' " 
: Maximal faecal concentration (cfu/g). 
: Number of days with positive faecal samples. 
Table IV. Influence of cephradine on indicators of impairment of 
colonization resistance of the bowel 
Volunteer Faecal concentration of : 
number Gram-negative Gram-positive Yeasts SSC* Challenge 
bacilli cocci strain 
+ 
+ 
+ 
+ 
" : Spontaneously acquired secondary colonization. 
- : No increase. 
+ : Increase. 
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Abstract 
The contribution of Escherichia coli to the microbial colonization 
resistance (CR) of the bowel was investigated in six healthy 
volunteers. E. coli was eliminated from faeces by the adminstration 
of a low dose (20 mg) of Pefloxacin. This did not cause an increase 
in the faecal concentration of aerobic Gram-positive cocci or yeasts, 
nor did it facilitate colonization of the bowel by a pefloxacin-
resistant challenge strain of Klebsiella pneumoniae. Therefore, E. 
coli does not appear to contribute to the microbial CR. After 18 days 
of Pefloxacin, clindamycin 300 mg was administered twice daily for 
ten days. Clindamycin caused a significant increase in the faecal 
concentration of enterococci, yeasts and the K. pneumoniae 
challenge strain, indicating that the study design was suitable to 
demonstrate impairment of microbial CR if it occurred. 
Introduction 
The microbial CR limits both the number of aerobic species and 
their concentration in the digestive tract (1). Some authors presume 
that microbial CR is provided exclusively by the obligate anaerobic 
flora (2, 3). Others have shown that indigenous aerobic flora also 
contributes to CR in gnotobiotic animals (4, 5, 6). However, it 
should be noted that all animal experiments that give support to the 
contribution of aerobic flora in maintaining CR were performed in 
animals in whom the anaerobic flora that provides CR was absent or 
incomplete, causing an abnormally high faecal concentration of E. 
coli. So, although E. coli limits the concentration of other Gram-
negative bacilli in the bowel of animals in whom the autochthonous 
anaerobic flora is not intact, the role of E. coli in normal animals 
and in man remains unknown. The present study was designed to 
investigate the contribution of E. coli to CR in human volunteers by 
studying the influence of its selective elimination on the faecal 
concentrations of indigenous aerobic flora of the bowel, and on the 
CR against a pefloxacin-resistant challenge strain of Klebsiella 
pneumoniae. However, because the anaerobic flora that provides CR 
is unknown, it is impossible to calculate the dosage of an 
antimicrobial agent that will achieve a faecal concentration above the 
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MIC of E. coli and, at the same time, below the MIC of the 
anaerobic flora that provides CR. Therefore, we decided to use the 
lowest effective dosage of an agent that is much more active against 
E. coli than against known species of anaerobic flora. In this regard 
quinolones are suitable candidates. In an unpublished pilot study we 
found that the diffusible faecal concentration of Pefloxacin is the 
biologically active faecal concentration, and that pefloxacin 800 mg 
daily gives a diffusible faecal concentration of about 160 mg/1. 
Because the MIC of most strains of E. coli is below 4 mg/1, we 
decided to aim at a diffusible faecal concentration of 4 mg/1. 
Therefore a dosage of 20 mg pefloxacin was appropriate. To 
demonstrate that our study design was suitable to show a significant 
increase in aerobic flora in case of impairment of CR, the 
pefloxacin-period was followed by a period in which we ad-
ministered clindamycin. If elimination of E. coli in the pefloxacin 
period would not facilitate colonization by the challenge strain, this 
could be ascribed to possible sub-MIC effects of pefloxacin. To ex-
clude this possibility, continued administration of pefloxacin 
occurred during the first five days of the clindamycin-period. 
Methods 
Study design 
During the study, daily faecal samples were analyzed for their 
concentration of Gram-negative bacilli, enterococci and yeasts. Daily 
production of faeces was an admission criterion for the volunteers. If 
more than one motion was passed, a sample of the first motion was 
used for analysis. The data from the first day of the two antibiotic 
periods were not used for analysis, because influence of antibiotics 
on these samples will be small or absent. The sample of the first 
morning after termination of clindamycin was used as the last 
treatment sample of that period. 
The study was divided in four periods: 
Period A, a pre-treatment period of ten days, served to investigate 
the normal concentration of aerobic flora and the CR against a 
pefloxacin-resistant challenge strain of K. pneumoniae. 
In period B, pefloxacin 20 mg was administered for 18 days, in 
order to investigate the influence of elimination of indigenous Gram-
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negative bacilli (especially E. coli) on the CR against enterococci, 
yeasts and pefloxacin-resislant species of Gram-negative bacilli. The 
duration of this treatment period was longer than the ten days we 
have advocated before (7), because several days pass before E. coli 
is eliminated from faeces and it was our intention to study a period 
of ten days in which the volunteers would be free of indigenous 
Gram-negative bacilli. 
In period C, clindamycin was administered for ten days in order to 
investigate the influence of disturbance of the CR on the faecal 
concentration of indigenous aerobic flora and on the CR against the 
challenge strain. During the first five days of this period 
administration of Pefloxacin 20 mg daily was continued, to exclude 
possible sub-MIC effects of Pefloxacin as a cause of failure of the 
challenge strain to colonize the bowel during period B. 
In period D, the post-treatment period, no antibiotics were 
administered. In this period, analysis of daily faecal samples was 
continued in each volunteer until the faecal concentration of the 
challenge strain was below detection limit for at least three days. 
Challenge with 10" cfu of a pefloxacin resistant strain of K. pneu­
moniae was performed on day 3 of the periods A and C, and on day 
8 of period B. During periods В and C, the faecal concentration of 
pefloxacin was analyzed by an agar diffusion method. 
Volunteers. 
Six healthy volunteers, one female (age 24) and five male (age 23, 
25, 39, 40 and 47) participated in the study. The volunteers had not 
used antibiotics for at least one month and gave written informed 
consent before the start of the study. Permission for this study was 
obtained from the ethics committee of the Canisius-Wilhelmina 
Hospital. 
The female volunteer did not participate in part С of the study, 
because of the possibility that clindamycin may interfere with oral 
anticonception (8). 
Drugs 
Pefloxacin capsules 20 mg, prepared in the hospital pharmacy, were 
taken once daily with lunch. Two 150 mg capsules of clindamycin 
were taken twice daily after lunch and evening dinner. 
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Challenge. 
As a challenge strain we used a strain of К. pneumoniae, highly 
resistant to Pefloxacin (MIC=56 mg/1). 
For administration, colonies of the challenge strain grown overnight 
on solid medium were suspended in a glass of water and drunk after 
a warm meal. 
Bacteriology. 
Serial 1/10 dilutions of faeces were made in Thioglycollate medium 
(BBL). One-microlitre volumes of each dilution were inoculated on 
to solid media to isolate Gram-negative bacilli (eosin methylene-
blue lactose sucrose agar, Merck), the K. pneumoniae challenge 
strain (eosin methylene-blue lactose sucrose agar, Merck, with 
Pefloxacin 5 mg/1), amoxycillin-resistant Gram-negative bacilli (5% 
sheep blood in blood agar base, Oxoid, with amoxycilin 10 mg/1), 
enterococci and streptococci (5% sheep blood in blood agar base, 
Oxoid, with nalidixic acid 50 mg/1), and yeasts (Sabouraud dextrose 
agar, Gibco, with chloramphenicol 125 mg/1). The solid media were 
also inoculated with 100-microlitre volumes of the first 1/10 
dilutions of faeces, lowering the detection limit to 100 micro­
organisms per gram of faeces. Concentrations were expressed as the 
logarithms to the base of 10 of the counts per gram of faeces, 
rounded up or down to whole numbers. Micro-organisms were 
identified by standard laboratory methods. 
Faecal concentration of antibiotics 
The diffusible faecal concentration of Pefloxacin was determined by 
an agar-diffusion method, using a solid medium seeded with E. coli 
(ATCC 25922). The MIC of this strain for pefloxacin is 0.25 mg/1. 
The diameter of the inhibition zone was compared with the 
diameters of the inhibition zones around standard solutions of 
pefloxacin in normal saline. 
Statistics 
We analyzed the influence of the antibiotics on the faecal 
concentration of Gram-negative bacilli, enterococci and yeasts. 
Because the faecal concentration of antibiotics and the susceptibility 
to antibiotics of the faecal flora that provides CR may differ between 
volunteers, the data were analyzed for each volunteer individually, 
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using single case statistical techniques (7). 
The absence of serial dependency of the data was verified by 
computing auto-correlations for time lags of one to four days for 
each series of data. For time lags of two to four days the correlation 
coefficients scattered around zero, as expected under the null-
hypothesis of zero-correlation. For a time lag of one day a slight 
autocorrelation (r = 0.24) did not disprove sufficiently the 
prerequisite independence of observations. Thus the Mann-Whitney-
Wilcoxon test could be employed to evaluate the influence of the 
antibiotics on the faecal concentrations of Gram-negative bacilli, 
enterococci and yeasts. The counts in the pre-treatment samples were 
used as a baseline. 
Results 
The median level and range of the faecal concentrations of Gram-
negative bacilli, enterococci and yeasts are shown in Tables I, II and 
III. 
The maximal faecal concentrations of the challenge strain and the 
number of days this strain was detectable after challenge are shown 
in Table IV. 
Period A. 
Except in volunteer 6, E. coli was the dominant species of Gram-
negative bacilli in all faecal samples. Gram-negative bacilli other 
than E. coli were detected in eight, zero, two, zero, three and two 
samples of volunteers 1-6 respectively. All these species were 
susceptible to Pefloxacin. In volunteer 6 the concentration of Gram-
negative bacilli was below detection limit in eight of ten samples. In 
the other two samples 105 cfu Enterobacter cloacae and 102 cfu K. 
pneumoniae were found respectively. In volunteer 6, bèta-haemo-
lytic streptococci group G outnumbered enterococci. In the other 
volunteers the concentration of enterococci was higher than the con-
centration of streptococci. The faecal concentration of the challenge 
strain dropped below detection limit within 4 days in all volunteers. 
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Period В. 
From three days after the start of administration of Pefloxacin the 
diffusible faecal concentration of all samples of all volunteers was 
between 1 and 6 mg/1. The median diffusible faecal concentration of 
Pefloxacin in volunteers 1-6 respectively was 4, 4, 2, 4, 3 and 2 
mg/1. E. coli was eliminated from faeces of volunteers 1-5 on days 
4, 4, 3, 7 and 5 respectively. (In volunteer 6 Gram-negative bacilli 
were even not detectable before start of Pefloxacin). Secondary 
Gram-negative bacilli other than the challenge strain were detectable 
only in the first three treatment samples in volunteers 1 and in one 
treatment sample (day 4) in volunteer 6. In volunteer 5 recoloni-
zation with E. coli occurred at day 8 and continued for the rest of 
period B. The MIC of this strain of E. coli for pefloxacin was 3 
mg/1, equal to the diffusible faecal concentration in this volunteer, 
which fluctuated between 2 and 4 mg/1 (median 3 mg/1). 
The elimination of E. coli in period В did not facilitate colonization 
by the challenge strain compared to the pre-treatment period. As in 
the pre-treatment period, all samples were negative within four days. 
The faecal concentration of enterococci and yeasts did not increase 
significantly in any volunteer. In volunteer 3 the concentration of 
bèta-haemolytic streptococci group В became higher than the con­
centration of enterococci in period B, but did not increase above the 
concentration of enterococci in the pre-treatment period. In volunteer 
6, the faecal concentration of streptococci remained higher than the 
concentration of enterococci, but at the same level as in the pre­
treatment period. 
Period C. 
The faecal concentration of the challenge strain in the first sample 
after administration (107 cfu/gram in one volunteer and IO8 cfu/gram 
in the other four) was much higher than in period A and В and 
stable, high level colonization persisted in all five volunteers. The 
faecal concentration of the challenge strain in period С was signifi­
cantly higher than the faecal concentration of Gram-negative bacilli 
in periods A and B. 
Although administration of clindamycin did not influence the faecal 
concentration of pefloxacin, it caused a significant increase in the 
faecal concentration of E. coli in volunteer 5, and recolonization 
with Enterobacteriaceae occurred in volunteers 4 and 6 before ad-
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ministration of Pefloxacin was terminated. E. coli (MIC 0,25 - 0,5 
mg/1) was detectable again at day 4 in volunteer 4. Volunteer 6 was 
colonized at day two of this period with a spontaneously acquired 
strain of K. pneumoniae (MIC 1 mg/1), different from the challenge 
strain. In most samples of volunteers 2 and 4 the concentration of 
streptococci and enterococci could not be measured because of over-
growth by the challenge strain. In the other volunteers the faecal 
concentration of enterococci increased significantly. In this period 
enterococci outnumbered streptococci in all volunteers, including 
volunteers 3 and 6. The faecal concentration of yeasts increased 
significantly in volunteers 2-5, but not in volunteer 6. 
Period D. 
Recolonization with E. coli occurred at day 2 of period D in volun-
teers 2, 3 and 6. (The other volunteers were recolonized before). 
The challenge strain dropped below the detection limit at days 23, 
27, 18, 11 and 9 respectively in volunteers 2-6. Volunteer 6, who 
was free from Gram-negative bacilli in most faecal samples in the 
pre-treatment period, remained colonized with both E. coli (>107 
cfu/g) and the spontaneously acquired K. pneumoniae (> 103 cfu/g) 
up to the last sample we investigated (day 42 after termination of 
clindamycin). 
Discussion 
Colonization resistance 
With normal food we probably ingest between a few thousand and a 
few million cfu of Gram-negative bacilli, especially via salads (9, 
10). So, a challenge dose of 10" cfu K. pneumoniae exceeds the 
normal intake of Gram-negative bacilli. Nevertheless, in the pre-
treatment period this challenge dose was eliminated from the bowel 
within four days in all six volunteers. This demonstrates the high 
efficacy of CR of the bowel against exogenous micro-organisms. 
This powerful mechanism of defence appears to collapse completely 
following administration of clindamycin, but not at all following a 
low dosage of Pefloxacin. 
The simultaneous increase of the faecal concentration of Gram-
negative bacilli, enterococci and yeasts in volunteers 3 and 5 
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following clindamycin (period C) demonstrates that none of these 
three groups of aerobic micro-organisms limits the concentration of 
the other. This supports the hypothesis that the limiting action of 
autochthonous flora on the faecal concentration of these three groups 
of aerobic micro-organisms is provided by anaerobic flora. 
The faecal concentration of enterococci and of yeasts did not in-
crease in any volunteer following elimination of E. coli in period B, 
demonstrating that indigenous Gram-negative bacilli do not contri-
bute to the limiting action of the normal flora on the faecal 
concentration of other groups of aerobic micro-organisms. This is 
supported by the observation that the CR against enterococci, yeasts 
and the challenge strain was maintained in volunteer 6 during the 
pre-treatment period, although this volunteer was not colonized by 
Gram-negative bacilli during that period. The two samples positive 
for Gram-negative bacilli in this volunteer during the pre-treatment 
period were probably caused by micro-organisms ingested with food, 
which also failed to colonize the bowel. So, this study shows that 
the indigenous Gram-negative bacilli do not provide CR against 
enterococci, yeasts or exogenous Gram-negative bacilli. Therefore, it 
is possible to eliminate Gram-negative bacilli from the bowel 
without impairing CR (selective decontamination). 
It was our working-hypothesis that disturbance of the anaerobic flora 
that provides CR will cause a simultaneous increase of Gram-
negative bacilli, aerobic Gram-positive cocci and yeasts, if 
antibiotic-resistant micro-organisms are present (7). However, in 
volunteer 6 the concentration of yeasts did not increase following 
clindamycin, although CR against Gram-negative bacilli and entero-
cocci was strongly impaired. This shows that even strong dis-
turbance of the anaerobic flora that provides CR against Gram-
negative bacilli and aerobic Gram-positive cocci is not necessarily 
accompanied by increase of the faecal concentration of yeasts. 
Secondary colonization 
Contrary to our expectation, selective elimination of E. coli did not 
facilitate low level colonization of the bowel by other Gram-nega-
tive bacilli, called "substitution colonization" (1). Admittedly, our 
results do not prove that the phenomenon of substitution colonization 
does not exist, because we only used one challenge strain. It cannot 
be excluded that another strain of Gram-negative bacilli would have 
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succeeded in colonizing the bowel. However, following administra-
tion of clindamycin, our challenge strain appeared to be perfectly 
able to colonize the bowel in all five volunteers who participated in 
this part of the study, even in a concentration higher than the 
original concentration of E. coli. Therefore we conclude that it is 
unlikely that substitution colonization by secondary Gram-negative 
bacilli will occur very easily. So, the increase of secondary 
colonization following roxithromycin, co-trimoxazole and doxycyline 
in our previous studies (11, 12) was probably caused by disturbance 
of anaerobic flora that provides CR and not by "substitution coloni-
zation" following a decrease of the faecal concentration of E. coli. 
Further research is required to investigate whether the phenomenon 
of' substitution colonization" exists at all. 
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Table I. Influence of antibiotics on faecal concentration* of 
Gram-negative bacilli 
Volunte 
1 
2 
3 
4 
5 
6 
er Period A 
8 (6-8) 
6 (6-8) 
6 (2-7) 
7 (5-7) 
7 (5-9) 
<2(<2-5) 
Period В 
<2 (<2-5)--
<2 (<2-4) "" 
<2 (<2-6)'" 
<2 (<2-7)-' 
4 (<2-6)--
<2 (<2-3)ns 
Period B' 
<2 (<2-<2)'" 
<2 (<2-<2) "' 
<2 (<2-<2) "' 
<2 (<2-<2)" 
4 ( 2- 6 ) " 
<2 (<2-<2)ns 
Period С 
# 
8 (<2-9)** 
8 (<2-9)** 
7 (<2-9)^ 
8 (6-10) 
8 ( 2-8)** 
: Log10 median faecal concentration and range. 
Period A : Pre-treatment period (n=10). 
Period В : Pefloxacin 20 mg daily (n=17). 
Period B1: Last 10 samples of period В (E. coli absent in 
all samples of volunteers 1, 2, 3, 4 and 6). 
Period С : Clindamycin 300 mg bid (n=10). (Pefloxacin 20 mg 
daily continued for the first five days). 
# : Volunteer did not participate in this period. 
** or " : Ρ < 0.01 ; * or : Ρ < 0.05 ; та : Ρ > 0.05, two sided 
significance of a difference in concentration between pre­
treatment period and treatment period. 
Table II. Influence of antibiotics on total faecal concentration 
of enterococci and streptococci 
Volunteer Period A Period В Period B' Period С 
1 
2 
3 
4 
5 
6 
4 
4 
4 
7 
4 
5 
(2-6) 
(3-7) 
(2-5) 
(5-8) 
(3-7) 
(4-6) 
4(<2-7)ns 
4(<2-6)ns 
4(<2-5)ns 
6( 3-7)" 
5( З-в)"5 
5(<2-6)-
3(<2- ) ю 
4(<2-5)ns 
4(<2-5)ne 
6( 4-6)ns 
5( 3-8)ns 
5( 3-6)та 
# 
( a )
 « 7(<2-8)** 
( a )
 •. 8 (7-8)** 
8 (4-9)** 
(a) : Most samples overgrown by challenge strain. 
Other legends as in Table I. 
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Table III.Influence of antibiotics on faecal concentration of 
yeasts 
Volunteer 
1 
2 
3 
4 
5 
6 
Period A 
<2 (<2-3) 
2 (<2-3) 
3 (<2-4) 
2 (<2-3) 
2 (<2-3) 
<2 (<2-2) 
Period В 
<2 (<2-3)ns 
2 (<2-3)та 
3 (<2-5)ns 
2 (<2-3)ns 
3 (<2-5)™ 
<2 (<2-3)ns 
Period B' 
<2 (<2-2)ns 
2 (<2-3)ns 
3 (<2-4)ns 
2 (<2-3)ns 
3 (<2-5)га 
<2 (<2-3)ns 
Period С 
# 
4 (3-6)** 
5 (2-5) 
5 (4-5) 
3 (2-4)** 
<2(<2-2)ns 
Legends as in Table I. 
Table IV. Influence of antibiotics on colonization by the 
challenge strain8 
Volunteer 
number 
1 
2 
3 
4 
5 
6 
Period A 
c M«
u 
105 
104 
10* 
10ó 
106 
<102 
duration' 
3 
3 
2 
2 
2 
0 
Period В 
duration 
Period C+D 
_ duration 
10" 
103 
103 
10ó 
106 
<102 
10y 
10' 
10' 
10 
10' 
10 
30 
34 
25 
18 
16 
8
 : 1011 cfu Klebsiella pneumoniae, resistant to Pefloxacin 
(MIC = 56 mg/1). 
Periods А, В and С as in Table I. ; Period D : Post-treatment 
period. 
: Maximal faecal concentration (cfu/g). 
c
 : Number of days with positive faecal samples. 
# : Volunteer did not participate in this period. 
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Abstract 
Intravenous administration of Pefloxacin 400 mg twice daily rapidly 
decontaminated the bowel from Gram-negative bacilli in ten healthy 
volunteers. The faecal concentrations of enterococci and yeasts did 
not change significantly. Further, pefloxacin did not facilitate 
colonization of the bowel by a highly resistant challenge strain 
(Klebsiella pneumoniae, MIC = 56 mg/1). 
The diffusible faecal concentration of pefloxacin was between 110 
and 260 mg/1 in all samples from day 3 of treatment onwards. 
It is concluded that parenteral administration of pefloxacin is very 
effective for decontamination of the bowel from Gram-negative 
bacilli and provides reliable prophylaxis against colonization of the 
bowel by highly resistant Gram-negative bacilli ingested with food. 
Introduction 
Decontamination of the digestive tract from Gram-negative bacilli is 
useful in the prevention of infections in leukopenic patients (1), in 
patients on mechanical ventilation (2) and in patients with trans-
urethral catheters (3). Until now, decontamination has usually been 
performed by oral administration of antimicrobial agents. Some 
patients who are treated with cytostatic agents, however, cannot 
tolerate an oral regimen because of severe vomiting. Further, in 
many patients who are receiving mechanical ventilation, decontami-
nation of the bowel will be delayed if an oral regimen is used, 
because of initial paralytic ileus. Availability of a reliable parenteral 
regimen for decontamination of the bowel is therefore highly 
desirable. 
Decontamination of the bowel from Gram-negative bacilli has been 
achieved with parenteral administration of aztreonam or temocillin 
(4, 5). Both drugs, however, are completely inactivated in faeces of 
some volunteers (5). Enzymatic inactivation in faeces has also been 
described for ceftriaxone (6). Pefloxacin has two possible advantages 
for parenteral decontamination of the bowel. Firstly, it attains high 
concentrations in faeces following oral administration, although it is 
nearly completely absorbed (7). Equally high faecal concentrations 
can therefore be expected following intravenous administration. 
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Secondly, enzymatic inactivation of quinolones in faeces has never 
been reported. 
We therefore investigated the influence of parenteral administration 
of pefloxacin on the normal aerobic faecal flora, and on colonization 
of the bowel by a highly resistant challenge strain. 
Methods 
Study design 
In five volunteers (1-5), daily faecal samples were analyzed for their 
concentration of Gram-negative bacilli, enterococci and yeasts 
during a treatment period of five days and on one day before (day 0) 
and one day after treatment (day 6). 
Five other volunteers (6-10) had faecal samples analyzed in the same 
way, but were also given 10" cfu of a pefloxacin-resistant strain of 
Klebsiella pneumoniae in the pre-treatment period and in the treat-
ment period, and the faecal concentration of pefloxacin of these 
volunteers was analyzed. 
Volunteers 
Five healthy volunteers (two female, three male), aged 27 - 53 years 
(median age 42 years) participated in the first part of the study, and 
five other volunteers (all male), aged 31-47 years (median age 45 
years) in the second part of the study. The volunteers had not 
received antibiotics for at least one month before the start of the 
study. Written informed consent was obtained from the volunteers 
and permission for the study was granted by the ethics committee of 
the Canisius-Wilhelmina Hospital. 
Drugs 
Pefloxacin was administered intravenously twice daily at 09.00 and 
17.00 hours. One ampoule of pefloxacin 400 mg was added to 
dextrose 5 % infusion fluid and infused through a Venflon needle. 
Challenge 
As a challenge strain for the second set of volunteers (6-10), we 
used the strain with the highest resistance of a species of Entero-
bacteriaceae that we could obtain. The MIC for pefloxacin of this 
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strain (of К. pneumoniae) was 56 mg/1, but it was highly sensitive to 
cefotaxime and co-trimoxazole. The challenge strain could therefore 
easily be isolated from faeces with selective culture medium. At the 
same time, effective antibiotics were available in case of infection by 
the challenge strain. The challenge strain was administered in a 
dosage of 10" cfu at day 12 before the start of Pefloxacin and at the 
second day of Pefloxacin administration. Colonies of the challenge 
strain, grown overnight on solid medium, were suspended in a glass 
of water and drunk after a warm meal to bypass the acidic 
environment of the stomach. 
Bacteriology 
One gram of faeces was suspended in 9 ml of Thioglycollate 
medium (BBL), and serial 1/10 dilutions were made. One microlitre-
volumes of each dilution were inoculated on to solid media to isolate 
Gram-negative bacilli (eosin methylene-blue lactose sucrose agar, 
Merck), the K. pneumoniae challenge strain (eosin methylene-blue 
lactose sucrose agar, Merck, with pefloxacin 5 mg/1), enterococci 
(5% sheep blood in blood agar base, Oxoid, with nalidixic acid 50 
mg/1), and yeasts (Sabouraud dextrose agar, Gibco, with chlor­
amphenicol 125 mg/1). The solid media were also inoculated with 
100-microlitre volumes of the first 1/10 dilution of faeces, lowering 
the detection limit to 100 micro-organisms per gram of faeces. 
Concentrations were expressed as the logarithms to the base 10 of 
the counts per gram of faeces, rounded up or down to whole 
numbers. Micro-organisms isolated were identified by standard 
laboratory methods. 
The faecal concentration of pefloxacin was determined by an agar-
diffusion method. Faeces was put in a well in a solid medium seeded 
with Escherichia coli (ATCC 25922). The MIC of this strain for 
pefloxacin is 0.25 mg/1. The diameter of the inhibition zone was 
compared to the diameters of the inhibition zones around standard 
solutions of pefloxacin in saline in wells in the same agar plate. The 
concentration found was called the diffusible faecal concentration. 
Statistics 
Friedman's test was employed for evaluation of the influence of 
pefloxacin on the counts of micro-organisms in faeces. The counts in 
the samples of the day before the first administration of pefloxacin 
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(day 0) were used as a base-line. The data of day 1 were not 
analyzed, because these samples may be influenced by drug treat-
ment if they are produced after the first dosage of Pefloxacin. The 
morning-samples after the last day of pefloxacin-treatment were 
counted as the last treatment samples. 
Results 
Pefloxacin rapidly eliminated indigenous Gram-negative bacilli from 
faeces. The median time for elimination of Gram-negative bacilli 
was two days (Table I). Gram-negative bacilli were no longer 
detectable after one day in volunteers 4, 6 and 10, after two days in 
volunteers 3, 5, 8 and 9, after three days in volunteer 7, and after 
five days in volunteer 2. In volunteer 1 the decontamination 
proceeded irregularly. Gram-negative bacilli were not detectable at 
days 3 and 5, but the concentrations of E. coli on days 4 and 6 were 
104 and 103 cfu/g faeces respectively. 
Administration of Pefloxacin did not facilitate colonization of the 
bowel by the challenge strain (K. pneumoniae, Table II). 
Pefloxacin did not cause a significant change in the faecal concen-
tration of enterococci (P = 0.11) or yeasts (P = 0.70), (Tables HI 
and IV). 
The diffusible faecal concentration of pefloxacin increased up to a 
plateau-level at about day 4. The median faecal concentration 
between days 4 and 6 was 140, 238, 150, 175, and 160 mg/1 in 
volunteers 1-5 respectively. From day 3 onwards, the faecal concen-
tration was between 110 and 260 mg/1 in all samples (Table V). 
Discussion 
Intravenous administration of pefloxacin, in a standard dosage of 
400 mg twice daily, proved to be suitable for decontamination of the 
bowel from indigenous Gram-negative bacilli and could be con-
sidered for decontamination in high risk patients unable to tolerate 
an oral regimen. 
Adminstration of pefloxacin did not facilitate colonization of the 
bowel following a challenge dose with a highly resistant strain of 
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К. pneumoniae (MIC = 56 mg/1). In a previous study, the same 
strain of Klebsiella caused high-level colonization of the bowel in 
volunteers in whom colonization resistance (CR) was impaired by 
administration of clindamycin (8). Therefore, this strain seemed 
suitable for demonstration of impairment of CR. However, in this 
study the failure of the challenge strain to colonize the bowel does 
not prove that Pefloxacin left CR unimpaired, because the diffusible 
faecal concentration of Pefloxacin was higher than the MIC of the 
challenge strain in all volunteers. If we assume that the diffusible 
faecal concentration represents the active concentration in the bowel, 
then we were unable to investigate the influence of Pefloxacin 800 
mg daily on CR against Gram-negative bacilli, as a Gram-negative 
bacillus with a MIC higher than the diffusible faecal concentration of 
Pefloxacin was not available. 
Pefloxacin did provide effective prophylaxis against colonization of 
the bowel by the most resistant strain available, to emphasize the 
excellent safety-margin of Pefloxacin for prophylaxis of endogenous 
Gram-negative infections. 
The data for the diffusible faecal concentrations of Pefloxacin are 
within a very small range, after the plateau-level has been attained at 
day 4. From the first 24 h of treatment, the diffusible faecal concen­
tration of Pefloxacin was far above the MIC of normally occurring 
Gram-negative bacilli. Parenteral administration of pefloxacin thus 
provides highly reliable concentrations of antibiotic in the bowel. 
Increase of the faecal concentration of yeasts was not observed for 
this group of volunteers. A larger number of pre-treatment and treat­
ment samples is required however, to investigate whether CR against 
yeasts remains unaffected in all of the volunteers individually (9). 
We conclude that parenteral administration of pefloxacin is a very 
suitable method for the elimination of Gram-negative bacilli from 
the bowel, and that it provides reliable prophylaxis against coloni­
zation of the bowel by Gram-negative bacilli ingested with food. In 
the case of gastric retention in mechanically ventilated patients, 
however, gastric decontamination may be a critical factor in the 
prevention of infections. It is not known whether gastric decon­
tamination in those patients will be achieved by parenteral ad­
ministration of pefloxacin. So, as yet, it is advisable to decon­
taminate the gastric contents in those patients by local administration 
of antimicrobial agents as well. 
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Table I.Influence of Pefloxacin' on the faecal concentration6 of 
Gram-negative bacilli 
Volunteer 
number 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
0 
7 
9 
5 
6 
6 
5 
7 
4 
7 
2 
2 
3 
4 
2 
<2 
3 
<2 
6 
2 
7 
<2 
Day ; 
3 
<2 
4 
<2 
<2 
<2 
<2 
3 
<2 
<2 
<2 
4 
4 
2 
<2 
<2 
<2 
<2 
<2 
<2 
<2 
<2 
5 
<2 
2 
<2 
<2 
<2 
<2 
<2 
<2 
<2 
<2 
6 
3 
<2 
<2 
<2 
<2 
<2 
<2 
<2 
<2 
<2 
400 mg intravenously twice daily day 1-5. 
Log,0 concentration (cfu/g). 
Excluding the challenge strain (in volunteers 6-10). 
Table II.Influence of Pefloxacin on colonization of the bowel by 
the challenge strain* 
Volunteer 
number 
Pretreatment period Treatment period 
duration duration 0 
6 
7 
8 
9 
10 
IO3 
<10 2 
10 4 
10 4 
10* 
<10,: 
10 3 
<10 2 
10 5 
<10 2 
8
 : Oral administration of 10 cfu K.pneumoniae 12 days 
before treatment with Pefloxacin and on the second day 
of the Pefloxacin period. 
ь
 : Maximal faecal concentration (cfu/g). 
c
 : Number of days with positive faecal samples. 
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Table III. Influence of Pefloxacin* on the faecal concentration6 
of enterococci 
Volunteer 
number 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
0 
5 
6 
5 
4 
5 
3 
3 
5 
5 
4 
2 
3 
6 
6 
4 
5 
<2 
6 
<2 
4 
4 
Day : 
3 
5 
5 
6 
4 
4 
<2 
3 
<2 
5 
3 
4 
<2 
2 
5 
4 
5 
<2 
<2 
<2 
5 
4 
5 
5 
2 
5 
4 
5 
<2 
<2 
3 
3 
3 
6 
<2 
<2 
5 
2 
4 
2 
3 
3 
3 
4 
400 mg intravenously twice daily day 1-5. 
Log10 concentration (cfu/g). 
Table IV. Influence of Pefloxacin on the faecal concentration 
of yeasts 
Volunteer 
number 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
0 
<2 
2 
<2 
<2 
<2 
3 
3 
3 
<2 
2 
2 
<2 
<2 
3 
<2 
4 
3 
3 
3 
<2 
2 
Day : 
3 
<2 
<2 
3 
<2 
<2 
2 
3 
3 
<2 
2 
4 
<2 
<2 
3 
<2 
3 
2 
3 
4 
<2 
<2 
5 
3 
2 
3 
<2 
2 
3 
3 
3 
<2 
2 
6 
<2 
2 
4 
<2 
3 
2 
3 
4 
<2 
2 
400 mg intravenously twice daily day 1-5. 
Log10 concentration (cfu/g). 
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Table V. Diffusible faecal concentration of Pefloxacin* 
volunteer no. day 1 day 2 day 3 day 4 day 5 day 6 
6 
7 
8 
9 
10 
0 
0 
0 
0 
0 
92 
34 
100 
110 
90 
125 
110 
122 
118 
150 
140 
125 
170 
180 
160 
130 
260 
150 
154 
150 
150 
238 
155 
175 
218 
' : mg Pefloxacin gram faeces, measured by an agar-diffusion 
method. 
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CHAPTER XI 
INFLUENCE OF PEFLOXACIN ON MICROBIAL 
COLONIZATION RESISTANCE IN HEALTHY 
VOLUNTEERS 
E.J. Vollaard', H.A.L. Clasenerb and A.J.H.M. Janssen6. 
Departments of "Pharmacy and bMicrobiology, Canisius-Wilhelmina 
Hospital, St. Annastraat 289, 6525 GT Nijmegen, The Netherlands 
Abstract 
The influence of Pefloxacin, 400 mg twice daily for ten days, on 
microbial colonization resistance (CR) was investigated in six 
healthy volunteers. Increase in the faecal concentration of Gram-
negative bacilli, aerobic Gram-positive cocci and yeasts, and 
facilitation of colonization by a highly resistant challenge strain 
(Klebsiella pneumonia, MIC = 56 mg/1), were used as indicators for 
disturbance of the flora that provides CR. Because the faecal 
concentration of Pefloxacin during treatment is higher than the MIC 
of the challenge strain, challenge was repeated in the post-treatment 
period. 
Because the influence of antibiotics on CR may differ between 
volunteers, data were analyzed for the volunteers individually. 
The median faecal concentrations in the samples between day 5 and 
the first post-treatment day, were between 119 and 231 mg/1 
(median value 154 mg/1). 
Gram-negative bacilli were rapidly eliminated from faeces in all 
volunteers, and the faecal concentration of aerobic Gram-positive 
cocci decreased in five of six volunteers. 
In three of six volunteers, disturbance of CR-flora was indicated by 
a significant increase in the faecal concentration of yeasts. In two of 
them, this was confirmed by facilitation of colonization by the 
challenge strain in the post-treatment period. In the third one this did 
not occur, because CR was restored too rapidly. 
It is concluded that Pefloxacin is a highly reliable agent for 
elimination of Gram-negative bacilli from faeces. In a dosage of 400 
mg twice daily pefloxacin impairs CR in some volunteers, but 
bacterial overgrowth is prevented by the high faecal concentration of 
pefloxacin. 
Introduction 
Quinolones have been used successfully for elimination of Gram-
negative bacilli from the bowel in neutropenic patients (1), in 
patients who are mechanically ventilated (2, 3), and in patients with 
transurethral catheters (4). It is usually assumed that decolonization 
by quinolones is "selective" (5), id est that quinolones do not disturb 
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the anaerobic flora that provides CR (6). However, an increase in 
the faecal concentration of Candida spp. has been found following 
ciprofloxacin (7) and ofloxacin (8), casting doubt on sparing of the 
CR-flora by these quinolones. 
It has been postulated that "selective" elimination of Gram-negative 
bacilli from the bowel is not possible, because elimination of aerobic 
flora would increase the oxygen tension in the bowel, causing 
elimination of the most sensitive anaerobic species (9). This might 
explain the discrepancy between the observed increase of the faecal 
concentration of yeasts following antimicrobial agents that are 
supposed to spare the anaerobic flora that provides CR. 
However, using a sensitive method of establishing impairment of 
CR, we did not find a decrease in CR against a resistant challenge 
strain of Klebsiella pneumoniae, enterococci or yeasts in volunteers 
following elimination of Escherichia coli with a low dosage (20 mg 
daily) of Pefloxacin (10). Hence, increase of the faecal concentration 
of yeasts demonstrates disturbance of the anaerobic flora that 
provides CR. 
Bacterial overgrowth of the bowel following quinolones has not been 
reported, but this might be caused by the absence of strains that are 
sufficiently resistant to the very high faecal concentration of 
quinolones, in stead of by sparing of the anaerobic flora that 
provides CR. In a pilot study, we found that a highly resistant 
challenge strain of K. pneumoniae (MIC for Pefloxacin 56 mg/1), 
did not colonize the bowel in a volunteer who was treated with 
Pefloxacin 400 mg twice daily. During treatment the diffusible faecal 
concentration of Pefloxacin was about about 160 mg/1. However, 
when Pefloxacin was stopped and the diffusible faecal concentration 
of Pefloxacin dropped below the MIC, the challenge strain re-
appeared spontaneously in faeces and remained detectable for about 
two weeks (Figure). 
This challenge strain disappears from faeces within 5 days following 
a challenge dose, if CR is not disturbed (10, 11). So, although this 
strain is not sufficiently resistant to be used as a challenge for the 
influence of pefloxacin on CR against Gram-negative bacilli during 
treatment, this strain might be suitable shortly after treatment with 
pefloxacin. We decided to try this method in a larger number of 
volunteers. The study was designed to enable demonstration of a 
tenfold change in the faecal concentration of aerobic indigenous flora 
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with statistical significance (11). We also studied the diffusible 
faecal concentration of pefloxacin during and after treatment, and 
the time of re-colonization with Gram-negative bacilli after 
treatment. 
Methods 
Study design 
Daily faecal samples were analyzed for their concentrations of 
Gram-negative bacilli, aerobic Gram-positive cocci and yeasts during 
a pre-treatment period, a treatment period and a post-treatment 
period of ten days each. An oral dose of 10" cfu of a pefloxacin-
resistant challenge strain of K. pneumoniae was administered on day 
4 of the pre-treatment period, on day 2 of the treatment period, and 
on day 3 of the post-treatment period. The first challenge was 
intended to investigate the normal CR against Gram-negative bacilli. 
The second challenge was intended to repeat our previous 
observation that colonization by this strain does not occur if the 
diffusible faecal concentration is higher than the MIC of the 
challenge strain (Figure). The third challenge was intended to 
investigate whether the influence of pefloxacin on the autochthonous 
flora would facilitate colonization by a challenge strain when the 
diffusible faecal concentration dropped below the MIC of the 
challenge strain. 
After the first ten days of the post-treatment period, faecal sampling 
was continued three times a week until two succeeding samples 
contained Gram-negative bacilli again and until the challenge strain 
was no longer detectable. 
Volunteers 
Six healthy volunteers, two female (both 44 years old) and four male 
(age 18, 28, 41 and 50 years) participated in the study. The 
volunteers had not received antibiotics for at least one month before 
the start of the study. Written informed consent was obtained from 
the volunteers and permission for the study was granted by the ethics 
committee of the Canisius-Wilhelmina Hospital. 
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Drug 
Pefloxacin tablets 400 mg were administered twice daily after meals. 
Challenge 
As a challenge, we used the strain with the highest resistance of a 
species of Enterobacteriaceae that we could obtain. The MIC of this 
strain of K. pneumoniae for Pefloxacin is 56 mg/1. Therefore, the 
challenge strain can easily be isolated from faeces with a selective 
culture medium. Since this strain is highly sensitive to cefotaxime 
and to co-trimoxazole, effective antibiotics are available in case of 
infection with the challenge strain. It has been shown before, that 
this strain is suitable for demonstration of impairment of CR (10). 
For administration, colonies of the challenge strain grown over-
night on solid medium were suspended in saline. The suspension was 
poured in a glass of water, and drunk after a warm meal, 
immediately followed by another glass of water. In this way, the 
bacterial suspension was expected to bypass the acidic environment 
of the stomach. 
Bacteriology 
Serial 1/10 dilutions of faeces were made in Thioglycollate medium 
(BBL). One microlitre-volumes of each dilution were inoculated on 
to solid media to isolate Gram-negative bacilli (Mc Conkey agar, 
Oxoid), amoxycillin-resislant Gram-negative bacilli (5% sheep-
blood in blood agar base, Oxoid, plus amoxycillin 10 mg/1), 
quinolone-resistant Gram-negative bacilli (McConkey agar, plus 
norfloxacin 8 mg/I), enterococci and streptococci (5% sheep blood 
in blood agar base, plus nalidixic acid 50 mg/1), staphylococci 
(mannitol salt agar, bióMerieux), and yeasts (Sabouraud dextrose 
agar, Gibco, plus chloramphenicol 125 mg/1). The solid media were 
also inoculated with 100-microlitre volumes of the first 1/10 
dilutions of faeces, lowering the detection limit to 100 micro-
organisms per gram of faeces. The detection limit of the challenge 
strain was lowered to 10 micro-organisms per gram of faeces by 
inoculating 1 ml-volumes of the first 1/10 dilution of faeces on to 
extra-large Petri-dishes (diameter 14 cm) containing the selective 
medium. 
Concentrations of micro-organisms were expressed as the logarithms 
to the base of 10 of the counts per gram of faeces, rounded up or 
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down to whole numbers. 
Micro-organisms isolated were identified and their sensitivities to 
antibiotics was determined by standard laboratory methods. 
Faecal concentration ofpefloxacin 
Faecal concentrations of Pefloxacin were determined by an agar-
diffusion method. Faeces was put in a well in a solid medium 
(isosensitest-agar, Oxoid), seeded with E. coli (ATCC 25922). The 
MIC of this strain for Pefloxacin is 0.25 mg/1. The diameter of the 
inhibition zone was compared to the diameters of the inhibition 
zones around standard solutions of Pefloxacin in normal saline in 
wells in the same bio-assay plate. The detection limit was about 1 
mg/1. All samples were analyzed in triplicate and the median value 
was used. The concentration found in this way will be called the 
diffusible faecal concentration. 
Statistics 
The influence of pefloxacin on the faecal concentrations of aerobic 
micro-organisms in faeces was evaluated with the Mann-Whitney-
Wilcoxon test for each volunteer individually, using single case 
statistical techniques as described before (10, 11). 
Results 
The diffusible faecal concentration of pefloxacin was higher than the 
MIC of the challenge strain on day 2 in five of six volunteers and on 
day 3 in all volunteers. The diffusible faecal concentration increased 
up to a plateau-level at about day 5. Between day 5 and the first 
post-treatment day, the median faecal concentration was 138, 134, 
195, 119, 170, and 231 mg/1 in volunteers 1-6 respectively. After 
the pefloxacin period, the faecal concentration of pefloxacin dropped 
rapidly, as in the Figure. The faecal concentration of pefloxacin 
dropped below detection limit (1 mg/1) in 7 days in three volunteers 
and in 4, 5 and 6 days in the other ones. 
In the pre-treatment period, E. coli was the dominant species of 
Gram-negative bacilli in all volunteers. Colonization with Gram-
negative bacilli other than E. coli (secondary colonization) was 
detected in 1, 4, 7, 6, 7, and 3 samples in volunteers 1-6 
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respectively, in a median concentration of 104 cfu/g (range 102 - 10' 
cfu/g). 
The influence of Pefloxacin on the faecal concentration of in-
digenous aerobic flora is shown in Table I. 
Pefloxacin rapidly eliminated indigenous Gram-negative bacilli from 
faeces. The concentration was below detection limit (102 cfu/g) on 
day 2 in volunteers 2 and 6, and on day 3 in the other four. 
Enterococci were the dominant species of aerobic Gram-positive 
cocci in all volunteers during the pre-treatment and the treatment 
period. The faecal concentration of aerobic Gram-positive cocci 
decreased significantly in volunteers 2-6, but not in volunteer 1. 
Pefloxacin did not influence the MIC of the enterococci that were 
isolated from faeces. During the pre-treatment period as well as the 
treatment and post-treatment period the MIC of nearly all 
enterococci was between 4 and 16 mg/1. 
Pefloxacin caused a significant increase in the faecal concentration of 
yeasts in volunteers 3, 4, and 5. 
In the post-treatment period, colonization of the bowel by the 
challenge strain was facilitated in volunteers 3 and 4, but not in 
volunteers 1, 2, 5 and 6 (Table II). In volunteer 3, the challenge 
strain re-appeared spontaneously in the first faecal sample of the 
post-treatment period and remained detectable in all samples up to 
day 6 and in a sample on day 10. In volunteer 4, faecal samples 
were positive for the challenge strain for eight days. 
Gram-negative bacilli re-appeared in faeces at day 13, 5, 9, 13, 6 
and 17 of the post-treatment period in volunteers 1-6 respectively. In 
four of six volunteers E. coli was the first species of Gram-negative 
bacilli to re-appear. In the other two volunteers Klebsiella (other 
than the challenge strain), Acinetobacter and Citrobacter spp. 
appeared first. 
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Discussion 
The influence of antimicrobial agents on CR can not be assessed by 
measuring the faecal concentration of anaerobic flora. The 
composition of the anaerobic flora that provides CR is unknown, 
therefore analysis of the concentration of the minor fraction of the 
anaerobic flora that is cultivatable yields inconclusive results. Also, 
antimicrobial agents might impair CR by diminishing the production 
of inhibitory substances, without reducing the concentration of the 
CR-flora. 
Hence, disturbance of this flora has to be deduced from an increase 
in the intestinal concentration of 1) Gram-negative bacilli, 2) aerobic 
Gram-positive cocci or 3) yeasts, or by increase in secondary 
colonization (10, 11). It should be noted, that overgrowth by these 
micro-organisms is possible only if species are present that are 
resistant to the active concentration of the antibiotic in the bowel. 
Therefore, if the active faecal concentration of an antibacterial agent 
is high compared to the MIC of prevailing aerobic bacteria, the 
faecal concentration of yeasts remains as the best indicator of 
impairment of CR (10). 
Between the fifth and the last day of treatment, the median faecal 
concentration of the volunteers was between 119 and 231 mg/1 
(median value 154 mg/1). In a previous study (12), the median 
faecal concentration following intravenous adminstration of 
Pefloxacin in five volunteers was between 140 and 238 mg/1 (median 
value 160 mg/1). The equivalence of the faecal concentration of 
Pefloxacin following oral and parenteral administration confirms the 
excellent bio-availability of Pefloxacin after oral administration and 
suggests that the influence of Pefloxacin on the faecal flora will be 
similar following oral and parenteral administration. 
The faecal concentration of yeasts was significantly increased in 
volunteers 3, 4 and 5, indicating disturbance of the anaerobic flora 
that provides CR. In volunteers 3 and 4 this was confirmed by 
facilitation of colonization with the Klebsiella challenge strain in the 
post-treatment period. In volunteer 3 the challenge strain re-
appeared spontaneously in faeces in the first sample of the post-
treatment period, following 6 negative faecal samples (in the 
treatment period). This demonstrates that the challenge strain had 
survived somewhere in the digestive tract, after the faecal samples 
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had become negative. A similar phenomenon occurred in the 
volunteer of the pilot trial (Figure). This shows that elimination of 
micro-organisms from faeces does not prove that they have been 
eliminated from the bowel. Probably the active concentration of 
Pefloxacin is higher in the colon than in the rest of the bowel, 
enabling survival (for example in the ileum or in the caecum) of 
strains with a MIC below the diffusible faecal concentration of 
Pefloxacin. 
In volunteer 5, impairment of CR (as indicated by increase of the 
concentration of yeasts), could not be confirmed with the challenge 
strain in the post-treatment period. This was due to rapid reversal of 
impairment of CR. The faecal concentration of yeasts in this 
volunteer was between 104 and 10* cfu/g in the last four samples 
during Pefloxacin and in the next two samples. From the third day 
of the post-treatment period onwards, all samples were below 104 
cfu/g again. 
In volunteer 3 also, the rapid reversal of CR would not have allowed 
detection of disturbance of CR if the challenge strain would not have 
re-appeared spontaneously in the first faecal sample after treatment. 
So, in general, impairment of CR following Pefloxacin is reversed 
too rapidly to allow reliable detection of this impairment by 
challenge in the post-treatment period. 
The faecal concentration of enterococci decreased significantly in 
five of six volunteers. In volunteers 2, 3, 4, and 6 the last two 
treatment samples were free of enterococci. However, elimination of 
enterococci from faeces appears to proceed much slower than 
elimination of Gram-negative bacilli. This slow elimination, together 
with the small number of samples and the short period of 
investigation used in most studies, might explain why influence of 
quinolones on faecal concentration of enterococci is not detected in 
most studies (5, 12). 
We had expected that the MIC of the enterococci in the last treat-
ment samples of the Pefloxacin period would have been higher than 
the diffusible faecal concentration of Pefloxacin. However, before, 
during and after treatment with Pefloxacin, the MIC of the majority 
of isolates was between 4 and 16 mg/1. This is about 20 times lower 
than the diffusible faecal concentration of pefloxacin (119-231 mg/1 
in this study). On the other hand, faecal samples were rapidly 
cleared of the K. pneumoniae challenge strain in volunteers 3, 4 and 
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5 (although CR was impaired in these volunteers), though the 
diffusible faecal concentration of Pefloxacin was only about three 
times higher than the MIC of the challenge strain. This confirms 
earlier observations that the diffusible faecal concentration is about 
equal to the concentration required for elimination (or at least 
reduction of the faecal concentration) of Gram-negative bacilli (10, 
Figure). Apparently, elimination of enterococci from faeces requires 
a higher faecal concentration of Pefloxacin relative to their MIC, 
than elimination of Gram-negative bacilli. We have no explanation 
for this remarkable phenomenon. 
We did not observe an increase in the faecal concentration of 
staphylococci, as was reported in a study with pefloxacin 400 mg 
three times daily (13). Possibly, that dosage provoked colonization 
with staphylococci by stronger impairment of CR than occurs 
following 400 mg twice daily. 
The data of volunteers 1, 2 and 6 in this study show that the normal 
dosage of pefloxacin does not impair CR in all volunteers, and 
confirm our previous finding that it is possible to eliminate 
indigenous Gram-negative bacilli from faeces, without impairing CR 
against yeasts (10). 
We conclude that pefloxacin is a highly reliable agent for elimi-
nation of Gram-negative bacilli from faeces. Although pefloxacin 
400 mg twice daily impairs CR in part of the volunteers, this does 
not result in overgrowth with bacteria, because the active faecal 
concentration is too high during treatment, and because CR is 
restored rapidly after treatment. 
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Table I. Influence of Pefloxacin on the faecal concentration" of 
aerobic flora 
Volun- Gram-negative 
teer bacilli 
number A В 
Gram-pos it ive 
cocci 
A В 
Yeasts 
В 
8(6-
6(5-
6(4-
7(5-
4(4-
6(3-
9) 
7) 
8) 
8) 
7) 
8) 
<2 (<2-3) 
<2(<2-<2) 
<2 (<2-3) 
<2 (<2-4) 
<2(<2-<2) 
<2 (<2-4)' 
4(3-6) 
4(3-7) 
5(3-5) 
6(3-8) 
6(6-7) 
5(2-7) 
4(<2-5)r 
3(<2-5)' 
3( 2-3)· 
3(<2-5)· 
5( 4-7)" 
3(<2-5)-
<2(<2-
3(<2-
<2(<2-
3(<2-
<2(<2-
<2(<2-
2) 
4) 
2) 
4) 
3) 
2) 
<2(<2-
3( 2-
3( 2-
5( 3-
3(<2-
<2(<2 
5) r 
5) r 
6) 
<2)' 
0
 : IiOg10 median concentration (cfu/g) and range. 
A : Pre-treatment period (n=10); В treatment period (n=10, 
except in volunteer 5; η = 9). 
" or : Ρ < 0.01 ; * or : Ρ < 0.05 ; "* : Ρ > 0.05 , two sided 
significance of a difference between periods A and B. 
Table II. Influence of Pefloxacin on colonization of the bowel 
by the challenge strain 
Volunteer Pre-treatment 
number Period 
С .
ь
 duration' 
Treatment 
Period 
„
v
b
 duration0 
Post-treatment 
Period 
C_„b durâtion' 
1 
2 
3 
4 
5 
6 
IO* 
IO6 
IO7 
1 0
я 1 0 е 
IO 3 
1 
3 
1 
3 
4 
2 
10' 
IO5 
IO5 
10* 
IO6 
IO2 
ι ο­
ίο
7 
IO5 
IO6 
IO4 
IO6 
cfu of Klebsiella pneumoniae, " : Oral administration of 1011 
MIC for Pefloxacin 56 mg/1. 
ь
 : Maximal faecal concentration (cfu/g). 
c
 : Number of days with positive faecal samples 
155 
240 
Pefloxacin (mg/kg faeces) log 10 cfu/g faeces 
200 -
160 
120 
80 
40 -
яоюі 
Figure. Influence of Pefloxacin on the faecal concentration of 
Escherichia coli and of the Klebsiella pneuinoniae-challenge 
strain in the pilot trial. 
*-*-* : Diffusible faecal concentration of Pefloxacin. 
x-x-x : Faecal concentration of the challenge strain, detection 
limit 10 cfu/g faeces. 
Day 0 - Day 10 : 400 mg Pefloxacin twice daily. 
Day 5 : Oral adminstration of 1011 cfu Klebsiella pneumoniae. 
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CHAPTER XII 
THE CONCEPT OF COLONIZATION RESISTANCE. 
A RE-APPRAISAL 
Introduction 
In 1987, we reviewed the data concerning the concept of microbial 
colonization resistance (CR). At that time, application of this 
concept had resulted in several papers reporting successful 
prevention of infections in leukopenic patients by selective 
decontamination, and selective decontamination in patients on 
mechanical ventilation had just been started. However, the concept 
was based on data obtained in animal experiments and had not been 
validated in man. 
In the mean time a large number of new studies reporting successful 
application of selective decontamination have been published, and 
studies in man have been performed. These studies throw a new 
light on the concept and improve the understanding of the 
determinants of the influence of antimicrobial agents on the aerobic 
flora of the bowel. 
So, it is time for a re-appraisal of the concept. 
Autochthonous, normal and indigenous flora 
Administration of antibiotics may disrupt the microbial ecology of 
the bowel, causing overgrowth by resistant micro-organisms and 
increasing the risk of superinfections (1). Apparently, microbial 
flora of the bowel protects against overgrowth by potentially 
pathogenic micro-organisms. The crucial question is : which part of 
the flora provides that protection ? 
To tackle this question, Dubos made a distinction between the 
autochthonous flora, the normal flora and the indigenous flora of the 
bowel (2). In his words, ". the autochthonous flora is a collection of 
micro-organisms that has achieved a symbiotic state with their host 
during a long period of evolutionary association". This flora plays 
an essential role in the development and physiological activities of 
normal animals and man and provides the protection against coloni-
zation by potentially pathogenic flora. The autochthonous flora may 
differ between species, but is identical in all individuals of a species. 
The "normal flora" is the sum of the autochthonous flora and of 
other micro-organisms that are so widely distributed and so adapted 
to the circumstances in the bowel that they succeed in colonizing 
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practically all members of a community. 
"Indigenous flora" designates all micro-organisms colonizing an 
individual. 
The composition of the normal flora is not identical in people all 
over the world. This provides a way to identify some organisms that 
belong to the normal flora but not to the autochthonous flora. For 
example, in a large part of the world, healthy adults excrete 
Escherichia coli strains, belonging to their normal bowel flora, that 
may kill their children and sicken many tourists. So the normal flora 
may contain real pathogens. Absence of these organisms in people in 
other parts of the world appears to be perfectly compatible with 
normal health, so these organisms do not belong to the 
autochthonous flora. 
Dubos emphasized that the normal flora consists of high numbers of 
obligate anaerobic flora and much lower, erratic numbers of aerobic 
flora. He concluded that enterococci and Enterobacteriaceae do not 
belong to the autochthonous flora because "..in all colonies of mice 
so far tested, the changes in population size of enterobacteria and 
enterococci (shortly after birth) suggest that these organisms cause 
an intestinal infection, but one from which the animals recover. In 
this light, the persistence of these organisms in the faces would 
correspond to a carrier state, or to a low grade continuous infectious 
process" (2). Summarizing, in his opinion the protective flora is 
composed of (an unknown part of the) obligate anaerobic flora, and 
aerobic flora is potentially pathogenic. 
The concept of colonization resistance 
The term "colonization resistance" was introduced by van der Waaij, 
who presented further evidence that the obligate anaerobic flora of 
the bowel limits colonization of the bowel by exogenous aerobic 
flora (3), and also limits the faecal concentration of indigenous 
aerobic flora (4, 5). He emphasized the importance of sparing the 
flora that provides CR when using antimicrobial chemotherapy, 
presuming the availability of antimicrobials that did so (6). By this 
presumption, the fatalistic attitude that administration of antibiotics 
inevitably increases the risk of superinfections, changed into the 
hopeful expectation that this problem might be circumvented. If the 
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concept of CR is right, the risk of antibiotic-related superinfections 
will be eliminated by selecting antibiotics that do not disturb that 
part of the anaerobic flora that provides CR (CR flora). This would 
not be a problem, because most infections are caused by aerobic 
flora. Furthermore, it would be possible to prevent infections in 
compromised patients, by elimination of indigenous aerobic flora 
with antibiotics that do not disturb the CR-flora. 
This concept challenges the conclusions that had been drawn from 
prophylaxis with penicillins and tetracyclines. Experience had taught 
that prophylactic administration of these antibiotics to compromised 
patients increases the risk of infections (7, 8, 9, 10). Therefore, 
prophylactic administration of antibiotics was strongly advised 
against by microbiologists, in general with rather limited success. 
Instead, the concept of CR predicts that it is possible to eliminate 
indigenous aerobic flora prophylactically, without increasing the risk 
of superinfections by resistant strains (selective decolonization). 
Clinical observations supporting the concept 
The concept of CR was based on data from experiments in animals. 
However, it cannot be taken for granted, that the influence of 
antimicrobial agents in man and mice is identical. Therefore, this 
issue has to be studied in man. Unfortunately, interpretation of data 
on the influence of antibiotics on CR in patients is rather 
complicated, because CR may be impaired by illness (11), old age 
(12), hospitalization (13) and stress of surgery (14). Still, it has been 
shown in patients that the risk of superinfections is not increased to 
the same extent by all antibiotics. For example, cefaclor (which was 
presumed to spare the CR) caused less oropharyngeal colonization 
by Enterobacteriaceae and yeasts and less superinfections than 
amoxycillin (which impairs CR) in patients treated for pulmonary 
infections (15). A clinical trial in neutropenic patients showed that 
therapy with a combination of aztreonam plus tobramycin, which 
had a minimal impact on the intestinal flora, was associated with 
fewer fungal infections than either aztreonam plus cloxacillin or 
moxalactam plus tobramycin, both of which more strongly disrupted 
the intestinal anaerobic microflora (16). These data were considered 
as indications that, in man also, disturbance of anaerobic flora 
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increases the risk of superinfections. 
Much more supportive evidence for the concept came from pro-
phylactic administration of antibiotics. When co-trimoxazole was 
given on a long-term basis to children with acute leukaemia, in order 
to prevent Pneumocystis carinii infections, an unexpected benefit 
was a decrease in the number of bacterial infections compared to the 
placebo group (17). Subsequently, successful prophylaxis of 
infections in neutropenic patients by long-term administration of co-
trimoxazole or quinolones has been demonstrated in a large number 
of studies (18, 19). Proponents of the concept of CR ascribed the 
success of these prophylactic regimens to elimination of Gram-
negative bacilli from the bowel without disturbing the CR-flora. 
Therefore, this method of prophylaxis was called "selective 
decontamination" (18). In the rest of this paper we will use the term 
"decolonization", because "decontamination" is associated with 
elimination of micro-organisms from inanimate objects. 
Selective decolonization has also been applied successfully for 
prevention of infections in patients who are mechanically ventilated 
(20), and for prevention of Gram-negative bacilluria in patients with 
transurethral catheters (21). 
It should be noted that these regimens were called "selective" 
because it was assumed that they did not impair CR in man, but this 
was based on extrapolation of data obtained in mice. 
Definition of the concept of colonization resistance 
Up to here, we have described "CR" as a philosophy, but that does 
not provide a suitable basis to test the concept. Validation of a 
theory requires verifiable hypotheses. To this purpose the concept 
had not been defined properly. On the contrary, much confusion has 
arisen because "CR" does not mean the same to every author at 
every time. 
The term CR was introduced by van der Waaij in 1971, to indicate 
resistance against colonization by exogenous strains quantitatively. 
He defined it as the logarithm of the bacterial dose resulting in 
colonization for at least two weeks in 50% of the contaminated 
animals (3). 
In 1974 van der Waaij reported that the faecal concentration of 
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enterococci and yeasts remained unchanged following elimination of 
Enterobacteriaceae from the bowel of mice and monkeys by 
administration of nalidixic acid. From this he concludes : "Ibis 
indicates that the fraction of the anaerobic microflora which is 
responsible for the CR of the digestive tract is not affected by the 
treatment", and (in the discussion) " Inasmuch as the concentration 
of enterococci remained unchanged during the treatment, it appears 
that the CR was unaffected. The fact that the C. albicans concen-
tration remained low in the monkeys during treatment further 
supports the interpretation that nalidixic acid does not affect CR" 
(5). In other words, increase in enterococci or yeasts would have 
been taken as evidence of impairment of CR. From this we con-
cluded, that the limiting action of CR-flora on the faecal concen-
tration of indigenous microflora had been included in the definition 
of CR by that time. 
In 1986, however, van der Waaij again defines "the concept of CR" 
as "the ability of the normal gut flora to combat colonization by 
extrinsic bacteria" (22). The same definition is used by Nord (23). 
So, these authors do not include the influence on indigenous flora in 
the definition of CR. It is not clear whether this implies that an 
increase in the concentration of parts of the indigenous aerobic flora 
is not considered impairment of CR by these authors. However, 
Barza et al. are explicit at this point. They define CR as "the 
resistance displayed by the normal host to the implantation of new 
strains (as opposed to overgrowth of already present strains) in the 
faecal microflora" (24). 
We think this is highly confusing. If the CR-flora is considered to 
have a limiting action on both exogenous flora and on indigenous 
flora, it is not logical to reserve the term CR for resistance against 
colonization by exogenous strains. We considered it more logical to 
interpret the term (microbial) CR as the limiting action (of 
autochthonous micro-organisms) on colonization of the body by 
potentially pathogenic micro-organisms, both exogenous and 
endogenous. The limiting action results in total exclusion from the 
bowel of most species of aerobic flora, and in a restricted 
concentration of some specially adapted aerobic species (indigenous 
aerobic flora). This was our approach from the first study onwards 
(chapter III). 
So, in our interpretation, the concept of colonization resistance 
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consisted of the three following hypotheses (chapter III) : 
1. Microbial CR against aerobic flora is provided exclusively by 
obligate anaerobic flora (2, 3). 
2. Microbial CR limits colonization of the bowel by exogenous 
micro-organisms (2, 3). 
3. Microbial CR limits the faecal concentration of indigenous 
aerobic micro-organisms (2, 4, 5). 
In general, the data of our studies up to now have not necessitated 
major changes in this concept. As will be discussed however, 
indigenous Gram-negative bacilli may contribute to CR against 
exogenous Gram-negative bacilli if the CR-flora has been disturbed. 
Study design for the classification of antimicrobial agents 
according to their influence on colonization resistance 
1. Study subjects 
The first data on the influence of antimicrobial agents came from 
experiments in animals, mostly mice. 
Animal studies have been important for demonstration of the 
existence and of the potential clinical importance of CR. The first 
tentative classification of antimicrobial agents according to their 
influence on CR in man, was based on extrapolation of data obtained 
in mice (6). However, it is unlikely that the CR-flora is identical in 
mice and in man. Moreover, the dosage of an antimicrobial agent 
that has been used in animal experiments can not be reliably 
extrapolated to man. Accurate extrapolation is of utmost importance 
however, because it has been shown that the influence of penicillin 
on CR in man strongly depends on the dosage (10). Therefore, 
classification of antimicrobial agents according to their influence on 
CR has to be based on studies performed in man. 
As argued before, patients are not ideal subjects for this kind of 
investigations, because the concentration of indigenous aerobic flora 
may be increased due to their disease. Moreover, it is difficult to 
obtain faeces from hospital patients regularly. Therefore, volunteers 
are to be preferred for studies on the influence of antimicrobial 
agents on CR. 
In some studies the study subjects are called volunteers, but it 
appears that these volunteers are patients, so the results of these 
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studies have to be interpreted cautiously (25). 
2. What should be measured ? 
2. a. Anaerobic flora ? 
Although we presume that microbial CR is provided by anaerobic 
flora, it is our opinion that analysis of anaerobic flora in faeces does 
not give useful information on the influence of antimicrobial agents 
on CR. Firstly, the composition of the CR-flora is unknown and 
most anaerobic species cannot be cultured selectively. Secondly, it is 
not certain that impairment of CR requires reduction of the 
concentration of anaerobic species involved in CR ; reduction of the 
production of inhibiting substances might be sufficient. So, although 
all data on the influence of antimicrobial agents on the faecal flora 
are of scientific interest, determination of the concentration of the 
few cui ti valable anaerobic species does not contribute to knowledge 
concerning the influence of antimicrobial agents on CR. 
Some authors rely, at least partially, on anaerobic flora as an 
indicator of impairment of CR (24, 25, 26). This may lead to wrong 
conclusions. 
2.b. Total aerobic flora ? 
Some investigators use the total concentration of aerobic flora as an 
indicator of the influence of antimicrobial agents on CR (26). This 
gives no reliable information however, because the total 
concentration remains unchanged if the dominant group of aerobic 
flora is not affected. On the other hand, a decrease of the faecal 
concentration of the dominant group of aerobic flora may cause a 
decrease of the total concentration of aerobic flora, even if the faecal 
concentration of another group of aerobic flora is increased. For 
example, significant increase in the faecal concentration of yeasts 
indicated impairment of CR in three volunteers following Pefloxacin 
400 mg twice daily, but the total faecal concentration of aerobic 
flora decreased due to reduction of the concentration of Gram-
negative bacilli and aerobic Gram-positive cocci (chapter XI). 
I.e. Groups of aerobic flora 
Impairment of CR can be demonstrated by an increase in the faecal 
concentration of Gram-negative bacilli, aerobic Gram-positive cocci 
or yeasts, and by facilitation of colonization of the bowel by other 
Gram-negative bacilli than E. coli. Of course, an increase in aerobic 
flora following impairment of CR will occur only if resistant species 
are present in the bowel before or are ingested with food during 
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administration of the antimicrobial agent. Therefore, the 
concentration of Gram-negative bacilli and aerobic Gram-positive 
cocci may give false negative results. However, yeasts are not 
susceptible to antibacterial agents. Therefore, yeasts are a useful 
endogenous indicator of impairment of CR if the faecal concen-
tration of antibacterial agents is high. 
Furthermore, it should be noted that detection of an increase in the 
occurrence of low concentrations of Gram-negative bacilli other than 
E. coli, following antimicrobial agents that decrease the faecal 
concentration of E. coli, does not necessarily prove an actual 
increase in occurrence of those strains, because elimination of E. 
coli makes it much easier to detect low level concentrations of other 
Gram-negative bacilli. This problem can be reduced by using 
selective culture media, apart from the usual ones. If the 
antimicrobial agent under investigation is added to the culture 
medium for Gram-negative bacilli, this improves the chance of 
detection of low-level colonization by secondary Gram-negative 
bacilli during the pre-treatment period. 
Increase of enterococci has been misinterpreted in some studies. 
Since it was assumed that cefotaxime spares CR, cefotaxime was 
excluded as a possible cause of an observed increase of the faecal 
concentration of enterococci. As a consequence, the increase of 
enterococci was tentatively explained as a result of selective 
decontamination (16, 27, 28). However, selective elimination of E. 
coli does not cause an increase in the faecal concentration of 
enterococci (chapter IX), but cefotaxime does (chapter VII). 
2.d. Challenge-strains. 
Impairment of CR will go unnoticed if resistant micro-organisms are 
not present. Therefore we advice to use challenge strains. So far, 
our experience is limited to challenge with Gram-negative bacilli. 
The ideal challenge strain is a strain that has been acquired from 
surveillance cultures of a patient treated prophylactically with the 
antimicrobial agent one wants to investigate, provided that this strain 
did not cause problems to the patient. Moreover, the strain should be 
susceptible to non-toxic antibiotics. 
The challenge strain should be administered twice, once during the 
pretreatment period and once during the treatment period. If 
administration of the antimicrobial agent facilitates colonization by 
the challenge strain, this indicates impairment of CR. 
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It should be emphasized that the challenge strain has to be resistant 
to the active antimicrobial concentration in the bowel. This may 
deviate strongly from the levels achievable in blood. For example, 
erythromycin is not effective for treatment of infections with Gram-
negative bacilli. Yet it eliminates Gram-negative bacilli from faeces 
(chapter III). 
It is a problem that the methodology for analysis of the active faecal 
concentration of antimicrobial agents has not been developed yet. 
We have found indications that the active faecal concentration of 
quinolones is about equal to the diffusible faecal concentration 
(chapter XI). However, these data are preliminary and it is not 
known whether similar data will be found with other groups of 
antimicrobial agents. As long as this problem has not been solved, 
failure of colonization of the bowel by a challenge strain suggests 
absence of impairment of CR only when the strain does grow out 
when an antimicrobial agent impairing CR is added to the agent 
under investigation (chapter IX). 
Apart from technical problems, emotional problems have hampered 
the use of challenge strains. Many investigators are afraid to 
administer bacteria to volunteers. In fact however, the risk of 
administration of a challenge strain (with the specifications described 
before) does not exceed the risk of ingesting Gram-negative bacilli 
contained in normal food. On the contrary, the risk of the challenge 
strain is lower because it is known before that the challenge strain is 
susceptible to non-toxic antibiotics. 
The paper of Barza et al. (24) is frequently cited as evidence that the 
importance of anaerobic flora for CR is doubtful. In that study 
however, challenge strains were used which were susceptible to the 
antibiotics under investigation (for ethical reasons). Because the 
challenge strains did of course not succeed to colonize when 
administered during antibiotic treatment, the challenge was repeated 
after treatment, and the duration of colonization was recorded. 
However, this is not a reliable method either, because CR may be 
restored soon after the end of treatment, as we have seen with 
peñoxacin (chapter XI). 
3. Statistical analysis of the data 
In the usual study design, the influence of antimicrobial agents on 
faecal flora is investigated by studying its influence on the median 
faecal concentration in a group of volunteers (25). However, the 
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antimicrobial susceptibility of the CR-flora may differ between 
volunteers. Therefore, the influence on CR is not necessarily the 
same in all volunteers. For example we found no impairment of CR 
in three of 11 volunteers following amoxycillin (chapter VI) and in 
three of six volunteers following Pefloxacin (chapter XI). Obviously, 
the chance of obtaining a significant increase in the median faecal 
concentration of aerobic flora in a group of volunteers decreases 
with the proportion of volunteers in whom CR is not impaired. This 
may explain why we did not demonstrate impairment of CR follow-
ing Pefloxacin when the data were analyzed for the group of volun-
teers (chapter X). We conclude that the influence of antimicrobial 
agents on CR has to be analyzed in each volunteer separately. The 
normal fluctuation of the faecal concentration of Gram-negative 
bacilli is such that a tenfold change will be demonstrated with 
statistical significance if ten pre-treatment samples and ten treatment 
samples are used (chapter VI). 
We wish to emphasize that each volunteer should be his or her own 
control. In the paper of Barza (24), the duration of colonization by 
challenge strains administered after treatment with antibiotics was 
compared to the duration of colonization in four volunteers who 
served as a control. This is not a reliable study design, because 
susceptibility to challenge strains depends on many factors and may 
show large differences between volunteers (chapter VI). 
Validation of the concept of colonization resistance 
At the start of our studies we had little doubt concerning the 
rightness of that concept. Our only intention was to separate the safe 
drugs from the dangerous ones, expecting that we would add 
evidence of the rightness of the concept at the same time. 
However, we got into problems almost immediately. We observed 
an increase in the number of samples with Gram-negative bacilli 
other than E. coli (secondary Gram-negative bacilli), following 
agents that did not increase the total faecal concentration of Gram-
negative bacilli, of enterococci or of yeasts. So according to our 
hypothesis, the CR-flora was not impaired. The most simple 
explanation would be that increase of secondary colonization was 
just an artefact, due to the fact that it is easier to detect low level 
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concentration of secondary Gram-negative bacilli following a 
decrease of the faecal concentration of E. coli. Though this could 
not be excluded, we did not consider it a very likely explanation. 
Therefore, we introduced the hypothesis of "substitution coloni-
zation", which states that low-level secondary colonization is facili-
tated by a decrease of the faecal concentration of E. coli itself, and 
does not proof impairment of the CR-flora. 
Re-evaluating the data of the first two studies (chapters III and IV), 
we realized ourselves that both the hypotheses and our study design 
were not satisfactory. Obviously, outgrowth of aerobic flora will 
occur only if resistant species are present, and the antimicrobial 
susceptibility of the CR-flora may differ between volunteers. 
Moreover, the hypothesis of substitution colonization necessitated a 
change in the hypothesis that CR is provided exclusively by 
anaerobic flora, and the original hypotheses (page 163) did not state 
clearly whether impairment of CR is expected to cause an increase 
in all three groups of aerobic flora. Therefore, we changed our study 
design as discussed in the preceding section, and reformulated our 
hypotheses as follows : 
1. The total faecal concentration of Gram-negative bacilli, of aerobic 
Gram-positive cocci and of yeasts is limited exclusively by an 
anaerobic flora that provides CR. 
2. Impairment of the anaerobic flora that provides CR will cause an 
increase in the faecal concentration of Gram-negative bacilli as well 
as of aerobic Gram-positive cocci and of yeasts, if resistant strains 
are present. 
3. Selective elimination of E. coli facilitates low level colonization 
of the bowel by other Gram-negative bacilli (substitution 
colonization). 
4. Disturbance of the anaerobic flora that provides CR will result in 
high-level colonization by resistant challenge strains. 
We will now discuss the results of the validation of these 
hypotheses. 
ad 1. The faecal concentration of Gram-negative bacilli, of aerobic 
Gram-positive cocci and of yeasts is limited exclusively by an 
anaerobic flora that provides CR. 
Up to now, we have not obtained data that speak against this 
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hypothesis. Elimination of indigenous Gram-negative bacilli with 20 
mg Pefloxacin daily, did not cause an increase in the faecal 
concentration of enterococci or yeasts (chapter IX). So it would 
appear that Gram-negative bacilli do not suppress enterococci or 
yeasts (at least if the CR-flora is not disturbed). Several volunteers 
with normal CR were not colonized by yeasts. So yeasts are also not 
important for CR. The role of enterococci is more difficult to 
ascertain, because they colonize almost all people and because agents 
for selective decolonization of enterococci are not available. 
However, in one of our volunteers CR was maintained in the pre-
treatment period of the amoxycillin-study, although enterococci were 
not detectable in eight of ten samples (chapter VI). This makes it 
unlikely that the contribution of enterococci is of major importance. 
Further, we observed a simultaneous increase in the concentration of 
Gram-negative bacilli, of aerobic Gram-positive cocci and of yeasts 
following amoxycillin (in one volunteer who appeared to have 
acquired resistant enterococci, chapter VI), clindamycin (chapter IX) 
and cefotaxime (chapter VII). The same had been described before 
following cefoxitin (30). Simultaneous increase of the three groups 
of aerobic flora indicates that they have no major mutual inhibitory 
action. 
Conclusion : Increase in the faecal concentration of Gram-negative 
bacilli, aerobic Gram-positive cocci or yeasts indicates disturbance 
of an anaerobic flora that provides CR. 
ad 2. Impairment of the anaerobic flora that provides CR causes an 
increase in all three groups of indigenous aerobic flora, if resistant 
species are present. 
This hypothesis states that the limiting action of species of the 
anaerobic flora on aerobic flora is not selective to subgroups of 
aerobic flora. We have just mentioned some observations demon-
strating that a simultaneous increase of the three groups of aerobic 
flora is possible. However in four of five volunteers in whom a 
significant increase in the faecal concentration of enterococci and 
yeasts indicated disturbance of the CR-flora following cefotaxime, 
the faecal concentration of Gram-negative bacilli did not increase 
above the level in the pre-treatment period, although the bowel was 
colonized with a highly resistant challenge strain (chapter VII). 
Moreover, in one volunteer in whom the faecal concentration of 
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Gram-negative bacilli and enterococci increased strongly following 
clindamycin, outgrowth of yeasts did not occur (chapter IX). 
So, it appears that disturbance of the CR-flora is not always 
followed by overgrowth of all groups of aerobic flora. Possibly, CR-
flora consists of several species that do not inhibit all three groups of 
aerobic flora to the same extent. It is also possible that factors other 
than CR-flora (for example antibodies in mucous secretions or 
absence of essential nutrients), do not impede outgrowth of specific 
aerobic species to the same extent in all volunteers. This might be 
investigated by impairing CR in such volunteers with other anti-
microbial agents, but such studies have not been performed. 
Conclusion : Absence of an increase in the concentration of one of 
the three groups of aerobic flora does not disprove impairment of the 
CR-flora. 
ad 3. Selective elimination of Escherichia coli facilitates low-level 
colonization of the bowel by other Gram-negative bacilli (substitution 
colonization). 
Contrary to our expectation, selective elimination of indigenous 
Gram-negative bacilli did not facilitate low-level colonization by a 
resistant challenge strain (chapter IX). Daily administration of 20 mg 
Pefloxacin eliminated Gram-negative bacilli from faeces, but did 
neither cause an increase in the faecal concentration of enterococci 
or yeasts, nor did it facilitate colonization of the bowel by a highly 
resistant strain of Klebsiella pneumoniae, whereas clindamycin 
enabled high-level colonization by this strain in all volunteers. 
Although this study does not exclude entirely that the phenomenon 
of substitution colonization may exist, it is unlikely that it occurs 
very easily. Therefore, it is our present view that the increase of 
secondary colonization following co-trimoxazole, doxycycline and 
roxithromycin which we observed in previous studies (chapters III 
and IV), should be regarded as suggestive evidence that these agents 
impair the CR-flora. The fact that the faecal concentration of 
secondary Gram-negative bacilli remained below the pre-treatment 
value of E. coli following those antimicrobial agents, is probably 
due to the fact that the active faecal concentration of antimicrobial 
agents was too low to cause complete elimination and too high to 
allow overgrowth of these secondary Gram-negative bacilli. This 
issue should be investigated by comparing the MIC of colonizing 
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Gram-negative bacilli with the faecal concentration of the agent 
under investigation. 
Conclusion : Increase of low-level secondary colonization should be 
regarded as suggestive evidence of disturbance of the anaerobic flora 
that provides CR. 
ad 4. Disturbance of the anaerobic flora that provides CR results in 
high-level colonization by challenge strains. 
Although disturbance of the anaerobic CR-flora may enable high-
level colonization of the bowel by resistant challenge strains, false 
negative results are possible. It appears that colonization of the 
bowel by exogenous Gram-negative bacilli following disturbance of 
the CR-flora may be impeded by indigenous Gram-negative bacilli. 
We have found definite examples of mutual competition between 
Gram-negative bacilli. When microbial CR against indigenous flora 
was impaired (as indicated by an increase in one of the three groups 
of aerobic flora), colonization of the bowel by a resistant challenge 
strain occurred more reliably if other Gram-negative bacilli were 
suppressed (chapters VII, IX and XI), and could fail if indigenous 
Gram-negative bacilli were resistant and were growing out (chapters 
VI and VIII). This is in agreement with the observation in mice, that 
E. coli decreased the faecal concentration of Shigella flexneri, if the 
CR-flora was impaired (29, chapter II). 
Conclusion : Failure of challenge strains of resistant Gram-negative 
bacilli to colonize the bowel does not disprove disturbance of the 
anaerobic flora that provides CR 
In summary, our studies give further support to the hypothesis that 
the microbial CR is provided by autochthonous anaerobic flora, and 
that it is possible to eliminate aerobic flora from the bowel without 
increasing the risk of superinfections. However, impairment of CR-
flora does not invariably cause an increase of all three groups of 
aerobic flora. Moreover, if CR-flora is impaired, indigenous Gram-
negative bacilli may contribute to the CR against exogenous Gram-
negative bacilli. 
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Determinants of the influence of antimicrobial agents on the 
faecal concentration of aerobic flora 
It should be emphasized that the influence on CR is of no 
importance when all potentially pathogenic micro-organisms are 
killed by the antimicrobial agents. So, the influence on the CR-flora 
only modifies the influence of antimicrobial agents on the faecal 
concentrations of surviving potentially pathogenic micro-organisms. 
The influence of antimicrobial agents on the aerobic flora of the 
bowel depends on 1) the active concentration of antimicrobial agents 
in the bowel, 2) the susceptibility of aerobic micro-organisms and 3) 
the susceptibility of the CR-flora. 
It should be noted that H antibiotic-susceptibility of CR-flora" 
includes impairment of the production of inhibiting substances, apart 
from bactericidal or bacteriostatic action. The theoretical possibilities 
are as follows (Figure). 
Possibility 1 : Both aerobic flora and the CR-flora are not affected. 
We have not yet found an example of possibility 1. Agents used for 
the treatment of lower urinary tract infections have the best chance 
to meet the requirements. If absorption is complete and excretion in 
urine is rapid, such agents may have bowel concentrations and tissue 
levels below the MIC of any indigenous micro-organism. However, 
contrary to our expectations, cephradine 500 mg twice daily did not 
fulfil these requirements (chapter VIII). 
Possibility 2 : (Part of the) aerobic flora is affected and the CR-
flora is not affected (selective decolonization). 
The only example of this possibility we have demonstrated so far is 
Pefloxacin 20 mg once daily (chapter IX). This is not a therapeutic 
dosage, but the experiment was devised to investigate whether selec-
tive decolonization is possible at all. 
Possibility 3 : (Part of the) aerobic flora is not affected and the CR-
flora is impaired. 
Examples of possibility 3 are amoxycillin, cefotaxime and 
clindamycin (chapter VI, VII and IX). These agents impair CR in 
most or in all volunteers. Their spectrum of activity against aerobic 
flora is not the same, however, causing differences in the influence 
of these agents on the aerobic flora of the bowel : 
- Clindamycin causes an increase in the faecal concentration of 
Gram-negative bacilli, aerobic Gram-positive cocci and yeasts. 
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aerobic flora affected (a) 
no yes 
CR-flora 
affected 
(b) 
no 
yes 
no change 
overgrowth 
1 
3 
se lec t ive 
decolonalization 
2 
4 
••unselective" 
decolonization 
Figure. Influence of antimicrobial agents on the concentration of 
aerobic flora in the bowel. 
(a) : Active faecal concentration > MIC aerobic micro-organisms. 
(b) : Active faecal concentration > MIC CR-flora or high enough to 
decrease production of inhibiting substances. 
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- Amoxycillin causes an increase in the faecal concentration of 
Gram-negative bacilli and yeasts, but a decrease in the faecal 
concentration of enterococci. Overgrowth of enterococci may occur, 
however, if resistant enterococci are acquired during therapy. 
- Cefotaxime causes an increase in the faecal concentration of 
enterococci and yeasts, but resistant Gram-negative bacilli are not 
prevalent. Therefore the faecal concentration of indigenous Gram-
negative bacilli will generally decrease. However, if resistant Gram-
negative bacilli are acquired, overgrowth may occur. 
Possibility 4 : Both aerobic flora and the CR-flora are affected 
("unselective decontamination "). 
Examples of possibility 4 are norfloxacin 400 mg three times a day 
and Pefloxacin 400 mg three times a day (31). At this dosage, 
Enterobacteriaceae were eliminated from faeces in all five patients 
and enterococci in four of five patients. However, 400 mg two times 
a day already disturbs the CR-flora, causing outgrowth of yeasts 
(chapter XI). In the study of Giuliano this was not observed, because 
the patients were protected by simultaneous treatment with oral 
amphotericin В (31). Each regimen for decolonization that contains 
one or more components that impair CR falls into category 4, for 
example cefotaxime-containing regimens (chapter VII). 
Discussion 
At the start of our studies, we intended to validate and expand the 
"green list" of CR-sparing antimicrobial agents (6) and to improve 
the safety of antibiotic therapy in our hospital by reserving anti­
microbial agents that impair CR for treatment of infections for which 
no CR-sparing agent was available. We improved the study design 
for investigation of the influence of antimicrobial agents on CR and 
we could demonstrate that it is possible to eliminate Gram-negative 
bacilli from faeces without impairing microbial CR. However, our 
studies unmasked most "safe" antibiotics and did not add new ones. 
So, although it remains our ideal to select antimicrobial agents for 
therapy that do not disturb microbial CR, most (if not all) presently 
available antimicrobial agents do not fulfil this criterion. Therefore, 
it is important that the pharmaceutical industry focuses on the 
development of antimicrobial agents with a large difference of 
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activity against aerobic potentially pathogenic micro-organisms on 
one hand, and against known anaerobic species on the other hand. 
In the mean time, we will give preference to the second best group 
of antimicrobial agents, id est those agents that achieve sufficiently 
high active concentrations in the bowel to inhibit outgrowth of 
aerobic bacteria. It should be noted that in this way Candida spp. 
will not be covered, and that problems will occur if resistant aerobic 
bacteria or Clostridium difficile are acquired. Unexpectedly, this 
problem is illustrated by the development of bloody diarrhoea in one 
of our volunteers during cefotaxime and by the frequent occurrence 
of Candida-vaginitis in female volunteers in our studies. Bloody 
diarrhoea following challenge with Enterobacter cloacae has also 
been observed in a study with amoxycillin (32). So, contrary to our 
original expectations, it appeared that overgrowth of resistant micro-
organisms due to disturbance of CR may cause infections in healthy 
volunteers with (presumably) normal infection resistance. 
In females between 20 and 50 years old, Candida vaginitis probably 
is the most frequently occurring superinfection. So, female patients 
and volunteers should be warned for this problem, as well as for the 
risk of failure of oral anticonception following antimicrobial agents 
(chapter V). Even although all or most available antibacterial agents 
increase the risk of superinfection with Candida spp., those agents 
that rarely allow overgrowth by resistant bacteria remain preferable 
to those that cause this effect in the majority of patients. In this 
regard, co-trimoxazole, doxycycline and quinolones are preferable to 
penicillins. 
The importance of "selectivity" of antimicrobial agents used for 
prophylaxis has been overestimated. This idea arose from the 
observation that "selective decontamination" was more effective in 
the prevention of infections in leukopenic patients than prophylaxis 
by regimens that were known to impair CR (18). The idea was 
strengthened by the success of "selective decontamination" in 
patients who are mechanically ventilated. As Gurwith rightly noted 
however, the absolute necessity of selectivity can easily be refuted 
by the observation that addition of vancomycin (which impairs CR) 
to co-trimoxazole (which was used for selective decontamination in 
granulocytopenic patients) did not abolish the prophylactic efficacy 
of co-trimoxazole, but actually increased it (33). A similar 
argumentation applies to "selective decontamination" in patients who 
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are mechanically ventilated. Cefotaxime is included in most of these 
regimens (20), because it improved the results when added to oral 
non absorbable agents (34). We could show, however, that cefo-
taxime impairs CR (chapter VII). 
So, effective concentrations against prevailing potentially pathogenic 
micro-organisms are more important than sparing of the CR-flora. 
As selectivity is not an absolute requirement and as most regimens 
used for "selective decontamination" are not selective, we 
recommend to change the term "selective decontamination" into 
"prophylactic decolonization". It is striking that, in this way, we 
return again to the terminology that has been used in one of the first 
publications of the clinical application of prophylactic decolonization 
in leukopenic patients : "partial antimicrobial decontamination" (35). 
It now appears that "partial" is much more appropriate than 
"selective" for the regimens that have been used so far. 
Presently, quinolones are the safest antimicrobials for prophylactic 
decolonization and for therapy, as far as the risk of superinfections 
is concerned. Aerobic bacteria resistant to the diffusible faecal con-
centration of norfloxacin and Pefloxacin do not exist. Disturbance of 
CR following Pefloxacin occurred in half of our volunteers, but was 
reversed before the faecal concentration of Pefloxacin dropped far 
enough to allow recolonization by Gram-negative bacilli acquired 
with food. The same will probably apply to norfloxacin. In standard 
dosage (400 mg twice daily) the diffusible faecal concentration of 
norfloxacin is about 400 mg/1 (not published). Norfloxacin was used 
successfully as the basis of regimens for prophylactic decolonization 
of the bowel in patients on mechanical ventilation (36, 37, 38), in 
neutropenic patients (39), and in patients with transurethral cathe-
terization (21). An important advantage of norfloxacin is that it is 
not only very effective, but also very cheap. 
For treatment of systemic infections with Gram-negative bacilli, 
third generation quinolones are preferable to aminoglycosides and to 
cephalosporins like cefuroxime, cefotaxime and ceftazidime. The 
ratio between tissue levels and MIC's is at least as good, there is 
little inoculum effect on the MIC, enzymatic inactivation in faeces 
has not been observed and we have never succeeded in obtaining 
Gram-negative bacilli resistant to the diffusible faecal concentration 
of Pefloxacin. Furthermore, a major advantage of quinolones is that 
oral administration is possible. 
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The weak spot of quinolones is their minor activity against 
streptococci and enterococci at achievable tissue levels. If these 
organisms have to be covered at the same time as Gram-negative 
bacilli, combination of quinolones with a penicillin is preferable to 
combination with third generation cephalosporins. In this kind of 
combinations, quinolones may prevent the overgrowth with Gram-
negative bacilli, which is associated with administration of 
penicillins alone. 
Conclusion 
Antimicrobial agents may cause superinfections by overgrowth of 
resistant micro-organisms as a result of disturbance of (part of the) 
autochthonous anaerobic microflora of the digestive tract. Therefore, 
it would be desirable to select antimicrobial agents that do not cause 
this unfavourable effect. 
The influence of antimicrobial agents on the aerobic flora of the 
bowel has to be investigated in healthy volunteers, because 
extrapolation of animal data to man is not reliable and because in 
patients an increase in the aerobic flora may be caused by their 
disease. 
The data have to be analyzed for each volunteer individually, 
because the susceptibility of the CR-flora to antimicrobial agents is 
not necessarily the same in all volunteers. The normal fluctuation of 
the concentration of aerobic flora is such, that a tenfold change in 
the faecal concentration will be demonstrated with statistical 
significance if ten pre-treatment samples and ten treatment samples 
are used. 
In patients with normal CR, the faecal concentration of aerobic flora 
is not limited by Gram-negative bacilli, aerobic Gram-positive cocci 
or yeasts. Thus, the hypothesis still remains unaffected, that 
microbial CR is provided by obligate anaerobic flora. Yet, the faecal 
concentration of anaerobic species does not give information on the 
microbial CR, because the composition of the CR-flora is unknown, 
and because reduction of the production of inhibiting substances by 
the CR-flora might occur although the concentration of the CR-flora 
remains unchanged. 
When CR is impaired, competition between Gram-negative bacilli 
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may occur. Therefore, resistant challenge strains will not always 
reveal impairment of CR. 
Disturbance of the CR-flora may cause an increase in the concen-
tration of Gram-negative bacilli as well as of aerobic Gram-positive 
cocci and of yeasts. Of course, a prerequisite is the presence of 
strains resistant to the active concentration of the antimicrobial 
agent. It should be noted that the active concentration of anti-
microbial agents may be much higher in the bowel than in plasma. 
For example, the active faecal concentration of pefloxacin and 
norfloxacin is so high, that impairment of CR by these agents will 
not be followed by an increase in the faecal concentration of aerobic 
bacteria, because sufficiently resistant aerobic bacteria do not exist 
or are extremely rare. Yeasts are not susceptible to antibacterial 
agents. Therefore the faecal concentration of yeasts is a useful 
endogenous indicator of CR when the faecal concentration of 
antibacterial agents is high. 
Although impairment of microbial CR removes a major impediment 
to outgrowth of aerobic flora, impairment of microbial CR does not 
always result in an increase in the faecal concentration of all three 
groups of aerobic flora. It is not known whether this is explained by 
selectivity of the limiting action of some anaerobic species to special 
parts of the indigenous aerobic flora, or by interindividual 
differences in other inhibiting factors, for example secretion of 
antibodies in mucous fluid or absence of essential nutrients. 
Despite impairing CR, some antimicrobial agents do not cause bac-
terial overgrowth because their active antimicrobial concentration in 
the bowel is higher than the MIC of prevailing aerobic bacteria. 
These agents will be unmasked when resistant challenge strains are 
administered, or when the concentration of yeasts is studied. For the 
same reason, these agents increase the risk of superinfections with 
yeasts and they will cause problems when resistant bacteria are 
encountered. 
As the indigenous aerobic flora does not contribute to normal CR, it 
is theoretically possible to treat aerobic infections with antimicrobial 
agents that do not increase the risk of superinfections. 
Unfortunately, it has not been shown for any antimicrobial agent that 
it spares the microbial CR in all volunteers when administered in 
normal therapeutic dosage. Selective decolonization is possible 
however by administration of a low dosage of quinolones. 
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The common belief that the risk of superinfections may be reduced 
by avoiding broad-spectrum agents is not right. On the contrary, as 
long as we do not dispose of antimicrobial agents that spare the CR-
flora (in therapeutic dosage), agents with the broadest spectrum of 
activity against aerobic flora and high active concentration in the 
bowel will cause the lowest risk of bacterial superinfections. In this 
regard, quinolones are the preferable agents for prophylaxis and for 
therapy of infections by Gram-negative bacilli. In patients with 
strongly decreased resistance to infection however, oral amphotericin 
should be added for prevention of fungal infections. 
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SUMMARY 
According to the concept of colonization resistance (CR), (part of) 
the autochthonous anaerobic flora limits the concentration of 
potentially pathogenic micro-organisms in the digestive tract. If this 
concept is right, occurrence of superinfections caused by anti­
microbial agents (AMA) may be avoided by using AMA which do 
not disturb the anaerobic flora that provides CR (CR-flora). If the 
active concentration of those AMA in the digestive tract is higher 
than the minimal inhibitory concentration (MIC) of normally 
occurring potentially pathogenic micro-organisms, they can be used 
safely for selective decolonization. 
It was our aim to investigate which AMA are preferable (from this 
point of view) for prophylaxis and for therapy of infections. 
Chapter I explains why we started these investigations and briefly 
discusses results of the studies and considerations that lead to 
subsequent investigations. 
Chapter II reviews the literature on this subject. 
Chapters III and Г describe the influence on CR of amoxycillin, 
cefaclor, co-trimoxazole, doxycycline, erythromycin, phenethicillin 
and roxithromycin. These studies demonstrated impairment of CR 
following amoxycillin and phenethicillin. The faecal concentration of 
Gram-negative bacilli, enterococci or yeasts did not increase 
following the other antimicrobials, but low-level colonization with 
Gram-negative bacilli other than E. coli (secondary colonization) 
was seen more often, especially if the faecal concentration of E. coli 
had been reduced. The faecal concentration of secondary Gram-
negative bacilli did not increase above the concentration of E. coli in 
the pre-treatment period, however, as occurred following amoxy­
cillin and phenethicillin. It seemed as if a normal concentration of E. 
coli was necessary to prevent secondary colonization, and as if a 
decrease in the concentration of E. coli allowed low-level coloni­
zation with secondary Gram-negative bacilli ("substitution coloni­
zation"). Therefore, we felt that increase of low-level secondary 
colonization could not be regarded as a definite proof of disturbance 
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of the CR-flora. However, in chapter IX we found that elimination 
of E. coli with a low dose of Pefloxacin did not facilitate 
colonization of the bowel by a highly resistant challenge strain of 
Klebsiella pneumoniae (secondary colonization), whereas this strain 
colonized the bowel in high concentration when clindamycin was 
added. Therefore, we now think that increase of secondary coloni-
zation is suggestive evidence of disturbance of the CR-flora. 
Chapter V describes the influence of clindamycin, dicloxacillin, 
norfloxacin and minocycline on the faecal concentration of uro-
bilinogen. We had come to the conclusion that challenge with 
resistant strains is necessary to show impairment of CR following 
AMA that eliminate normally occurring Gram-negative bacilli, but 
we were afraid to do so and looked for an alternative method. 
It had been shown that strong impairment of CR could be shown by 
an increase in the faecal concentration of bèta-aspartylglycine, but 
this method was not sensitive enough to detect a small impairment of 
CR. In the mean time, it had been shown that urobilinogen is absent 
from faeces of germ-free animals and is absent or strongly reduced 
in faeces from animals treated with AMA that strongly reduce CR. 
AMA that were presumed not to impair CR, had no demonstrable 
effect on the faecal concentration of urobilinogen in animals. 
Therefore, we wanted to know whether it would be possible to use 
faecal urobilinogen as an indicator of the influence of AMA on the 
CR in man. Our study shows that the faecal concentration of uro-
bilinogen was significantly reduced following clindamycin and 
dicloxacillin. These agents strongly reduce CR. Norfloxacin and 
minocycline, which were presumed to spare CR, also reduced the 
faecal concentration of urobilinogen, but not significantly. We 
concluded that decrease of the faecal concentration of urobilinogen 
was caused by inhibition of the anaerobic flora of the bowel, and 
was possibly useful for investigating the influence of AMA on CR. 
Later studies showed, however, that minocycline impairs CR in part 
of the volunteers. The same applies to Pefloxacin, which is 
comparable to norfloxacin. Hence the difference between clinda-
mycin and dicloxacillin at one hand, and norfloxacin and mino-
cycline at the other hand was caused by a difference in the degree to 
which the CR was impaired. So, the urobilinogen-method is also not 
sufficiently sensitive to demonstrate minor impairment of CR. Since 
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decrease of the faecal concentration of urobilinogen by AMA is 
caused by inhibition of metabolic activity of the anaerobic flora that 
deconjugates bilirubin-glucuronides, it is possible that such AMA 
disrupt enterohepatic cycling of substances which are deconjugated 
by microbial glucuronidases after excretion with bile, for example 
oestrogens. Therefore, administration of antibiotics that inhibit 
anaerobic flora might cause failure of oral anticonception. 
Chapters VI, П, Ш, IX and XI describe the influence on CR 
of amoxycillin, cefotaxime, cephradine, clindamycin and Pefloxacin. 
The studies in chapters III and IV were performed according to the 
classical study design. However, this study design has major short­
comings. Therefore, the following adaptations were made. 
1. Analysis in volunteers individually, instead of analyzing the data 
for the group of volunteers. From the normal fluctuation of the 
concentration of aerobic flora it was calculated that a tenfold change 
in the faecal concentration of aerobic flora would be detected with 
statistical significance with ten pre-treatment and ten treatment 
samples. This way, each volunteer served as its own control and 
administration of "control" AMA was not necessary, shortening the 
experiments considerably. 
2. Administration of challenge strains, resistant to the active faecal 
concentration in the bowel. In this way, impairment of CR would 
not be missed by lack of resistant micro-organisms. 
3. Use of selective culture media, in order to improve the chance of 
detecting secondary Enterobacteriaceae in the presence of high con­
centrations of E. coli. 
Using this improved study design we investigated the influence of 
AMA on the faecal concentration of (1) the predominant Gram-
negative bacilli, (2) of secondary Gram-negative bacilli occurring 
spontaneously or (3) administered intentionally and of (4) aerobic 
Gram-positive cocci and (5) yeasts. 
When CR is impaired, all five indicators of impairment of CR may 
become positive. However, it appears that impairment of CR may 
allow competition among different species of Gram-negative bacilli. 
Therefore indicators 2 and 3 may remain negative if the indigenous 
E. coli is not susceptible to the AMA under investigation, and 
rapidly occupies the "space" that has come available due to 
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impairment of CR. 
From this it follows that resistant challenge strains are not always 
the most sensitive indicator for impairment of CR, but only if the 
challenge strain has no competition from other Gram-negative 
bacilli. 
Indicators 1, 4 and 5 may all become positive when CR is impaired. 
However, it was shown that this is not necessarily so. In one of five 
volunteers the concentration of yeasts did not rise following clinda-
mycin (despite increase of the concentration of enterococci and 
yeasts), and in four of five volunteers in which the CR was impaired 
following cefotaxime (as shown by increase of enterococci and 
yeasts), the concentration of resistant Gram-negative bacilli did not 
increase above the pre-treatment level of Gram-negative bacilli. This 
points to the possibility of a certain selectivity of different species of 
the CR-flora as regards their inhibitory action on groups or species 
of aerobic flora of the bowel. 
Contrary to our expectations, all agents investigated appeared to 
impair CR, although not to the same degree and not in all volun-
teers. Candida appeared to be a very reliable indicator of impair-
ment of CR. Candida is carried by most volunteers and is resistant 
to antibacterial agents. 
Following cefotaxime and Pefloxacin, demonstration of impairment 
of CR against Gram-negative bacilli is possible only by ad-
ministration of resistant challenge strains. Although we did not 
succeed in obtaining Gram-negative bacilli sufficiently resistant to 
the concentration of Pefloxacin in the bowel during treatment, we 
could demonstrate impairment of CR against Gram-negative bacilli 
by administration of the challenge strain after the treatment-period in 
two of the three volunteers in whom impairment of CR was in-
dicated by a significant increase in the concentration of yeasts. It 
should be noted, that this method is possible only if impairment of 
CR lasts longer than the active concentration in the bowel. 
Chapter IX investigates the contribution of indigenous Gram-
negative bacilli, especially E. coli , on the CR. We had found the 
active faecal concentration of quinolones to be about equal to the 
diffusible faecal concentration. The MIC for Pefloxacin of most 
Gram-negative bacilli is below 4 mg/1. We calculated that this 
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concentration would be achieved in faeces with 20 mg Pefloxacin 
orally once daily ; 2.5% of the normal daily dosage used for 
therapy. This dosage eliminated the Gram-negative bacilli from 
faeces, without causing a change in the faecal concentration of 
enterococci or yeasts, and without causing facilitation of colonization 
of the bowel by a highly resistant challenge strain of Klebsiella 
pneumoniae. This shows that indigenous Gram-negative bacilli do 
not contribute to CR. Therefore, selective decolonization of the 
bowel from Gram-negative bacilli, id est decolonization without 
disturbing the CR-flora, is possible. 
Chapter X describes the influence of parenteral administration of 
Pefloxacin on the faecal concentration of indigenous Gram-negative 
bacilli and of a highly resistant challenge strain. Indigenous Gram-
negative bacilli rapidly disappeared from faeces and the challenge 
strain did not succeed in colonizing the bowel. Although this was the 
most resistant strain of Gram-negative bacilli we could obtain, the 
MIC of this strain (56 mg/1) was lower than the diffusible faecal 
concentration of Pefloxacin (160 mg/1). Therefore this study did not 
prove that decolonization with Pefloxacin 800 mg daily is selective. 
Moreover, the study design was not suitable to use the faecal con-
centration of yeasts as an indicator of the influence on CR in 
individual volunteers, because the study period was too short. 
Nevertheless, it was shown that parenteral administration of 
Pefloxacin is highly effective in eliminating indigenous Gram-
negative bacilli from faeces, and for prevention of new colonization 
by very resistant exogenous bacteria. This enables parenteral 
administration of Pefloxacin for prophylactic decolonization in 
patients who can not be treated orally, for example because of 
vomiting. 
Chapter XII discusses the findings of our studies and the impli-
cations for antimicrobial therapy. It is concluded that these studies 
give further evidence that the CR-flora consists exclusively of 
anaerobic bacteria. Therefore, it is theoretically possible to treat 
infections by aerobic micro-organisms without a risk of super-
infections. However, most or all AMA presently available impair 
this flora in at least part of the population. Nevertheless, effective 
decolonization is possible at the present time already, by designing 
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regimens that achieve active concentrations of AMA higher than the 
MIC of known aerobic micro-organisms. AMA achieving active 
concentrations in the bowel higher than the MIC of prevailing 
aerobic bacteria cause a lower risk of bacterial superinfections, than 
AMA for which the concentration in the bowel is below the MIC of 
prevailing aerobic bacteria. In this regard, clindamycin and 
penicillins are the most dangerous AMA and quinolones are the 
safest available agents. However, the search for agents that do not 
impair CR should be continued. 
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SAMENVATTING 
Volgens het concept van de kolonisatieweerstand (KW) beperkt (een 
deel van de) autochtone anaërobe flora de concentratie van poten-
tieel pathogène micro-organismen in het spijsverteringskanaal. Als 
dit concept juist is, kunnen superinfecties ten gevolge van anti-
microbi ële middelen (AMM) worden vermeden door AMM te ge-
bruiken die de KW-flora niet aantasten. Als bovendien de concen-
tratie van deze middelen in het spijsverteringskanaal hoger is dan de 
minimale remmings-concentratie (MRC) van normaal voorkomende 
potentieel pathogène micro-organismen, dan is hiermee langdurige 
preventie van infecties mogelijk (selectieve dekolonisatie). 
Het was onze doelstelling te onderzoeken welke AMM vanuit deze 
optiek de voorkeur verdienen voor preventie en therapie van 
infecties. 
In Hoofdstuk I wordt beschreven waarom we met dit onderzoek 
begonnen. Er wordt kort ingegaan op de resultaten van de onder-
zoekingen en met name op de overwegingen die leidden tot vervolg-
onderzoek. 
Hoofdstuk Π geeft een overzicht van de literatuur over dit 
onderwerp. 
In de Hoofdstukken III en IV wordt het onderzoek beschreven naar 
de invloed op de KW van amoxicilline, cefaclor, Cotrimoxazol, 
doxycycline, erythromycine, phenethicilline en roxithromycine. 
Deze studies tonen aan dat de KW wordt verstoord door amoxi­
cilline en phenethicilline. De faecesconcentratie van Gram-negatieve 
bacillen, enterococcen of gisten nam niet toe na de andere middelen. 
We vonden echter vaker kolonisatie met lage concentraties van 
andere Gram-negatieve bacillen dan Escherichia coli (secundaire 
kolonisatie), vooral als de faecesconcentratie van E. coli was 
verlaagd. De concentratie van secundaire Gram-negatieve bacillen 
was dan echter niet hoger dan de concentratie van E. coli vóór 
behandeling. Na amoxicilline en phenethicilline was dat wel het 
geval. Het leek alsof een normale concentratie van E. coli nodig is 
om secundaire kolonisatie te voorkomen, en dat verlaging van de 
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concentratie van E. coli kolonisatie mogelijk maakt met andere 
Gram-negatieve bacillen in lage concentratie ("substitutie-koloni-
satie"). We meenden daarom dat toename van secundaire kolonisatie 
in lage concentratie niet kon worden beschouwd als definitief bewijs 
voor verstoring van de anaërobe flora die de KW veroorzaakt. 
In hoofdstuk IX toonden we echter aan dat eliminatie van E. coli 
met een lage dosis Pefloxacin kolonisatie van de darm door een 
resistente challenge stam van Klebsiella pneumoniae niet verge-
makkelijkte, terwijl deze stam de darm wel in hoge concentratie 
koloniseerde als clindamycine werd toegevoegd. Daarom zijn we nu 
van mening dat toename van secundaire kolonisatie een sterke 
aanwijzing vormt voor verstoring van de anaerobe flora die de KW 
veroorzaakt. 
In Hoofdstuk V beschrijven we onderzoek naar de invloed van clin-
damycine, dicloxacilline, norfloxacin en minocyline op de faeces-
concentratie van urobilinogeen. We waren tot de conclusie gekomen 
dat toedienen van resistente challenge-stam men nodig is om KW-
verstoring aan te tonen door antibiotica waarvoor normaal voor-
komende Gram-negatieve bacillen ongevoelig zijn. We schrokken 
daar echter voor terug en zochten naar een alternatief. 
Er was aangetoond dat sterke verstoring van de KW kon worden 
aangetoond door toename van de faecesconcentratie van bèta-
aspartylglycine, maar deze methode was niet gevoelig genoeg voor 
het aantonen van matige verstoring van de KW. Inmiddels was ook 
aangetoond dat urobilinogeen afwezig is in faeces van kiemvrije 
dieren en afwezig of sterk verlaagd is in faeces van dieren die waren 
behandeld met AMM die de KW sterk reduceren. Antibiotica waar-
van werd verondersteld dat ze de KW niet verstoren hadden geen 
aantoonbare invloed op de faecesconcentratie van urobilinogeen. We 
wilden daarom weten of het mogelijk was de faecesconcentratie van 
urobilinogeen te gebruiken als een indicator voor de invloed van 
antimicrobiële middelen op de KW van mensen. Het bleek dat de 
faecesconcentratie van urobilinogeen sterk werd verlaagd door toe-
diening van clindamycine en dicloxacilline. Deze middelen tasten 
ook de KW sterk aan. Na norfloxacin en na minocycline, waarvan 
werd aangenomen dat ze de KW niet verstoren, daalde de concentra-
tie van urobilinogeen wel, maar niet statistisch significant. 
We concludeerden dat afname van de faecesconcentratie van 
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urobilinogeen werd veroorzaakt door remming van de anaërobe flora 
van de darm, en mogelijk bruikbaar was voor onderzoek naar de 
invloed van AMM op de KW. 
Later onderzoek toonde echter aan dat minocycline de KW verstoort 
in een deel van de vrijwilligers. Hetzelfde geld voor Pefloxacin, dat 
vergelijkbaar is met norfloxacin. Het verschil in de resultaten met 
clindamycine en dicloxacilline enerzijds, en minocycline en nor-
floxacin anderzijds, werd dus veroorzaakt door een kwantitatief 
verschil in de aantasting van de KW-flora. De urobilinogeen-
methode is dus niet gevoelig genoeg om een geringe aantasting van 
de KW aan te tonen. 
Afname van de faecesconcentratie van urobilinogeen na toediening 
van AMM wordt veroorzaakt door remming van de metabole activi-
teit van de anaerobe flora die bilirubine-glucuroniden deconjugeert. 
Dit onderzoek wijst op de mogelijkheid dat remming van deze 
anaerobe flora de entero-hepatische kringloop kan onderbreken van 
stoffen die na excretie in de gal worden gedeconjugeerd door 
microbieel glucuronidase, bijvoorbeeld oestrogenen. Antibiotica die 
anaerobe flora aantasten kunnen dus mogelijk leiden tot falen van 
orale anticonceptie. 
In de Hoofdstukken VI, VII, Ш, IX en XI wordt de invloed op 
de KW onderzocht van amoxicilline, cefotaxim, cephradine, clin­
damycine en pefloxacin. 
De studies in de hoofdstukken III en IV waren uitgevoerd volgens de 
klassieke studie-opzet. Deze heeft echter een aantal ernstige 
tekortkomingen. We besloten daarom tot de volgende aanpassingen 
van de onderzoeksmethode. 
1. Analyse van de resultaten in iedere vrijwilliger apart, in plaats 
van analyse van de resultaten vrijwilligers als groep. Uit de 
fluctuatie van de concentratie van Gram-negatieve bacillen in faeces 
van vrijwilligers berekenden wij dat een controleperiode en een 
behandelingsperiode van ieder tien dagen voldoende zijn om een 
tienvoudige verandering in de faecesconcentratie met statistische 
significantie te kunnen aantonen. 
2. Toediening van challenge-stammen. resistent tegen de actieve 
faecesconcentratie in de darm. Op deze wijze zouden we niet langer 
afhankelijk zijn van toevallige aanwezigheid van resistente micro-
organismen. 
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3. Gebruik van selectieve voedingsbodems, teneinde de kans te 
verhogen op het aantonen van secundaire Gram-negatieve bacillen in 
aanwezigheid van een hoge concentratie van E. coli. 
De nieuwe onderzoeksmethode werd in de genoemde hoofdstukken 
toegepast en besproken. We onderzochten de invloed van AMM op 
de faecesconcentratie van (1) Gram-negatieve bacillen als groep, van 
(2) secundaire Gram-negatieve bacillen die spontaan aanwezig 
waren, van (3) resistente Gram-negatieve bacillen die als challenge 
waren toegediend, van (4) Gram-positieve coceen en van (5) gisten. 
Bij verstoring van de KW kunnen deze parameters voor de KW alle 
vijf positief worden. Bij verstoring van de KW bleek echter compe-
titie van Gram-negatieve bacillen onderling voor te komen. De para-
meters 2 en 3 kunnen dus negatief blijven als de eigen E. coli 
ongevoelig is voor het toegepaste AMM en zelf snel genoeg de 
"ruimte" bezet, die is vrijgekomen door verstoring van de KW. 
Hieruit blijkt dat resistente challenge-stammen niet altijd de meest 
gevoelige indicator zijn voor verstoring van de KW. Dit is wel het 
geval als de challenge-stam geen competitie ondervindt van andere 
Gram-negatieve bacillen. 
Bij aantasting van de KW en aanwezigheid van resistente stammen 
worden de parameters 1, 4 en 5 meestal alle drie positief. Dit blijkt 
echter niet altijd zo te zijn. Bij één van de vijf vrijwilligers steeg de 
concentratie van gisten niet na clindamycine (in tegenstelling tot de 
concentratie van Gram-negatieve bacillen en van enterococcen), en 
bij vier van de vijf vrijwilligers met verstoorde KW na cefotaxim 
(blijkens stijging van de concentratie van enterococcen en gisten) 
werd de concentratie van resistente Gram-negatieve bacillen niet 
hoger dan de concentratie van Gram-negatieve bacillen in de periode 
vóór behandeling. Dit wijst op de mogelijkheid van een zekere 
selectiviteit van verschillende soorten van de anaërobe KW-flora 
voor wat betreft hun remmende werking op groepen of soorten van 
de aërobe flora in de darm. 
In tegenstelling tot onze verwachtingen bleek dat alle onderzochte 
middelen de KW verstoorden, hoewel niet in dezelfde mate en niet 
bij alle vrijwilligers. Uitgroei van Candida bleek een zeer betrouw-
bare indicator voor verstoring van de KW te zijn. Candida kwam bij 
de meeste vrijwilligers voor en is resistent tegen antibacteriële 
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middelen. 
Aantonen van verstoring van de KW tegen Gram-negatieve bacillen 
door cefotaxim of Pefloxacin is alleen mogelijk door resistente 
challenge-stammen toe te dienen. Hoewel we er niet in slaagden 
Gram-negatieve bacillen te verkrijgen die voldoende resistent zijn 
tegen de concentratie van Pefloxacin in de darm tijdens behandeling 
met Pefloxacin, konden we verstoring van de KW tegen Gram nega-
tieve bacillen aantonen door toediening van de challenge stam na de 
pefloxacin-periode, namelijk bij twee van de drie vrijwilligers 
waarin verstoring van de KW tijdens behandeling bleek uit een 
significante stijging van gisten. De methode van challenge na 
behandeling is echter alleen mogelijk als verstoring van de KW 
langer duurt dan dat de actieve concentratie in de darm boven de 
MRC van de challenge stam ligt. 
In Hoofdstuk IX onderzoeken we ook de bijdrage van Gram- nega-
tieve bacillen in de darm, met name E. coli, aan de KW. We hadden 
aanwijzingen gevonden dat de actieve faeces-concentratie van 
quinolonen ongeveer gelijk is aan de diffundeerbare faeces-
concentratie. De meeste Gram-negatieve bacillen hebben een MRC 
voor pefloxacin beneden 4 mg/l. We berekenden dat deze concen-
tratie in faeces zou worden bereikt door orale toediening van 20 mg 
pefloxacin éénmaal daags. Deze dosis verwijderde Gram-negatieve 
bacillen uit faeces zonder een verandering te veroorzaken in de 
faeces-concentratie van enterococcen of gisten, en zonder kolonisatie 
van de darm door een resistente challenge-stam van Klebsiella pneu-
moniae te bevorderen. Dit toont aan dat Gram-negatieve bacillen in 
de darm geen bijdrage leveren aan de KW. Selectieve dekolonisatie 
van de darm van Gram-negatieve bacillen (dwz. dekolonisatie zonder 
de KW-flora aan te tasten) is dus mogelijk. 
In Hoofdstuk X beschrijven we de invloed van parenterale toedie-
ning van pefloxacin op de faecesconcentratie van normaal aanwezige 
Gram-negatieve bacillen in de darm en van een zeer resistente 
challenge-stam. Gram-negatieve bacillen verdwenen snel uit de 
faeces, en de challenge stam slaagde er niet in de darm te koloni-
seren. Hoewel dit de meest resistente stam van Gram-negatieve 
bacillen was die we ooit in handen hebben kunnen krijgen, was toch 
de MRC van deze stam (56 mg/l) lager dan de diffundeerbare 
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faeces-concentratie van Pefloxacin (160 mg/1). Met dit onderzoek 
kon dus niet worden bewezen dat dekolonisatie met 800 mg Pefloxa-
cin per dag selectief is. Het onderzoek was daar bovendien niet voor 
geschikt omdat het te kort werd voortgezet om individuele analyse 
van de gist-concentratie als parameter te kunnen gebruiken. Wel 
werd hiermee aangetoond dat parenterale toediening van Pefloxacin 
zeer effectief is voor eliminatie van Gram-negatieve bacillen uit de 
faeces en voor preventie van nieuwe kolonisatie met zeer ongevoeli-
ge exogene bacteriën. Dit maakt het mogelijk Pefloxacin parenteraal 
toe te dienen voor profylactische dekolonisatie van patiënten die niet 
oraal kunnen worden behandeld, bijvoorbeeld in verband met 
braken. 
In Hoofdstuk XII worden de resultaten van onze onderzoekingen en 
de implicaties daarvan voor het antibiotica-beleid besproken. 
Er wordt geconcludeerd dat deze onderzoekingen nieuwe argumenten 
leveren voor de veronderstelling dat de KW-flora uitsluitend bestaat 
uit anaerobe bacteriën. Het is daarom theoretisch mogelijk om 
infecties met aërobe micro-organismen te behandelen zonder risico 
op superinfecties. De meeste, zo niet alle, thans beschikbare anti-
biotica verstoren echter de KW-flora in tenminste een deel van de 
populatie. Effectieve profylaxe van infecties is niettemin reeds thans 
mogelijk, door regimes te ontwerpen die actieve faeces-concentra-
ties bereiken hoger dan de MRC van normaal voorkomende aërobe 
bacteriën, vooral Gram-negatieve bacillen. Met deze middelen heeft 
men een lagere kans op het veroorzaken van bacteriële super-
infecties dan met AMM die de KW verstoren en waarvan de faeces-
concentratie lager is dan de MRC van veel aërobe bacteriën. In dit 
opzicht zijn clindamycine en pénicillines de onveiligste, en 
quinolonen de veiligste thans beschikbare AMM. Het zoeken naar 
middelen die de KW niet aantasten dient echter te worden 
voortgezet. 
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